
<html lang="en"     class="pb-page"  data-request-id="988e9417-38d4-45e8-ae9e-84e5f415e4cf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00787;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues" /></meta><meta name="dc.Creator" content="Esben M.  Bech" /></meta><meta name="dc.Creator" content="Manuel C.  Martos-Maldonado" /></meta><meta name="dc.Creator" content="Pernille  Wismann" /></meta><meta name="dc.Creator" content="Kasper K.  Sørensen" /></meta><meta name="dc.Creator" content="Søren Blok  van Witteloostuijn" /></meta><meta name="dc.Creator" content="Mikkel B.  Thygesen" /></meta><meta name="dc.Creator" content="Niels  Vrang" /></meta><meta name="dc.Creator" content="Jacob  Jelsing" /></meta><meta name="dc.Creator" content="Søren L.  Pedersen" /></meta><meta name="dc.Creator" content="Knud J.  Jensen" /></meta><meta name="dc.Description" content="Noncovalent binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and renal clearance. Herein, we investigated the effect of mono- or divalent small-molecule a..." /></meta><meta name="Description" content="Noncovalent binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and renal clearance. Herein, we investigated the effect of mono- or divalent small-molecule a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 16, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00787" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00787" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00787" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00787" /></link>
        
    
    

<title>Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00787" /></meta><meta property="og:title" content="Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0009.jpeg" /></meta><meta property="og:description" content="Noncovalent binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and renal clearance. Herein, we investigated the effect of mono- or divalent small-molecule albumin binders for half-life extension of peptides. For proof-of-principle, the clinically relevant glucagon-like peptide 1 (GLP-1) was functionalized with diflunisal, indomethacin, or both. In vitro, all GLP-1 analogues had subnanomolar GLP-1 receptor potency. Surface plasmon resonance revealed that both small molecules were able to confer albumin affinity to GLP-1 and indicated that affinity is increased for divalent analogues. In lean mice, the divalent GLP-1 analogues were superior to monovalent analogues with respect to control of glucose homeostasis and suppression of food intake. Importantly, divalent GLP-1 analogues showed efficacy comparable to liraglutide, an antidiabetic GLP-1 analogue that carries a long-chain fatty acid. Finally, pharmacokinetic investigations of a divalent GLP-1 analogue demonstrated a promising gain in circulatory half-life and absorption time compared to its monovalent equivalent." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00787"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00787">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00787&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00787&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00787&amp;href=/doi/10.1021/acs.jmedchem.7b00787" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7434-7446</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00726" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00794" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Esben+M.++Bech">Esben M. Bech</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuel+C.++Martos-Maldonado">Manuel C. Martos-Maldonado</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pernille++Wismann">Pernille Wismann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kasper+K.++S%C3%B8rensen">Kasper K. Sørensen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%B8ren+Blok++van+Witteloostuijn">Søren Blok van Witteloostuijn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mikkel+B.++Thygesen">Mikkel B. Thygesen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0158-2802" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niels++Vrang">Niels Vrang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob++Jelsing">Jacob Jelsing</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%B8ren+L.++Pedersen">Søren L. Pedersen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Knud+J.++Jensen">Knud J. Jensen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3525-5452" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, University of Copenhagen, Frederiksberg 1870, Denmark</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Gubra Aps, Hørsholm 2970, Denmark</span></div><div class="corresp-info"><strong>*</strong>For K.J.J.: phone, +45 21516721); E-mail, <a href="/cdn-cgi/l/email-protection#f2999898b2919a979fdc9987dc9699"><span class="__cf_email__" data-cfemail="761d1c1c36151e131b581d0358121d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For S.L.P. phone, +45 31522650); E-mail: <a href="/cdn-cgi/l/email-protection#81f2edf1c1e6f4e3f3e0afe5ea"><span class="__cf_email__" data-cfemail="fd8e918dbd9a889f8f9cd39996">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00787&amp;href=/doi/10.1021%2Facs.jmedchem.7b00787" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7434–7446</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 3, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 May 2017</li><li><span class="item_label"><b>Published</b> online</span>16 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00787" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00787</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7434%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEsben%2BM.%2BBech%252C%2BManuel%2BC.%2BMartos-Maldonado%252C%2BPernille%2BWismann%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D17%26contentID%3Dacs.jmedchem.7b00787%26title%3DPeptide%2BHalf-Life%2BExtension%253A%2BDivalent%252C%2BSmall-Molecule%2BAlbumin%2BInteractions%2BDirect%2Bthe%2BSystemic%2BProperties%2Bof%2BGlucagon-Like%2BPeptide%2B1%2B%2528GLP-1%2529%2BAnalogues%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7446%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00787"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2163</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00787" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Esben&quot;,&quot;last_name&quot;:&quot;M. Bech&quot;},{&quot;first_name&quot;:&quot;Manuel&quot;,&quot;last_name&quot;:&quot;C. Martos-Maldonado&quot;},{&quot;first_name&quot;:&quot;Pernille&quot;,&quot;last_name&quot;:&quot;Wismann&quot;},{&quot;first_name&quot;:&quot;Kasper&quot;,&quot;last_name&quot;:&quot;K. Sørensen&quot;},{&quot;first_name&quot;:&quot;Søren&quot;,&quot;last_name&quot;:&quot;Blok van Witteloostuijn&quot;},{&quot;first_name&quot;:&quot;Mikkel&quot;,&quot;last_name&quot;:&quot;B. Thygesen&quot;},{&quot;first_name&quot;:&quot;Niels&quot;,&quot;last_name&quot;:&quot;Vrang&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;Jelsing&quot;},{&quot;first_name&quot;:&quot;Søren&quot;,&quot;last_name&quot;:&quot;L. Pedersen&quot;},{&quot;first_name&quot;:&quot;Knud&quot;,&quot;last_name&quot;:&quot;J. Jensen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7434-7446&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00787&quot;},&quot;abstract&quot;:&quot;Noncovalent binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and renal clearance. Herein, we investigated the effect of mono- or divalent small-molecule albumin binders for half-life extension of peptides. For proof-of-principle, the clinically relevant glucagon-like peptide 1 (GLP-1) was functionalized with diflunisal, indomethacin, or both. In vitro, all GLP-1 analogues had subnanomolar GLP-1 receptor potency. Surface plasmon resonance revealed that both small molecules were able to confer albumin affinity to GLP-1 and indicated that affinity is increased for divalent analogues. In lean mice, the divalent GLP-1 analogues were superior to monovalent analogues with respect to control of glucose homeostasis and suppression of food intake. Importantly, divalent GLP-1 analogues showed efficacy comparable to liraglutide, an antidiabetic GLP-1 analogue that carries a long-chain fatty acid. Finally, pharmacokinetic investigations of a divalent GLP-1 analogue demonstrated a&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00787&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00787" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00787&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00787" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00787&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00787" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00787&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00787&amp;href=/doi/10.1021/acs.jmedchem.7b00787" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00787" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00787" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00787%26sid%3Dliteratum%253Aachs%26pmid%3D28771355%26genre%3Darticle%26aulast%3DBech%26date%3D2017%26atitle%3DPeptide%2BHalf-Life%2BExtension%253A%2BDivalent%252C%2BSmall-Molecule%2BAlbumin%2BInteractions%2BDirect%2Bthe%2BSystemic%2BProperties%2Bof%2BGlucagon-Like%2BPeptide%2B1%2B%2528GLP-1%2529%2BAnalogues%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D17%26spage%3D7434%26epage%3D7446%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290851" title="Half-life">Half-life</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/jmcmar.2017.60.issue-17/20170914/jmcmar.2017.60.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Noncovalent binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and renal clearance. Herein, we investigated the effect of mono- or divalent small-molecule albumin binders for half-life extension of peptides. For proof-of-principle, the clinically relevant glucagon-like peptide 1 (GLP-1) was functionalized with diflunisal, indomethacin, or both. In vitro, all GLP-1 analogues had subnanomolar GLP-1 receptor potency. Surface plasmon resonance revealed that both small molecules were able to confer albumin affinity to GLP-1 and indicated that affinity is increased for divalent analogues. In lean mice, the divalent GLP-1 analogues were superior to monovalent analogues with respect to control of glucose homeostasis and suppression of food intake. Importantly, divalent GLP-1 analogues showed efficacy comparable to liraglutide, an antidiabetic GLP-1 analogue that carries a long-chain fatty acid. Finally, pharmacokinetic investigations of a divalent GLP-1 analogue demonstrated a promising gain in circulatory half-life and absorption time compared to its monovalent equivalent.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human serum albumin (HSA) is the most abundant protein in sera, where it primarily functions as a transporter for a myriad of molecules.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Among the bound molecules are fatty acids, which are known to have high albumin affinities. Peptide lipidation therefore promotes albumin interactions and can be exploited to improve the pharmacokinetic properties of peptide pharmaceuticals. This strategy has been successfully applied as exemplified by liraglutide, a GLP-1 analogue, and insulin detemir, a long-acting human insulin analogue, which are blockbuster drugs within the field of diabetes. For liraglutide, lipidation extends the circulatory half-life of GLP-1 from about 1 h to approximately 13 h in humans upon subcutaneous administration.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> However, lipidation is not generally applicable for peptide pharmaceuticals, as it can lead to a drastic reduction in solubility. Consequently, alternative strategies for mediating albumin interactions with enhanced HSA affinity, solubility, or additional medicinal properties continues to be attractive.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Herein, we addressed an alternative methodology by conjugating of small-molecule albumin binders to peptides.</div><div class="NLM_p">Anionic aromatic small molecules generally have high affinities for albumin and can be used as alternatives to lipidation. Small-molecule drugs primarily bind two sites in albumin, namely drug site I and II. The sites are structurally dissimilar, as drug site I comprises a central area from which three subchambers protrude, while drug site II consists of a single narrow crevise.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Of the two, drug site I is by far larger and is even capable of binding two different small molecules simultaneously.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> For a selection of small-molecule drugs, high affinities for drug site I or II have resulted in low in vivo efficacy compared to in vitro potency, and this has prompted the search for analogues with reduced HSA interaction.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6-9)</a> Compared to small molecule drugs, peptides generally have higher receptor potencies, and peptides are therefore less vulnerable to efficacy lowering effects stemming from HSA bindings. Thus, conjugating small-molecule drugs with high HSA affinities to prolong peptide half-life is an interesting alternative to lipidation.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10-14)</a> It has previously been demonstrated that GLP-1 conjugated to the small-molecule, monovalent albumin binder dicoumarol has a prolonged in vivo half-life in rats, as compared to liraglutide.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Multivalent small-molecule albumin ligands might further enhance peptide pharmacokinetics. To our best knowledge, all examples of peptide half-life extensions using small-molecule drugs have only utilized a single albumin ligand, i.e., monovalent albumin binding. Multivalent ligands have multiple affinities (avidity) for their targets, and the avidity of a multivalent ligand can be much higher than the sum of affinities for its inherent components.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Consequently, we hypothesized that multivalent small molecule albumin binders would be an effective method to further extend the circulatory half-lives of peptide pharmaceuticals.</div><div class="NLM_p">To investigate this hypothesis, we performed a series of proof-of-principle studies on peptides conjugated to one or two small-molecule albumin ligands (i.e., mono- and divalent). As a model peptide, we selected an analogue of native GLP-1 (<b>1</b>), [K34R]-GLP-1(7-37)-OH (<b>2</b>). In itself, GLP-1(7-37)-OH is a well characterized peptide hormone with short systemic half-life (1–2 min) and high clinical relevance,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and the K34R substitution allows for selective modifications at Lys26. Furthermore, peptide <b>2</b> is the backbone structure of liraglutide which is commonly used as a positive control and benchmark molecule in proof-of-principle studies in research on diabetes type 2. From <b>2</b>, six peptides (<b>3</b>–<b>8</b>) with albumin mono- or divalency were synthesized.</div><div class="NLM_p">For proof-of-principle, we selected the small-molecule drugs diflunisal and indomethacin as albumin ligands because of their well-characterized, high-affinity albumin binding properties.<a onclick="showRef(event, 'ref5 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref5 ref17 ref18 ref19">(5, 17-19)</a> Diflunisal binds HSA with a <i>K</i><sub>D</sub> of 3 μM through both drug site I and II as well as a less well-defined site between albumin subdomain IIA and IIB.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Indomethacin binds HSA with a <i>K</i><sub>D</sub> of 0.7 μM through drug site I and a lesser site in albumin subdomain IB.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A noteworthy feature of indomethacin’s binding to drug site I is its position in the cavity. While most drugs bind site I in the central part and/or near the entrance of the cavity, indomethacin occupies the front and lower parts.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This unusual position allows for the simultaneous binding of indomethacin and another small molecule to drug site I, as previously demonstrated with the two centrally binding compounds azapropazone and phenylbutazone.<a onclick="showRef(event, 'ref5 ref21'); return false;" href="javascript:void(0);" class="ref ref5 ref21">(5, 21)</a> As diflunisal binds drug site I exclusively at the entrance of the cavity,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> we hypothesize that cobinding can be achieved with diflunisal and indomethacin. If this could be accomplished, peptides conjugated to both diflunisal and indomethacin should be able to bind four different sites on HSA and bind drug site I in a divalent, high-avidity fashion.</div><div class="NLM_p">Diflunisal and indomethacin are both nonsteroidal anti-inflammatory drugs (NSAIDs) which inhibit cyclooxygenase (COX) 1 or 2.<a onclick="showRef(event, 'ref6 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref6 ref22 ref23">(6, 22, 23)</a> We hypothesize that NSAID’s conjugated to peptide hormones like GLP-1 will not generate NSAID-derived effects. COX is exclusively intracellularly located, while the GLP-1 receptors are located at the cell surface. In an elegant study from 2012, Finan and colleagues demonstrated how the conjugation of estrogen to a GLP-1 analogue abolish adverse estrogenic properties in tissues with low/no expression of the GLP-1 receptor.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Also, diflunisal and indomethacin are normally administered in hundreds of mg/day and with 80–100% bioavailability their pharmacologically relevant doses far exceed that of GLP-1 agonists (recommended dose of liraglutide is 0.6–1.8 mg/day).<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a></div><div class="NLM_p last">In the present study, we investigated divalent small-molecule albumin binders as an approach to improve peptide pharmacokinetics. For this purpose, we performed proof-of-principle studies using GLP-1 analogues conjugated to either diflunisal, indomethacin, or both.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of GLP-1 Analogues</h3><div class="NLM_p">To investigate multivalent small-molecule albumin binders as a methodology to enhance peptide pharmacokinetics, we conjugated diflunisal, indomethacin, or both to a GLP-1 model peptide, <b>2</b>. Both indomethacin and diflunisal contains a single carboxylic acid. This acid is highly important for diflunisal’s binding to HSA.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In contrast, the hydroxyl group of diflunisal can be removed with little impact on HSA affinity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Hence, diflunisal was modified to enable GLP-1 conjugation through its hydroxyl group (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The native carboxylic acid of diflunisal was protected as the <i>tert</i>-butyl ester (<b>9</b>), and subsequently the hydroxyl group was alkylated with benzyl bromoacetate by a Williamson ether synthesis (<b>10</b>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Finally, the introduced benzyl ester was deprotected by palladium-catalyzed hydrogenation affording a diflunisal analogue, <b>11</b>, ready for solid-phase peptide synthesis (SPPS). A similar synthesis route, via <b>12</b>–<b>14</b>, was used to make the defluorinated analogue of diflunisal, <b>15</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Scheme 1</a>). Following SPPS, the <i>tert</i>-butyl group protecting the carboxyl groups of <b>11</b> and <b>15</b> was removed by acid-catalyzed hydrolysis.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>11</b>: Preparation of Diflunisal for Solid-Phase Peptide Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Like diflunisal, the carboxylic acid of indomethacin is involved in its interaction with HSA.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, a certain degree of flexibility is allowed for this carboxylic acid, as it can bind either HSA amino acid Arg218 or flip and interact with K199.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Hence, we hypothesized that albumin affinity would be retained when linking indomethacin to the GLP-1 analogues through the indomethacin carboxyl as long as another carboxyl group is sterically close. For this reason, indomethacin was incorporated into the GLP-1 analogues through the <i>N</i><sup>α</sup>-amine of a glutamic acid with a free α-carboxylic acid, a γGlu.</div><div class="NLM_p">Five peptides, <b>3</b>–<b>7</b>, with either albumin mono- or divalency were synthesized by selective elongation of <b>2</b> at the ε-amine of Lys26 using Fmoc-based SPPS (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Selectivity was ensured by protection of the N-terminal α-amino group with the base-stable <i>tert</i>-butyloxycarbonyl (Boc) group. GLP-1 analogues <b>3</b>, <b>4</b>, and <b>6</b> were synthesized to enable comparison of mono- and divalent albumin valency, while peptides <b>5</b> and <b>7</b> contained an 8-amino-3,6-dioxaoctanoic acid (O2Oc) spacer allowing the investigation of the importance of a spacer. A sixth monovalent peptide (<b>8</b>) resembling <b>3</b> was synthesized in the same way (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Figure 13</a>).</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Strategy for Creating GLP-1 Analogues Containing Small-Molecule Albumin Binders<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(A) Fully protected Boc-[K34R]-GLP-1(7-37)-OH was synthesized by Fmoc-SPPS. Next, Lys26 ε-amine was selectively deprotected and subsequently modified for HSA mono- or divalency. Finally, TFA was used to deprotect- and release GLP-1 analogues <b>3</b>–<b>7</b>. <b>R</b> denotes either of the ligands shown in (B).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> GLP-1 Receptor Potency</h3><div class="NLM_p">The novel GLP-1 analogues were applied to a GLP-1 receptor (GLP-1R) cAMP activity assay to study whether attachment of the small molecules had changed the GLP-1 receptor potency. All analogues were found to be full GLP-1 agonists with subnanomolar functional activities (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Figure 15</a>). In general, the monovalent analogues (<b>3</b>–<b>5</b>, and <b>8</b>) demonstrated activity toward the GLP-1 receptor in the low nanomolar area, showing only slight reductions in potencies as a consequence of conjugation. Meanwhile, the divalent GLP-1 analogues (<b>6</b> and <b>7</b>) demonstrated a more profound reduction in GLP-1 activity compared to native GLP-1 (<b>1</b>) and their backbone peptide (<b>2</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. in Vitro Characterization of Native GLP-1 (<b>1</b>) and Derivatives of the Liraglutide Backbone Peptide (<b>2</b>) Modified at the Side Chain of lys26<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">backbone</th><th class="colsep0 rowsep0" align="center">K27 N<sup>ε</sup> modification</th><th class="colsep0 rowsep0" align="center">HSA valence</th><th class="colsep0 rowsep0" align="center" char="±">GLP-1 R EC<sub>50</sub> ± SEM (nM)</th><th class="colsep0 rowsep0" align="center">apparent <i>M</i><sub>w</sub> (kD)</th><th class="colsep0 rowsep0" align="center">oligomeric state (m)</th><th class="colsep0 rowsep0" align="center" char="±"><i>r</i><sub>H</sub> ± SEM (nm)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">GLP-1(7-36)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">none</td><td class="colsep0 rowsep0" align="char" char="±">0.044 ± 0.006</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">none</td><td class="colsep0 rowsep0" align="char" char="±">0.023 ± 0.004</td><td class="colsep0 rowsep0" align="center">5.1</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liraglutide</td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left">-γGlu-palmitic acid</td><td class="colsep0 rowsep0" align="center">mono</td><td class="colsep0 rowsep0" align="char" char="±">0.067 ± 0.009</td><td class="colsep0 rowsep0" align="center">43.4</td><td class="colsep0 rowsep0" align="center">11.6</td><td class="colsep0 rowsep0" align="char" char="±">9.6 ± 0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left">–<b>11</b></td><td class="colsep0 rowsep0" align="center">mono</td><td class="colsep0 rowsep0" align="char" char="±">0.148 ± 0.078</td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left">–γGlu- indomethacin</td><td class="colsep0 rowsep0" align="center">mono</td><td class="colsep0 rowsep0" align="char" char="±">0.068 ± 0.037</td><td class="colsep0 rowsep0" align="center">58.6 and N/A<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">15.2 and N/A<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left">–O2Oc-indomethacin</td><td class="colsep0 rowsep0" align="center">mono</td><td class="colsep0 rowsep0" align="char" char="±">0.221 ± 0.109</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left">–K(<b>11</b>)-γGlu-indomethacin</td><td class="colsep0 rowsep0" align="center">dual</td><td class="colsep0 rowsep0" align="char" char="±">0.547 ± 0.211</td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">21.6 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left">–O2Oc-K(<b>11</b>)-γGlu-indomethacin</td><td class="colsep0 rowsep0" align="center">dual</td><td class="colsep0 rowsep0" align="char" char="±">0.522 ± 0.265</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">[K34R]-GLP-1(7-37)-OH</td><td class="colsep0 rowsep0" align="left">–<b>15</b></td><td class="colsep0 rowsep0" align="center">mono</td><td class="colsep0 rowsep0" align="char" char="±">0.118 ± 0.081</td><td class="colsep0 rowsep0" align="center">32.1</td><td class="colsep0 rowsep0" align="center">11.6</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Human GLP-1 receptor EC<sub>50</sub> ± SEM were derived from three independent experiments carried out in triplicate (<i>n</i> = 3). Oligomeric states of <b>2</b>, liraglutide, <b>4</b>, <b>6</b>, and <b>8</b> were determined by SEC using a linear calibration curve. Supramolecular hydrodynamic radii (<i>r</i><sub>H</sub>) of liraglutide and <b>6</b> were determined by DLS and reported as mean ± SEM of the quadratic fits derived from cumulant analysis, <i>n</i> = 5.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">In the SEC study, <b>3</b> was substituted for <b>8</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Figure 13</a>) due to an acute lack of peptide.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">self-assembly size exceeded detection limits.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Biophysical Characterization</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Size Exclusion Chromatography</h4><div class="NLM_p">The self-assembly of peptides to form noncovalent oligomers can affect absorption rates as well as circulatory half-lives. It is thus important to study whether the introduction of a small molecule on the peptide affects GLP-1 self-assembly. Hence, the divalent GLP-1 analogue <b>6</b> and two monovalent GLP-1 analogues containing a diflunisal- or indomethacin-like moiety, respectively, were submitted to SEC and compared to their backbone peptide (<b>2</b>) and liraglutide (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Size exclusion chromatograms of GLP-1 analogues (100 μL, 1 mg/mL) divided into three separate chromatograms; the controls, <b>2</b>, and liraglutide are displayed to the left, monovalent GLP-1 analogues at the center, and divalent <b>6</b> to the right. Compound <b>8</b> was used as an analogue of <b>3</b>. The <i>x</i>-axis marks the retention volume, while the <i>y</i>-axis marks the eluate absorption at 280 nm normalized for clarity. Retention volume and apparent size of molecular markers are depicted by dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Peptide <b>2</b> was found to elute as a single, broad peak with a retention volume of 14.1 mL, which corresponded to an apparent molecular weight of 5 kDa (<i>m</i> = 1.5). This indicated that in solution the liraglutide backbone peptide, <b>2</b>, existed as a mix of monomers and dimers. Liraglutide was found with a <i>V</i><sub>R</sub> of 9.1 mL, corresponding to a supramolecule with an apparent molecular weight of 43 kDa and an oligomeric state of 11.6. Liraglutide has previously been shown to form a heptamer at pH 8 and in the presence of 100 mM NaCl.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Like liraglutide, both monovalent- and divalent GLP-1 analogues exhibited self-assembly, albeit to different degrees. Monovalent diflunisal-containing GLP-1 analogue <b>8</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Figure 13</a>), substituting for analogue <b>3</b> due to an acute lack of compound, eluted as a single peak with a <i>V</i><sub>R</sub> of 9.8 mL, which translated to an apparent molecular weight of 32 kDa (<i>m</i> = 8.8). Meanwhile, the indomethacin-containing monovalent peptide <b>4</b> eluted in a polydisperse fashion with two main peaks, of which the largest was at a <i>V</i><sub>R</sub> of 8.4 mL, corresponding to an apparent molecular weight of 59 kDa (<i>m</i> = 15.2). The second largest peak was at <i>V</i><sub>R</sub> of 6.8 mL, corresponding to a supramolecular size far beyond the upper limit of the standard curve. The divalent GLP-1 analogue <b>6</b> eluted with a <i>V</i><sub>R</sub> of 6.6 mL, also exceeding the limits of the column.</div><div class="NLM_p last">Aside from the described main peaks, the monovalent peptides <b>8</b> and, to a higher degree, <b>4</b>, also have less well-defined eluent peaks, especially at 14–16 mL (apparent molecular weights 2.2–5.3 kDa, <i>m</i> = 0.6–1.5). This indicates that the monovalent peptides assembled in several states of more or less organized structures. Contrary to this, the lone peak derived from the divalent peptide <b>6</b> points to the formation of a single, well-ordered structure.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Dynamic Light Scattering</h4><div class="NLM_p last">Divalent GLP-1 analogue <b>6</b> supramolecular self-assembly exceeded the limits of the SEC experiments. Thus, its hydrodynamic radius (<i>r</i><sub>H</sub>) was instead determined by dynamic light scattering (DLS). As a control, liraglutide <i>r</i><sub>H</sub> was investigated as well. As in the SEC experiment, DLS data analysis indicated monodisperse self-assembly of both liraglutide and <b>6</b> in solution (data not shown). The quadratic fit of second-order cumulant analysis were used to determine <i>r</i><sub>H</sub>. Supramolecular <i>r</i><sub>H</sub> of liraglutide and <b>6</b> was 9.6 ± 0.56 and 21.6 ± 0.11 nm, respectively, with narrow size distributions, as indicated by their low polydispersity indexes of 0.24 ± 0.01 and 0.19 ± 0.01. Thus, in PBS buffer, pH 7.4, at 1 mg/mL, the divalent GLP-1 analogue <b>6</b> self-assembled into an oligomer of far greater size than the liraglutide supramolecule.</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Surface Plasmon Resonance (SPR)</h4><div class="NLM_p">Immobilized HSA interacting with GLP-1 analogues <b>2</b>–<b>7</b>, in solution, were investigated using Biacore (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). A qualitative inspection of data revealed a remarkably high dissociation rate of the liraglutide peptide backbone, <b>2</b>, from HSA, indicating a weak, nonspecific binding. Compared to <b>2</b>, peptides <b>3</b> and <b>4</b> gave rise to higher concentration dependent responses and somewhat protracted dissociation rates (following an initial steep decline). Hence, the monovalent GLP-1 analogues appear to have increased albumin affinity compared to their backbone peptide. The divalent GLP-1 analogue <b>6</b> exhibited a further increase in concentration dependent responses and dissociation rate protraction. Hence, Biacore indicated that the divalent GLP-1 analogue <b>6</b> had a higher albumin affinity than its monovalent equivalents <b>3</b> and <b>4</b>. Meanwhile, comparing data from GLP-1 analogues with/without O2Oc revealed that, in this case, the spacer did not have beneficial effects on albumin affinity.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HSA interactions with GLP-1 analogues <b>2</b>–<b>7</b>. Sensorgrams were obtained from triple injections of peptides <b>3</b>–<b>7</b> (5–25 μM) and double/triple injections of <b>2</b> (1–100 μM) over a surface of 3555 RU immobilized HSA. Double referencing was used in all experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To determine equilibrium constants from Biacore data, interactions generally must follow a classic 1:1 binding pattern. However, the observed interactions between GLP-1 analogues <b>3</b>–<b>7</b> and HSA follow more complicated binding patterns of both (i) a nonspecific binding responsible for the initial, steep decline of the dissociation curve, and (ii) a slow dissociation symptomatic for high-affinity interactions. Such complicated interaction kinetics makes determination of kinetic constants unreliable.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Thus, kinetic constants and modeled best fits are not included.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Acute Effects in Vivo</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Oral Glucose Tolerance Test (OGTT)</h4><div class="NLM_p">An OGTT was performed to examine effects of the GLP-1 analogues on glucose homeostasis (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The OGTT comprised four groups of mice treated with either a mono- or divalent GLP-1 analogue (peptide <b>4</b> or <b>6</b>), vehicle, or liraglutide (5 mL/kg, 10 nmol/mL). Mice were sc dosed 45 min prior to the administration of a glucose bolus. As compared to the glucose baseline of vehicle controls, the blood glucose (BG) levels in mice treated with either of the GLP-1 analogues were significantly reduced at time 0 (<i>P</i> < 0.05 for vehicle vs liraglutide, and <i>P</i> < 0.001 for vehicle vs peptides <b>4</b> and <b>6</b>). Furthermore, the positive control liraglutide significantly blunted OGTT-evoked BG increases compared to the vehicle (AUC 0–120 min; liraglutide 788 ± 84 mmol/L, vehicle 1725 ± 257 mmol/L, <i>P</i> < 0.001). The same applied to GLP-1 analogues <b>4</b> and <b>6</b>, which reduced BG excursion levels to the same level as liraglutide (AUC 0–120 min: for <b>4</b>, 614 ± 80 mmol/L; for <b>6</b>, 642 ± 66 mmol/L; <i>P</i> < 0.001 vs vehicle).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oral glucose tolerance test on lean mice administered sc with vehicle, liraglutide, <b>4</b>, or <b>6</b>. Each group (<i>n</i> = 7) was dosed at <i>t</i> = −45 min (5 mL/kg, 10 nmol/mL). (left) Blood glucose in mmol/L ± SEM. (right) Area under the curve for the OGTT from 0 to 120 min. Asterisks represents <i>P</i> values below 0.001 derived from a one-way ANOVA analysis with Bonferroni’s posthoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Food Intake</h4><div class="NLM_p">Food intake of lean mice was monitored over 20 h to examine the appetite-regulating effects of the GLP-1 analogues. The first food intake study comprised four groups of mice treated with either a mono- or divalent GLP-1 analogue (<b>4</b> or <b>6</b>), vehicle, or liraglutide (5 mL/kg, 10 nmol/mL) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Compared to vehicle-dosed animals, mice treated with the positive control liraglutide consumed significantly less food over the course of 20 h (liraglutide 2.23 ± 0.27 g/20 h (<i>n</i> = 8), vehicle 3.51 ± 0.49 g/20 h (<i>n</i> = 4), <i>P</i> < 0.001). The effects of liraglutide on food intake was evident 4–5 h after administration and lasted throughout the study. Treatment with mono- or divalent GLP-1 analogues <b>4</b> and <b>6</b> showed different effects on acute food intake. The monovalent <b>4</b> did not reduce food intake compared to vehicle controls, and while <b>4</b> tended to reduce food intake in the first half of the study, the effect wore off in the second half. In contrast, the divalent GLP-1 analogue <b>6</b> promoted a significant reduction in food intake throughout the study (<b>6</b>: 1.62 ± 0.23 g/20 h (<i>n</i> = 8), <i>P</i> < 0.001 vs vehicle) with similar temporal pharmacodynamics as for liraglutide.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cumulated food intake of mice (g/mouse) administered sc with vehicle or a GLP-1 analogue (5 mL/kg, 10 nmol/mL). (A–C) Three separate experiments. Two-way ANOVA with Bonferroni’s posthoc test was used to compare food intake of treatment groups against the vehicle group. The asterisks *, **, and *** represents <i>P</i> values below or equal to 0.05, 0.01, and 0.001, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To compare the effects of GLP-1 analogues <b>3</b>–<b>7</b>, two additional food intake studies were performed (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B,C). None of the monovalent GLP-1 analogues, <b>3</b>–<b>5</b>, had a significant effect on the cumulated food intake during the 20 h study period (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). In contrast, both divalent GLP-1 analogues (<b>6</b> and <b>7</b>) lead to significant reductions in cumulated food intake.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Twenty hours of cumulated food intake of mice (g/mouse ± SEM) administered sc with vehicle or a GLP-1 analogue (5 mL/kg, 10 nmol/mL). A one-way ANOVA analysis with Bonferroni’s posthoc test was used to compare treatment groups to the vehicle animals. The asterisks represent <i>P</i> values below or equal to 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Pharmacokinetics in Lean Mice</h3><div class="NLM_p">The PK profiles of one mono- and one divalent GLP-1 analogue (<b>4</b> and <b>6</b>) were investigated. Lean mice were administered sc (5 mL/kg, 10 nmol/mL) and blood sampled at eight time-points within 24 h. Plasma concentrations of GLP-1 analogues <b>4</b> and <b>6</b> were determined by LOCI-technology and are shown on <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetic profiles of <b>4</b> and <b>6</b> administered sc in C57bl/6 mice (5 mL/kg, 10 nmol/mL). Each time point equals three mice, and peptide concentrations were measured in triplicate. Error bars are shown when larger than the symbols representing data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The PK analysis revealed a significant enhancement of in vivo half-life for the divalent GLP-1 analogue <b>6</b> compared to its monovalent equivalent <b>4</b>. The monovalent GLP-1 analogue <b>4</b> had a circulatory half-life of 55 min, while the divalent GLP-1 analogue <b>6</b> exhibited a circulatory half-life of 299 m.</div><div class="NLM_p last">Besides the prolonged half-life, the absorption of the divalent GLP-1 analogue <b>6</b> was significantly protracted compared to the monovalent GLP-1 analogue <b>4</b>. While blood concentrations of <b>4</b> had peaked 0.5 h after administration, the blood concentrations of <b>6</b> peaked around 4 h after administration. In summary, the attachment of a second small-molecule HSA ligand to a GLP-1 analogue dramatically increased half-life and protracted absorption rates in vivo.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Peptides are subject to extensive enzymatic degradation and rapid renal clearance. Consequently, half-life extension is a prerequisite for the development of many peptide pharmaceuticals. In this study, a novel method for peptide half-life extension using multivalent small-molecule albumin binders was explored and demonstrated for GLP-1 analogues.</div><div class="NLM_p">Five novel GLP-1 analogues with albumin binding motives were successfully synthesized. The ability of the selected small-molecule albumin ligands to confer HSA affinity to GLP-1 were studied by Biacore. Qualitative inspection of the data indicated that the small-molecule binders did indeed confer albumin affinity to GLP-1. Specifically, dissociation from albumin was protracted for the monovalent GLP-1 analogues compared to their backbone peptide, <b>2</b>. Rewardingly, the dissociation rates were further decreased for the divalent GLP-1 analogues, indicating higher albumin binding affinities compared to the monovalent GLP-1 analogues.</div><div class="NLM_p">Peptide self-assembly can dramatically alter subcutaneous absorption rates. As a consequence, self-assembly often affects pharmacokinetic profiles of peptide pharmaceuticals.<a onclick="showRef(event, 'ref29 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref31 ref32">(29, 31, 32)</a> For example, multimerization of liraglutide plays a role in its protracted absorption, which is important for its prolonged efficacy.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Here we observed how conjugation of either a diflunisal- or an indomethacin moiety to GLP-1 promoted self-assembly. The effect was further emphasized by the simultaneous introduction of both HSA ligands, i.e., SEC experiments indicated that divalent analogue <b>6</b> exhibited larger supramolecular structures than its monovalent equivalents. DLS experiments supported that <b>6</b> indeed self-assembled into large structures and that its supramolecular size far exceeded that of liraglutide. Whether this is a general characteristic of the divalent ligand or due to this particular combination of peptide sequence and small molecules remains to be studied.</div><div class="NLM_p">To further quantify the properties of our small-molecule functionalized GLP-1 analogues, their receptor potencies were evaluated. Functional screening showed that the attachment of single HSA ligands slightly decreased GLP-1 receptor potency and that the divalent albumin ligands decreased GLP-1 receptor potency further. This correlation between modification size and potency decrease could be the result of increased steric hindrance. A similar pattern has been observed for the acylation of native GLP-1 with single-chain fatty acids versus bulky fatty acids.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> However, this standard assay contained 0.1% BSA and the observed differences in GLP-1 receptor potency could also originate from variations in albumin affinities. Similar albumin concentrations are known to greatly impact GLP-1 receptor binding of liraglutide and other lipidated GLP-1 analogues.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The introduction of a spacer between the peptide and a bulky half-life extender has been used to circumvent potency-lowering effects of the bulky molecule.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Interestingly, introduction of an O2Oc spacer between GLP-1 and the albumin ligands had no effect on potency for our compounds. This could indicate that the observed decreases in GLP-1 receptor potencies were primarily caused by albumin interactions.</div><div class="NLM_p">Selected GLP-1 analogues were further evaluated in an OGTT, which demonstrated their blood glucose lowering efficacies and supported the in vitro results regarding subnanomolar functionality. The OGTT data showed that both monovalent analogue <b>4</b> and divalent analogue <b>6</b> decreased blood glucose levels with similar efficacy as compared to liraglutide. Accordingly, the slightly lower potencies observed for GLP-1 analogues with divalent ligands compared to monovalent ligands did not negatively impact efficacy at pharmacological doses in mice.</div><div class="NLM_p">The small-molecule functionalized GLP-1 analogues were also investigated for inhibitory effects on food intake, and here, a superior efficacy of the divalent GLP-1 analogues was evident. Monovalent GLP-1 analogues had minimal effects on feeding over the course of 20 h. In contrast, the divalent GLP-1 analogues significantly reduced food intake. This difference in efficacy between the mono- and divalent peptides was presumably related to different pharmacokinetics, as the OGTT revealed how both mono- and divalent peptides were fully active in vivo. Hence, the lack of robust anorectic effects of monovalent GLP-1 analogues were probably due to relatively short circulatory half-lives, as compared to the divalent GLP-1 analogues. This hypothesis was supported by a subsequent study investigating the PK properties of <b>4</b> and <b>6</b>.</div><div class="NLM_p">In C57Bl/6 mice, we found the circulatory half-life of the monovalent GLP-1 analogue <b>4</b> to be 55 min. A 55 min half-life is longer than would be expected for native GLP-1 because mice do not have subcutaneous fat to protract absorption and GLP-1 is metabolized almost instantaneously in plasma by DPP-IV (native GLP-1 <i>t</i><sub>1/2</sub> < 2 min, human iv). Hence, this study confirms findings in the literature<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10-14)</a> that monovalent small-molecule HSA ligands can be utilized for peptide half-life extension. Importantly, we found the half-life of the divalent GLP-1 analogue <b>6</b> to be more than five times longer than that of the corresponding monovalent analogue <b>4</b>. Peptide <b>6</b> had a half-life of 299 min, demonstrating that divalent small-molecule albumin binders can significantly prolong peptide half-life, as compared to their monovalent counterparts.</div><div class="NLM_p last">The observed PK properties of <b>6</b> could be explained by a dual mode-of-action comprising initial local drug deposition followed by albumin binding. It may be speculated that self-assembly or aggregation of <b>6</b> could lead to the formation of relatively stable depots at the subcutaneous injection site, from which the peptide would be slowly released to circulation. Once in circulation, <b>6</b> could bind albumin with high avidity, which would protect the peptide against degradation and renal clearance. Similar dual mode-of-actions are known for a number of other peptide pharmaceuticals, including liraglutide.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> For liraglutide, this combination of absorption protraction and half-life extension leads to its continuous efficacy at once-daily sc administration in humans (<i>t</i><sub>max</sub> 9–13 h, <i>t</i><sub>1/2</sub> 13 h).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> As liraglutide and the divalent GLP-1 analogue <b>6</b> have similar PK properties in mice (sc: <i>t</i><sub>max</sub> 6 h and <i>t</i><sub>1/2</sub> 4.4 h<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> vs <i>t</i><sub>max</sub> 4 h and <i>t</i><sub>1/2</sub> 5 h), it is feasible that peptide <b>6</b> is suitable for once-daily treatments.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Novel GLP-1 analogues with covalently attached mono- and divalent small-molecule albumin binders were synthesized. In vitro characterization studies supported the ability of monovalent small-molecule albumin binders to confer HSA affinity. The unprecedented divalent small-molecule albumin binders had a significantly increased affinity for albumin, which confirmed our original design. As a consequence of enhanced PK properties, divalent GLP-1 analogues exhibited superior in vivo efficacy compared to their monovalent analogues. In solution, the small-molecule binders directed self-assembly of the GLP-1 analogues, which may be important for eventual sc absorption rates. This study demonstrates a novel method for in vivo half-life extension of peptide pharmaceuticals, specifically, how divalent small-molecule albumin binders can promote longer-lasting in vivo efficacy of GLP-1 analogues. Further customization of the divalent albumin binder in applications for specific peptides and proteins can be envisioned. This could include changing the linker, adding additional HSA ligands, replacing functional groups of the ligands, replacing the ligand moieties themselves, and so forth. We find that divalent small-molecule albumin binders have a significant potential as alternatives to PEGylation and lipidation.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Materials</h3><div class="NLM_p">Synthesis and purification: <i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide (DCC), dichloromethane (DCM), 4-(dimethylamino)pyridine (DMAP), <i>tert</i>-butanol (<i>t</i>BuOH), heptane, indomethacin crystalline, 4-hydroxy-[1,1′-biphenyl]-3-carboxylic acid (diflunisal-desfluoro), ethyl acetate (EtOAc), potassium carbonate (K<sub>2</sub>CO<sub>3</sub>), <i>N</i>,<i>N</i>-dimethylformamide (DMF), benzyl bromoacetate, magnesium sulfate (MgSO<sub>4</sub>), palladium hydroxide on carbon (Pd(OH)<sub>2</sub>/C), Celite, borane dimethylamine complex, tetrakis(triphenylphosphine)palladium(0), triethylsilane (TES), diethyl ether (Et<sub>2</sub>O), acetonitrile (MeCN), sodium carbonate (Na<sub>2</sub>CO<sub>3</sub>), diflunisal, formic acid, and molecular sieves were purchased from Sigma-Aldrich (Brøndby, Denmark). <i>N</i>-[(1<i>H</i>-Azabenzotriazol-1-yl)(dimethylamino)methylene]-<i>N</i>-methylmethanaminium hexafluorophosphate <i>N</i>-oxide (HATU), <i>N</i>-[(1<i>H</i>-benzotriazol-1-yl)(dimethylamino)methylene]-<i>N</i>-methylmethanaminium hexafluorophosphate <i>N</i>-oxide (HBTU), and 1-hydroxy-7-azabenzotriazol (HOAt) were purchased from GL Biochem Ltd. (Shanghai, China). <i>N</i>,<i>N</i>′-Diisopropylcarbodiimide (DIC), 1-methylimidazole (MeIm), <i>N</i>-methyl-2-pyrrolidone (NMP), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), piperidine, trifluoroacetic acid (TFA), Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-O2Oc-OH), and all Fmoc- or Boc-protected amino acids were purchased from Iris Biotech GmbH (Marktredwitz, Germany). Sodium acetate (NaOAc) was acquired from Merck Millipore (Darmstadt, Germany), while Wang functionalized TentaGel S PHB resin (0.27 mmol/g) and Rink functionalized TentaGel S RAM (0.22 mmol/g) was purchased from Rapp Polymere GmbH (Tübingen, Germany).</div><div class="NLM_p">Human GLP-1 receptor activation assay: Growth medium (DMEM with glutaMAX-I and 4.5 g/L <span class="smallcaps smallerCapital">d</span>-glucose), fetal bovine serum, penicillin and streptomycin, Geneticin (G418), Hank’s Balanced Salt Solution (HBSS), and PBS without calcium chloride (CaCl<sub>2</sub>) and magnesium chloride (MgCl<sub>2</sub>) were all purchased from Gibco (Thermo Fisher Scientific, Hvidovre, Denmark). Zeocin was purchased from Invitrogen (Thermo Fisher Scientific, Hvidovre, Denmark). HEPES, MgCl<sub>2</sub>, CaCl<sub>2</sub>, bovine serum albumin, and cell dissociation solution (nonenzymatic) were purchased from Sigma-Aldrich (Brøndby, Denmark). The 384-well format black sterile microplates were purchased from BD Falcon (USA). Excitation filter CFP 430/24 (X430), emission filters FITC 535/25 (M535), and CFP 470/24 (M470) as well as a CFP/YFP D450_515 single mirror were purchased and placed in an Envision 2104 multilabel reader (PerkinElmer, Skovlunde, Denmark).</div><div class="NLM_p last">Size exclusion chromatography, dynamic light scattering, and surface plasmon resonance biosensing: Molecular weight standards aprotinin, ribonuclease, carbonic anhydrase, and ovalbumin were purchased from GE Healthcare (Denmark) and vitamin B12 from Sigma-Aldrich (Brøndby, Denmark), while peptide YY<sub>3–36</sub> was produced in-house. Gibco PBS buffer, pH 7.4, was purchased from Life Technologies (The Netherlands). <i>N</i>-Hydroxysuccinimide (NHS), ethanolamine, sodium hydroxide (NaOH), dimethyl sulfoxide (DMSO), and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC), as well as HSA essentially fatty acid free, were purchased from Sigma-Aldrich (Brøndby, Denmark).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Diflunisal-Linker Synthesis</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General</h4><div class="NLM_p last"><sup>1</sup>H, <sup>13</sup>C, and HMQC NMR spectra were recorded using a Bruker Avance 300 spectrometer with a BBO probe. The chemical shifts were referenced to the residual solvent signal. Column chromatography on silica gel was performed on a Biotage Isolera Spektra One instrument using SNAP HP-SIL columns. Mass determination (high-resolution MS, HRMS) was performed on a Bruker SolariX XR instrument (Bruker, Bremen, Germany) with ESI and MALDI probes.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl 2′,4′-Difluoro-4-hydroxy-[1,1′-biphenyl]-3-carboxylate (<b>9</b>)</h4><div class="NLM_p last">A solution of DCC (1.073 g, 5.200 mmol) in DCM (10 mL) was added to a mixture of diflunisal (1.000 g, 3.997 mmol) and DMAP (0.488 g, 3.994 mmol) in toluene/DCM/<i>t</i>BuOH 1:4:4 (45 mL). The resulting suspension was stirred at room temperature for 2.5 days. After that, it was filtered and the solvent was evaporated under reduced pressure. The crude was purified by column chromatography on silica gel using a Biotage Isolera Spektra One (SNAP HP-SIL 50 g, heptane/EtOAc 0% to 0% 3CV, 0% to 15% 22 CV) to obtain <b>9</b> (0.857 g, 70%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 11.14 (s, 1H, OH), 7.90 (dd, <sup>4</sup><i>J</i><sub>2,6</sub> = 2.2, <sup>5</sup><i>J</i><sub>H–F</sub> = 1.3 Hz, 1H, H<sub>ar</sub>-2), 7.61–7.52 (m, 1H, H<sub>ar</sub>-6), 7.38 (ddd, <sup>3</sup><i>J</i><sub>5′-6′</sub> = 8.8, <sup>4</sup><i>J</i><sub>H–F</sub> = 6.6, 1H, H<sub>ar</sub>-6′), 7.04 (d, <sup>3</sup><i>J</i><sub>5,6</sub> = 8.6 Hz, 1H, H<sub>ar</sub>-5), 7.01–6.86 (m, 2H, H<sub>ar</sub>-3′+5′), 1.64 (s, 9H, CH<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 169.8 (s, CO), 162.7 (dd, <sup>1</sup><i>J</i><sub>C–F</sub> = 181.7, <sup>3</sup><i>J</i><sub>C–F</sub> = 11.6 Hz, C<sub>ar</sub>-F), 161.6 (s, C<sub>ar</sub>-4), 159.4 (dd, <sup>1</sup><i>J</i><sub>C–F</sub> = 182.5, <sup>3</sup><i>J</i><sub>C–F</sub> = 11.8 Hz, C<sub>ar</sub>-F), 135.8 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz, C<sub>ar</sub>- 6), 131.2 (dd, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.4, 4.8 Hz, C<sub>ar</sub>-6′), 130.5 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.8 Hz, C<sub>ar</sub>-2), 125.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 0.9 Hz, C<sub>ar</sub>-1), 124.6 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 13.8, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.8 Hz, C<sub>ar</sub>-1′), 117.9 (s, C<sub>ar</sub>-5), 114.1 (s, C<sub>ar</sub>-3), 111.7 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.1, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.9 Hz, C<sub>ar</sub>-5′), 104.5 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 26.6, 25.3 Hz, C<sub>ar</sub>-3′), 83.4 (s, <i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 28.3 (s, CH<sub>3</sub>). HRMS (ESI): calcd for C<sub>17</sub>H<sub>17</sub>F<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 307.1146, C<sub>17</sub>H<sub>16</sub>F<sub>2</sub>O<sub>3</sub>Na [M + Na]<sup>+</sup> 329.0965; found 307.1140, 329.0960.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl 4-(2-(benzyloxy)-2-oxoethoxy)-2′,4′-difluoro-[1,1′-biphenyl]-3-carboxylate (<b>10</b>)</h4><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (632 mg, 4.573 mmol) was added to a solution of <b>9</b> (700 mg, 2.285 mmol) in DMF (8 mL), and the resulting mixture was stirred at room temperature for 5 min. After that, benzyl bromoacetate (542 μL, 3.431 mmol) was added, the temperature was raised to 45 °C, and the reaction was stirred for 2 h. Afterward, the reaction was diluted with 50 mL of EtOAc and washed with brine (3 × 50 mL). The organic phase was dried over MgSO<sub>4</sub>, filtered, and the solvent removed under reduced pressure. The crude was purified by column chromatography on silica gel using Biotage Isolera Spektra One (SNAP HP-SIL 50 g, heptane/EtOAc 0% to 0% 3CV, 0% to 10% 25 CV) to obtain <b>10</b> (1.031 g, 99%) as a colorless viscous oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.86 (dd, <sup>4</sup><i>J</i><sub>2,6</sub> = 2.3, <sup>5</sup><i>J</i><sub>H–F</sub> = 1.2 Hz, 1H, H<sub>ar</sub>-2), 7.51 (ddd, <sup>3</sup><i>J</i><sub>5,6</sub> = 8.6, <sup>4</sup><i>J</i><sub>2,6</sub> = 2.3, <sup>5</sup><i>J</i><sub>H–F</sub> = 1.8 Hz, 1H, H<sub>ar</sub>-6), 7.43–7.31 (m, 6H, H<sub>ar</sub>-6′+Bn), 7.01–6.85 (m, 3H, H<sub>ar</sub>-3′+ 5′+5), 5.26 (s, 2H, Ph<i>CH</i><sub>2</sub>), 4.78 (s, 2H, CO<i>CH</i><sub>2</sub>O), 1.60 (s, 9H, CH<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 168.5 (s, CO), 165.2 (s, CO), 162.8 (dd, <sup>1</sup><i>J</i><sub>C–F</sub> = 194.1, <sup>3</sup><i>J</i><sub>C–F</sub> = 11.7 Hz, C<sub>ar</sub>-F), 159.5 (dd, <sup>1</sup><i>J</i><sub>C–F</sub> = 195.3, <sup>3</sup><i>J</i><sub>C–F</sub> = 11.8 Hz, C<sub>ar</sub>-F), 156.8 (s, C<sub>ar</sub>-4), 135.3 (s, C<sub>ar</sub>-Bn<sub>ipso</sub>), 133.1 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.3 Hz, C<sub>ar</sub>-6), 132.0 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.4 Hz, C<sub>ar</sub>-2), 131.3 (dd, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.5, 4.8 Hz, C<sub>ar</sub>-6′), 128.8 (s, C<sub>ar</sub>-Bn), 128.7 (s, C<sub>ar</sub>-Bn), 128.6 (s, C<sub>ar</sub>-Bn), 128.6 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 0.7 Hz, C<sub>ar</sub>-1), 124.1 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 13.6, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.9 Hz, C<sub>ar</sub>-1′), 123.8 (s, C<sub>ar</sub>-3), 114.5 (s, C<sub>ar</sub>-5), 111.8 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.2, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.7 Hz, C<sub>ar</sub>-5′), 104.6 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 26.4, 25.4 Hz, C<sub>ar</sub>-3′), 81.8 (s, <i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 67.2 (s, Ph<i>CH</i><sub>2</sub>), 66.9 (s, CO<i>CH</i><sub>2</sub>O), 28.4 (s, CH<sub>3</sub>). HRMS (MALDI): calcd For C<sub>26</sub>H<sub>24</sub>F<sub>2</sub>O<sub>5</sub>Na [M + Na]<sup>+</sup> 477.1489; found 477.1481.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-((3-(<i>tert</i>-Butoxycarbonyl)-2′,4′-difluoro-[1,1′-biphenyl]-4-yl)oxy)acetic Acid (<b>11</b>)</h4><div class="NLM_p last"><b>10</b> (490 mg, 1.078 mmol) was dissolved in EtOAc (6 mL) under H<sub>2</sub> flow. Pd(OH)<sub>2</sub>/C (20 wt % loading, 60 mg, 0,085 mmol) was added and the resulting suspension stirred at room temperature for 1 h. Afterward, the suspension was filtered over Celite and the solvent removed under reduced pressure to obtain <b>11</b> (389 mg, 99%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.95 (dd, <sup>4</sup><i>J</i><sub>2,6</sub> = 2.2, <sup>5</sup><i>J</i><sub>H–F</sub> = 1.2 Hz, 1H, H<sub>ar</sub>-2), 7.71–7.61 (m, 1H, H<sub>ar</sub>-6), 7.38 (ddd, <sup>3</sup><i>J</i><sub>5′-6′</sub> = 8.7, <sup>4</sup><i>J</i><sub>H–F</sub> = 6.4, 1H, H<sub>ar</sub>-6′), 7.08 (d, <sup>3</sup><i>J</i><sub>5,6</sub> = 8.6 Hz, 1H, H<sub>ar</sub>-5), 7.02–6.88 (m, 2H, H<sub>ar</sub>-3′+5′), 4.82 (s, 2H, CH<sub>2</sub>), 1.63 (s, 9H, CH<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 169.7 (s, CO), 166.0 (s, CO), 162.9 (dd, <sup>1</sup><i>J</i><sub>C–F</sub> = 213.3, <sup>3</sup><i>J</i><sub>C–F</sub> = 11.9 Hz, C<sub>ar</sub>-F), 159.6 (dd, <sup>1</sup><i>J</i><sub>C–F</sub> = 213.9, <sup>3</sup><i>J</i><sub>C–F</sub> = 11.9 Hz, C<sub>ar</sub>-F), 157.8 (s, C<sub>ar</sub>-4), 134.8 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz, C<sub>ar</sub>-6), 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.8 Hz, C<sub>ar</sub>-2), 131.3 (dd, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.5, 4.7 Hz, C<sub>ar</sub>-6′), 129.8 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 0.9 Hz, C<sub>ar</sub>-1), 123.7 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 13.7, <sup>4</sup><i>J</i><sub>C–F</sub> = 4.0 Hz, C<sub>ar</sub>-1′), 121.6 (s, C<sub>ar</sub>-3), 116.4 (s, C<sub>ar</sub>-5), 112.0 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.2, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.8 Hz, C<sub>ar</sub>-5′), 104.7 (dd, <sup>2</sup><i>J</i><sub>C–F</sub> = 26.3, 25.4 Hz, C<sub>ar</sub>-3′), 83.6 (s, <i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 68.5 (s, CH<sub>2</sub>), 28.2 (s, CH<sub>3</sub>). HRMS (ESI): calcd for C<sub>19</sub>H<sub>18</sub>F<sub>2</sub>O<sub>5</sub>Na [M + Na]<sup>+</sup> 387.1020; found 387.1012.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Peptide Synthesis</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General</h4><div class="NLM_p">Peptides were assembled using Fmoc-based SPPS and were purified by RP-HPLC on a Dionex Ultimate 3000 system (Thermo Scientific, Hvidovre, Denmark) with preparative C18 columns (300 Å, 5 μm, 21.5 mm × 250 mm; FeF Chemicals, Køge, Denmark). Solvent A consisted of milli-Q water and TFA (0.1%). Solvent B consisted of HPLC grade MeCN and TFA (0.1%). The gradient used for separation was a linear 5–70% B for 25 min.</div><div class="NLM_p last">Liraglutide was purchased as Victoza (6 mg/mL<sup>–1</sup> formulation) and either used as such (for in vivo studies) or purified by preparative RP-HPLC prior to use (for functional screening and studies of physicochemical properties)</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Synthesis of GLP-1 Analogues <b>1</b> and <b>2</b></h4><div class="NLM_p">Peptide <b>1</b> and <b>2</b> were synthesized on 0.1 mmol and 2 × 0.5 mmol scale, respectively, using Fmoc-based SPPS. Peptide <b>1</b> was synthesized on a Rink-amide resin and <b>2</b> on a Wang functionalized resin. For peptide <b>2</b>, Fmoc-Gly-OH was anchored manually to a Wang functionalized resin by dissolving Fmoc-Gly-OH (10 equiv), DIC (5 equiv), and MeIm (5 equiv) per 1 equiv resin in 6 mL of DMF and 35 mL of DCM. The reaction was left on a plate shaker 12 h at room temperature, after which the resin was transferred to a fritted 20 mL syringe and washed with NMP (3×) and DCM (3×). This procedure was repeated, and the resin was dried 12 h in vacuo. The loading of the resin was 0.18 mmol/g.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p last">Peptide <b>1</b> and the remainder of <b>2</b> were synthesized using a fully automated Initiator+ Alstra automated microwave peptide synthesizer (Biotage, Sweden), where couplings were performed with Fmoc amino acids (5 equiv), HOAt (5 equiv), HBTU (4.75 equiv), and DIEA (9.75 equiv). Couplings 2–20 (C-to-N) were performed for 10 min at 75 °C. Fmoc-deprotection were carried out with piperidine/DMF (2:3) for 3 min and then piperidine/DMF (1:4) for 15 m. After each coupling and each Fmoc-deprotection, the resin was washed with NMP (3×), DCM (1×), and DMF (2×). The incorporation of amino acids 20–30 (C-to-N) were performed using double couplings under the same circumstances as well as an additional deprotection step with piperidine/DMF (1:4) for 15 min. Finally, the last amino acid of <b>2</b>, Boc-His(Trt)-OH, was attached by double couplings for 2 h at room temperature.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Synthesis of GLP-1 Analogues <b>3</b>–<b>8</b></h4><div class="NLM_p">To synthesize GLP-1 analogues <b>3</b>–<b>8</b>, resin-bound Boc-[K34R]-GLP-1(7-37) was selectively elongated at the ε-amine of Lys26 using SPPS (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The Alloc group protecting the ε-amine of Lys26 was selectively removed using 1 equiv tetrakis(triphenylphosphine)palladium(0) and 1.5 equiv borane dimethylamine complex in DCM, which had been bubbled with argon gas. The resin was added to DCM (10 mL), and a flow of argon was applied to the mixture for 10 min before addition of the borane dimethylamine complex and an additional 10 min of argon flow. Subsequently, tetrakis(triphenylphosphine)palladium(0) was added and the reaction was left with argon bubbling for 2 h at room temperature. Afterward, the resin was washed sequentially with DCM (3×), NMP (3×), and DCM (3×). Adequate Alloc-removal was confirmed by a LCMS of a mini-cleavage (10 mg resin) made using 1 mL of 95:2.5:2.5 TFA/TES/H<sub>2</sub>O for 1 h at room temperature. The Alloc deprotected Boc-[K34R]-GLP-1(7-37) now contained a single free amine in the peptide.</div><div class="NLM_p last">The resin containing the Alloc deprotected Boc-[K34R]-GLP-1(7-37) was divided into portions of 0.1 mmol, on which the various steps for synthesis of peptides <b>3</b>–<b>8</b> were performed. Couplings were performed in DMF using HATU (5 equiv), DIEA (7.2 equiv), and amino acids/Fmoc-O2Oc-OH/indomethacin/<b>11</b> or <b>15</b> (4 equiv). Reactions were shaken for 8 h (150 rpm) at room temperature, after which they were washed with DMF (3×). The couplings were then repeated and left on the shaker O/N. Fmoc protected amines were deprotected using piperidine/DMF (2:5) for 3 min and piperidine/DMF (1:4) for 15 min, while Alloc groups were removed as described above. After coupling and deprotection steps, the resin was washed with NMP (3×), DCM (3×), and DMF (3×). The six GLP-1 analogues, <b>3</b>–<b>8</b>, were modified as follows. <b>3</b>: Coupling of <b>11</b>. <b>4</b>: Coupling of Fmoc-<span class="smallcaps smallerCapital">l</span>-Glu-O<i>t</i>Bu, Fmoc-deprotection, and then the coupling of indomethacin. <b>5</b>: Coupling of Fmoc-O2Oc-OH, Fmoc-deprotection and then the coupling of <b>11</b>. <b>6</b>: Coupling of Fmoc-<span class="smallcaps smallerCapital">l</span>-Lys(Alloc)-OH, Fmoc-deprotection, coupling of Fmoc-<span class="smallcaps smallerCapital">l</span>-Glu-O<i>t</i>Bu, Fmoc-deprotection, and then the coupling of indomethacin. Afterward, the Alloc-group was removed and <b>11</b> coupled to <i>N</i><sup>ε</sup> of the lysine. <b>7</b>: Coupling of Fmoc-O2Oc-OH, Fmoc-deprotection, and then the same steps used to synthesize <b>6</b>. <b>8</b>: Coupling of <b>15</b>.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Peptide Purification</h3><div class="NLM_p last">After synthesis, resins were washed with DMF (3×) and DCM (3×). Peptides <b>1</b>–<b>8</b> were then cleaved from the resin by treatment with TFA/TES/H<sub>2</sub>O (95:2.5:2.5; 4 mL) for 15 min at room temperature, then another 4 mL for 2 h. Following cleavage, the TFA solutions were concentrated under nitrogen flow, and peptides were precipitated with Et<sub>2</sub>O to yield a crude product. Finally, all peptides were purified by preparative RP-HPLC and analyzed by LCS as well as HRMS (except <b>1</b>, <b>2</b>, and liraglutide, which were not examined by HRMS).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Peptide Analysis</h3><div class="NLM_p last">The peptides were analyzed on a Biotage Resolux 300 Å C18 column (5 μm, 150 mm × 4.6 mm) with a flow rate of 1.0 mL/min. Solvents consisted of A (milli-Q water and 0.1% formic acid) and B (LCMS grade MeCN and 0.1% formic acid). Peptides were eluted using a linear gradient of 5–70% of solvent B. LCMS revealed purities of ≥95% for all peptides, as determined by UV-absorption at 215 nm. Finally, ESI-MS-based identifications of peptides were confirmed by HRMS using a Bruker SolariX XR instrument (Bruker, Bremen, Germany) with ESI and MALDI probes. Results are shown in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Figures 1–12</a>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> In Vitro Studies</h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Human GLP-1 Receptor Activation Assay</h4><div class="NLM_p">A stable HEK293 cell line expressing the Epac cAMP-sensor as well as the GLP-1 receptor was used for functional screening of the GLP-1 analogues. This cell line utilizes mCerulean and mCitrine attached to the Epac protein as fluorescence resonance energy transfer (FRET) pair and was previously described by Mathiesen and co-workers.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Cells were kept at 37 °C in DMEM growth medium supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin–streptomycin in a humidified 5% CO<sub>2</sub> incubator. Furthermore, 0.05 mg/mL zeocin and 0.5 mg/mL Geneticin was added to the growth medium to maintain selection pressure.</div><div class="NLM_p last">For the real-time cAMP signaling assays, cells were detached using nonenzymatic cell dissociation solution, spun down and resuspended in assay buffer (HBSS with 20 mM HEPES supplemented with 1 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, and 0.1% albumin, pH 7.4) to a cell concentration of 10<sup>5</sup> cells per mL. Cells were then transferred to black 384-well microplates where ligands were added in the indicated concentrations. Immediately after, increases in cAMP levels were measured as increases in the mCerulean/mCitrine emission ratio using an Envision 2104 multilabel reader, with measurement starting from 1 min and continuing for 60 min after ligand addition. The energy donor mCerulean was excited using an optical filter CFP-430 (X430) and a CFP/YFP (D450_515) single mirror. Subsequently, emission from both the donor mCerulean and the acceptor mCitrine was measured using YFP-535 (M535) and CFP-470 (M470) filters. At the time point of maximum cAMP levels (30 min after addition of ligands), dose–response curves were generated and ligand EC<sub>50</sub> values were calculated (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Figure 15</a>).</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Size Exclusion Chromatography</h4><div class="NLM_p last">Samples (100 μL) were separated by size on a fast protein liquid chromatography instrument (ÄKTAPurifier100, GE Healthcare, Brøndby, Denmark) with a calibrated Superdex 75 10/300 column (Pharmacia, Uppsala, Sweden) at 10 °C using PBS pH 7.4 as running buffer and a flow rate of 0.45 mL min<sup>–1</sup>. Column eluate was monitored at 280 nm using an UV detector. Apparent molecular weight was calculated from molecular weight standards using a linear calibration curve generated from a plot of retention volume versus log(MW) (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">Figure 14</a>). Peak heights were normalized to 1 for all compounds in a figure.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Dynamic Light Scattering</h4><div class="NLM_p last">Samples (0.1 mg/mL in 0.1 mM PBS pH 7.4, 500 μL) of <b>6</b> or liraglutide were filtered into quartz cuvettes through 0.2 μm syringe filters (Whatman Anotop Plus, GE Healthcare, Brøndby, Denmark). Samples were analyzed at 25 °C using a DLS instrument consisting of a BI-200SM goniometer, a BI-APD Avalanche photodiode detector, a BI-9000AT digital autocorrelator, and a 632.8 nm HeNe laser with a power of 35 mW (Brookhaven Instruments Corp., New York, USA). Measurements were obtained as 5 acquisitions of 60 s. Data were analyzed using 9KDSLW software (Brookhaven Instruments Corp., New York, USA). A regularization algorithm (CONTIN) was applied initially to establish the presence of a monomodal size distribution, and second-order cumulant analysis was subsequently used to estimate the average hydrodynamic radius (<i>r</i><sub>H</sub>) of the particles via the Stokes–Einstein equation: <span class="NLM_inline-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/jm-2017-00787h_m001.gif" alt="" /></img></span> where <i>k</i><sub>B</sub> is the Boltzmann constant, <i>T</i> is the absolute temperature, η is the viscosity of the solvent, and <i>D</i><sub>τ</sub> is the translational diffusion coefficient calculated from the intensity autocorrelation function.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Surface Plasmon Resonance Biosensing</h4><div class="NLM_p">Surface plasmon resonance analysis were performed at 25 °C using a setup described by Rich and co-workers<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> on a Biacore X100 with a CM5 sensor chip (GE Healthcare Biosciences AB, Uppsala, Sweden).</div><div class="NLM_p">HSA was immobilized on the surface of the CM5 chip. The system was equilibrated with 10 mM PBS buffer, pH 7.4, at a flow rate of 10 μL/min, until a stable baseline was achieved. Flow cells 1 and 2 were activated for 7 min with a freshly prepared 1:1 mixture (v/v) of 1 M NHS and 1 M EDC. Subsequently, flow cell 1 was subjected to two injections of 30 μg/mL HSA in 10 mM NaOAc, pH 5.4, each lasting 7 min. Both flow cells were then capped by a 7 min injection of 1 M ethanolamine, pH 8.1. Finally, noncovalently bound HSA was removed with 3 × 12 s injections of 50 mM NaOH. The final amount immobilized corresponded to 3555 RU. The flow rate used for HSA attachment was 10 μL/min.</div><div class="NLM_p last">Interactions between the immobilized HSA and GLP-1 analogues <b>2</b>–<b>7</b> were studied at a flow rate of 30 μL/min using a running buffer of PBS buffer 10 mM with 3% DMSO, pH = 7.4. Peptides were dissolved in running buffer to prepare test samples, and concentrations were verified from UV absorption at 280 nm measured on a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Hvidovre, Denmark). All samples were measured in triplicate, and measurements were performed from low to high concentrations to minimize the risk of carryover between samples. Samples of GLP-1 analogues <b>3</b>–<b>7</b> were injected to the CM5 chip for 150 s, and the following dissociations were measured for 300 s. Peptide <b>2</b> was injected to the CM5 chip for 50 s, and dissociation was measured for 180 s. Between samples the surface was washed with 50 mM NaOH for 4 s and equilibrated with running buffer. It should be noted that each NaOH wash reduced the baseline by approximately 3 RU. Blanks were run every fifth sample.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> In Vivo Studies</h3><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Animals</h4><div class="NLM_p">NMRI mice (25–30 g body weight (BW) (approximately 5 weeks old at the time of arrival) were obtained from Taconic (Lille Skensved, Denmark) and C57Bl/6 mice (20–25 g BW (6–8 weeks old) at the time of arrival) from Janvier Laboratories (Le Genest-Saint-Isle, France). Animals were group-housed (NMRI, 4 mice/cage; C57Bl/6, 5 mice/cage) in a light-, temperature-, and humidity-controlled room (12 h:12 h light:dark cycle, lights on/off at 02:00/14:00, 22 ± 1 °C; 50 ± 10% relative humidity). Animals had ad libitum access to regular chow diet (Altromin 1324, Brogaarden A/S, Denmark) and domestic quality tap water.</div><div class="NLM_p last">All animal experiments were conducted in accordance with Gubra ApS bioethical guidelines, which were fully compliant to internationally accepted principles for the care and use of laboratory animals. The described experiments were covered by personal licenses for Jacob Jelsing (2013-15-2934-00784) issued by the Danish Committee for animal research.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Oral Glucose Tolerance Test</h4><div class="NLM_p last">The acute effect of the peptides on glucose homeostasis were assessed by an oral glucose tolerance test. NMRI mice (<i>n</i> = 32), acclimatized for 5 days, were randomized into four groups (<i>n</i> = 8 per group) based on body weight prior to semifasting (day 0). Concomitant to randomization, cages were changed. Animals were fasted for 4 h, and at <i>t</i> = −30 min, mice were weighed and injected subcutaneously (sc, 5 mL/kg) with vehicle, peptide <b>2</b>, <b>4</b>, or <b>6</b> (10 nmol/mL). At <i>t</i> = 0, animals received an oral glucose load (200 mg glucose/mL (Fresenius Kabi, Uppsala, Sweden), dosing volume of 10 mL/kg) administered as a gavage via a gastrically placed tube connected to a syringe. Tail vein blood was sampled at −30, 0, 15, 30, 60, and 120 min in 10 μL heparinized glass capillary tubes and immediately suspended in 0.5 mL of buffer (glucose/lactate system solution, EKF-diagnostics, Barleben, Germany). Blood glucose was measured using a BIOSEN c-Line glucose meter (EKF-diagnostics) according to the manufacturer’s instructions, and one-way ANOVA analysis with Bonferroni’s posthoc tests were used to compare blood glucose levels between groups.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Food Intake</h4><div class="NLM_p">The acute effect of the peptides on the feeding behavior was assessed in three separate experiments with similar setup. NMRI mice were acclimatized for 5 days prior to dosing. The mice were group-housed (four mice/cage) in custom-made cages in which individual food intake can be measured (HM-2 system, MBRose, Faaborg, Denmark). Animal-allocated food intake was discriminated from spillage by defining a minimum bout size (>0.05 g) per entry.</div><div class="NLM_p last">Prior to study start, animals were randomized into four or three groups (<i>n</i> = 8–9) based on body weight. After randomization, mice were fasted from 8:00 to 14:00. Dosing was administrated sc (dose volume 5 mL/kg, 10 nmol/mL) in the lower back between 13:00 and 14:00 (just prior to lights off). After dosing, individual animal food intake was measured continuously for 20 h. One-way ANOVA analysis with Bonferroni’s posthoc tests were performed to compare food intake between groups.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Pharmacokinetics</h4><div class="NLM_p">The 59 C57Bl/6 mice were acclimatized for 5 days and then randomized based on BW into four groups (untreated (<i>n</i> = 8), vehicle (<i>n</i> = 3), and two test groups treated with GLP-1 analogues <b>4</b> and <b>6</b> (<i>n</i> = 24)). GLP-1 analogues <b>4</b> and <b>6</b> were solubilized in 10 mM PBS with 0.1% BSA, pH 7.4, and animals were administrated sc (dose volume 5 mL/kg, 10 nmol/mL). Then 15 min post dosing, trunk blood was collected in separate Microvette 500 LH tubes (Sarstedt AG & Co, Nümbrecht, Germany) with 10 μL of 0.1 mM of the DPP-IV inhibitor linagliptin (Toronto Research Chemicals INC, Toronto, Canada) from three animals in the groups, which were treated with vehicle, peptide <b>4</b>, and <b>6</b>. Plasma was isolated by centrifugation, transferred to 0.5 mL Eppendorf Protein LoBind tubes (Eppendorf AG, Hamburg, Germany), and stored at −80 °C. For the treatment groups, this was repeated at seven set time-points over the course of 24 h. Blood from the untreated group was collected prior to dosing.</div><div class="NLM_p last">Peptide concentration was determined by a collaborator, Novo Nordisk A/S, using the luminescent oxygen channeling (LOCI) technology (Siemens Healthcare, Ballerup, Denmark). Plasma from the untreated groups were spiked with peptide <b>4</b> or <b>6</b> to create standard curves in the range of 200–300000 pM. Standard curves were made in duplicate. In vivo half-life was calculated using the exponential fitting “one-phase decay” in GraphPad Prism version 5.0 (San Diego, USA)</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00787">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10684" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10684" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00787" class="ext-link">10.1021/acs.jmedchem.7b00787</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">LCMS chromatograms and HRMS of peptides, structure of compound <b>8</b>, SEC calibration data, in vivo activity curves from the functional screening experiments, and information regarding the synthesis of <b>15</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf">jm7b00787_si_001.pdf (903.14 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00787" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Søren L. Pedersen</span> - <span class="hlFld-Affiliation affiliation">Gubra
Aps, Hørsholm 2970, Denmark</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b2c1dec2f2d5c7d0c0d39cd6d9"><span class="__cf_email__" data-cfemail="4f3c233f0f283a2d3d2e612b24">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Knud J. Jensen</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Copenhagen, Frederiksberg 1870, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3525-5452" title="Orcid link">http://orcid.org/0000-0003-3525-5452</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f1415153f1c171a1251140a511b14"><span class="__cf_email__" data-cfemail="a5cecfcfe5c6cdc0c88bced08bc1ce">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Esben M. Bech</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Copenhagen, Frederiksberg 1870, Denmark</span>; 
    <span class="hlFld-Affiliation affiliation">Gubra
Aps, Hørsholm 2970, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuel C. Martos-Maldonado</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Copenhagen, Frederiksberg 1870, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pernille Wismann</span> - <span class="hlFld-Affiliation affiliation">Gubra
Aps, Hørsholm 2970, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kasper K. Sørensen</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Copenhagen, Frederiksberg 1870, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Søren Blok van Witteloostuijn</span> - <span class="hlFld-Affiliation affiliation">Gubra
Aps, Hørsholm 2970, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mikkel B. Thygesen</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Copenhagen, Frederiksberg 1870, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0158-2802" title="Orcid link">http://orcid.org/0000-0002-0158-2802</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niels Vrang</span> - <span class="hlFld-Affiliation affiliation">Gubra
Aps, Hørsholm 2970, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob Jelsing</span> - <span class="hlFld-Affiliation affiliation">Gubra
Aps, Hørsholm 2970, Denmark</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>E.M.B., M.C.M., P.K.W., S.B.v.W., and M.B.T. performed the experiments. E.M.B., K.K.S., N.V., J.J., S.L.P., and K.J.J. discussed the data. E.M.B., S.L.P., and K.J.J. wrote the manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): E.M.B., P.W.I., S.B.v.W., N.V., J.J., and S.L.P. are employees of Gubra ApS. J.J. and N.V. are major shareholders of Gubra ApS.<br /></br></div></li></ul></div><div class="ack" id="ACK-d43e2899-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Christian Rosenquist, Dr. Suzi Høegh Madsen, and Susanne Halkier for analyzing blood samples used for PK analysis, Dr. Jesper Mosolff Mathiesen for providing the HEK293 cell line used for functional screening, and Dr. Søren Roi Midtgaard for aiding with SEC and DLS experiments. Mie Fabricius Wöldike and Prof. Hans Bräuner-Osborne are thanked for providing the facilities for conducting the functional assays. We acknowledge the Innovation Fund Denmark for cofinancing Ph.D. stipends to E.M.B., P.K.W, and S.B.v.W.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">After this paper was published ASAP on August 16, 2017, a correction was made to the name of author Manuel C. Martos-Maldonado. The corrected version was reposted August 25, 2017.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> Abbreviations Used</h2><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term"><i>t</i>BuOH</td><td class="NLM_def"><p class="first last"><i>tert</i>-butanol</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">diflunisal-desfluoro</td><td class="NLM_def"><p class="first last">4-hydroxy-[1,1′-biphenyl]-3-carboxylic acid</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DLS</td><td class="NLM_def"><p class="first last">dynamic light scattering</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle Medium</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">ESI-MS</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">Fmoc-O2Oc-OH</td><td class="NLM_def"><p class="first last">Fmoc-8-amino-3,6-dioxaoctanoic acid</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like peptide 1</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>N</i>-[(1<i>H</i>-azabenzotriazol-1-yl)(dimethylamino)methylene]-<i>N</i>-methylmethanaminium hexafluorophosphate <i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hank’s Balanced Salt Solution</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>N</i>-[(1<i>H</i>-benzotriazol-1-yl)(dimethylamino)methylene]-<i>N</i>-methylmethanaminium hexafluorophosphate <i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HM-2</td><td class="NLM_def"><p class="first last">HerdsMan-2</p></td></tr><tr><td class="NLM_term">NHS</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxysuccinimide</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazol</p></td></tr><tr><td class="NLM_term">MeIm</td><td class="NLM_def"><p class="first last">1-methylimidazole</p></td></tr><tr><td class="NLM_term">OGTT</td><td class="NLM_def"><p class="first last">oral glucose tolerance test</p></td></tr><tr><td class="NLM_term">RU</td><td class="NLM_def"><p class="first last">response unit</p></td></tr><tr><td class="NLM_term">SEC</td><td class="NLM_def"><p class="first last">size exclusion chromatography</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid-phase peptide synthesis</p></td></tr><tr><td class="NLM_term">SLS</td><td class="NLM_def"><p class="first last">static light scattering</p></td></tr><tr><td class="NLM_term">TES</td><td class="NLM_def"><p class="first last">triethylsilane</p></td></tr><tr><td class="NLM_term">Pd(OH)<sub>2</sub>/C</td><td class="NLM_def"><p class="first last">palladium hydroxide on carbon</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>R</sub></td><td class="NLM_def"><p class="first last">retention volume</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Fasano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galliano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanali, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narciso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascenzi, P.</span><span> </span><span class="NLM_article-title">The Extraordinary Ligand Binding Properties of Human Serum Albumin</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1080/15216540500404093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1080%2F15216540500404093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=16393781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGhtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=787-796&issue=12&author=M.+Fasanoauthor=S.+Curryauthor=E.+Terrenoauthor=M.+Gallianoauthor=G.+Fanaliauthor=P.+Narcisoauthor=S.+Notariauthor=P.+Ascenzi&title=The+Extraordinary+Ligand+Binding+Properties+of+Human+Serum+Albumin&doi=10.1080%2F15216540500404093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The extraordinary ligand binding properties of human serum albumin</span></div><div class="casAuthors">Fasano, Mauro; Curry, Stephen; Terreno, Enzo; Galliano, Monica; Fanali, Gabriella; Narciso, Pasquale; Notari, Stefania; Ascenzi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Human serum albumin (HSA), the most prominent protein in plasma, binds different classes of ligands at multiple sites.  HSA provides a depot for many compds., affects pharmacokinetics of many drugs, holds some ligands in a strained orientation by providing their metabolic modification, renders potential toxins harmless by transporting them to disposal sites, accounts for most of the antioxidant capacity of human serum, and acts as a NO carrier.  The globular domain structural organization of monomeric HSA is at the root of its allosteric properties which are reminiscent of those of multimeric proteins.  Here, structural, functional, biotechnol., and biomedical aspects of ligand binding to HSA are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcmxLuwoq-vrVg90H21EOLACvtfcHk0limxaTDTb4euw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGhtbnN&md5=451c58473be47c2561f830fe23c0bd3d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1080%2F15216540500404093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15216540500404093%26sid%3Dliteratum%253Aachs%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DTerreno%26aufirst%3DE.%26aulast%3DGalliano%26aufirst%3DM.%26aulast%3DFanali%26aufirst%3DG.%26aulast%3DNarciso%26aufirst%3DP.%26aulast%3DNotari%26aufirst%3DS.%26aulast%3DAscenzi%26aufirst%3DP.%26atitle%3DThe%2520Extraordinary%2520Ligand%2520Binding%2520Properties%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DIUBMB%2520Life%26date%3D2005%26volume%3D57%26issue%3D12%26spage%3D787%26epage%3D796%26doi%3D10.1080%2F15216540500404093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>Victoza (Liraglutide) EPAR Assessment Report; <span class="NLM_publisher-name">European Medicines Agency</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016.pdf" class="extLink">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016.pdf</a> (accessed Mar 1, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Victoza+%28Liraglutide%29+EPAR+Assessment+Report%3B+European+Medicines+Agency%3A+London%2C+2009%3B+http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_library%2FEPAR_-_Public_assessment_report%2Fhuman%2F001026%2FWC500050016.pdf+%28accessed+Mar+1%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DVictoza%2520%2528Liraglutide%2529%2520EPAR%2520Assessment%2520Report%26pub%3DEuropean%2520Medicines%2520Agency%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Agersø, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrønd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdravkovic, M.</span><span> </span><span class="NLM_article-title">The Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of NN2211, a New Long-Acting GLP-1 Derivative, in Healthy Men</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1007/s00125-001-0719-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1007%2Fs00125-001-0719-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=195-202&author=H.+Agers%C3%B8author=L.+B.+Jensenauthor=B.+Elbr%C3%B8ndauthor=P.+Rolanauthor=M.+Zdravkovic&title=The+Pharmacokinetics%2C+Pharmacodynamics%2C+Safety+and+Tolerability+of+NN2211%2C+a+New+Long-Acting+GLP-1+Derivative%2C+in+Healthy+Men&doi=10.1007%2Fs00125-001-0719-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00125-001-0719-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-001-0719-z%26sid%3Dliteratum%253Aachs%26aulast%3DAgers%25C3%25B8%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DL.%2BB.%26aulast%3DElbr%25C3%25B8nd%26aufirst%3DB.%26aulast%3DRolan%26aufirst%3DP.%26aulast%3DZdravkovic%26aufirst%3DM.%26atitle%3DThe%2520Pharmacokinetics%252C%2520Pharmacodynamics%252C%2520Safety%2520and%2520Tolerability%2520of%2520NN2211%252C%2520a%2520New%2520Long-Acting%2520GLP-1%2520Derivative%252C%2520in%2520Healthy%2520Men%26jtitle%3DDiabetologia%26date%3D2002%26volume%3D45%26spage%3D195%26epage%3D202%26doi%3D10.1007%2Fs00125-001-0719-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Sleep, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, L. R.</span><span> </span><span class="NLM_article-title">Albumin as a Versatile Platform for Drug Half-Life Extension</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1830</span><span class="NLM_x">, </span> <span class="NLM_fpage">5526</span><span class="NLM_x">–</span> <span class="NLM_lpage">5534</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2013.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.bbagen.2013.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=23639804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=5526-5534&author=D.+Sleepauthor=J.+Cameronauthor=L.+R.+Evans&title=Albumin+as+a+Versatile+Platform+for+Drug+Half-Life+Extension&doi=10.1016%2Fj.bbagen.2013.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin as a versatile platform for drug half-life extension</span></div><div class="casAuthors">Sleep, Darrell; Cameron, Jason; Evans, Leslie R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5526-5534</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Albumin is the most abundant plasma protein, is highly sol., very stable and has an extraordinarily long circulatory half-life as a direct result of its size and interaction with the FcRn mediated recycling pathway.  In contrast, many therapeutic mols. are smaller than the renal filtration threshold and are rapidly lost from the circulation thereby limiting their therapeutic potential.  Albumin can be used in a variety of ways to increase the circulatory half-life of such mols.  This article will review the mechanisms which underpin albumin's extraordinarily long circulatory half-life and how the understanding of these processes are currently being employed to extend the circulatory half-life of drugs which can be engineered to bind to albumin, or are conjugated to, or genetically fused to, albumin.  The recent and growing understanding of the pivotal role of FcRn in maintaining the extended circulatory half-life of albumin will necessitate a greater and more thorough investigation of suitable pre-clin. model systems for assessing the pharmacokinetic profiles of drugs assocd., conjugated or fused to albumin.  Assocn., conjugation or fusion of therapeutic drugs to albumin is a well-accepted and established half-life extension technol.  The manipulation of the albumin-FcRn interaction will facilitate the modulation of the circulatory half-life of albumin-enabled drugs, leading to superior pharmacokinetics tailored to the disease state and increased patient compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExYMlo75ySLVg90H21EOLACvtfcHk0lgiG4hIxFco2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cjsr4%253D&md5=0e4c382f353eef14774c423dcb3d1963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DSleep%26aufirst%3DD.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DL.%2BR.%26atitle%3DAlbumin%2520as%2520a%2520Versatile%2520Platform%2520for%2520Drug%2520Half-Life%2520Extension%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2013%26volume%3D1830%26spage%3D5526%26epage%3D5534%26doi%3D10.1016%2Fj.bbagen.2013.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ghuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunszain, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitpas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otagiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, S.</span><span> </span><span class="NLM_article-title">Structural Basis of the Drug-Binding Specificity of Human Serum Albumin</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.jmb.2005.07.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.jmb.2005.07.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=16169013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=38-52&author=J.+Ghumanauthor=P.+A.+Zunszainauthor=I.+Petitpasauthor=A.+A.+Bhattacharyaauthor=M.+Otagiriauthor=S.+Curry&title=Structural+Basis+of+the+Drug-Binding+Specificity+of+Human+Serum+Albumin&doi=10.1016%2Fj.jmb.2005.07.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Drug-binding Specificity of Human Serum Albumin</span></div><div class="casAuthors">Ghuman, Jamie; Zunszain, Patricia A.; Petitpas, Isabelle; Bhattacharya, Ananyo A.; Otagiri, Masaki; Curry, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-52</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concns.  The problem of overcoming the binding affinity of lead compds. for HSA represents a major challenge in drug development.  Crystallog. anal. of 17 different complexes of HSA with a wide variety of drugs and small-mol. toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation.  Numerous secondary binding sites for drugs distributed across the protein have also been identified.  The binding of fatty acids, the primary physiol. ligand for the protein, is shown to alter the polarity and increase the vol. of drug site 1.  These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKWUfReJZ-bVg90H21EOLACvtfcHk0linXqbFkySNtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ&md5=d82105920c360292329bf509667df42f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.07.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.07.075%26sid%3Dliteratum%253Aachs%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DZunszain%26aufirst%3DP.%2BA.%26aulast%3DPetitpas%26aufirst%3DI.%26aulast%3DBhattacharya%26aufirst%3DA.%2BA.%26aulast%3DOtagiri%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520of%2520the%2520Drug-Binding%2520Specificity%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D38%26epage%3D52%26doi%3D10.1016%2Fj.jmb.2005.07.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Rational Design of Diflunisal Analogues with Reduced Affinity for Human Serum Albumin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">10429</span><span class="NLM_x">–</span> <span class="NLM_lpage">10435</span><span class="refDoi"> DOI: 10.1021/ja015955b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja015955b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=10429-10435&issue=5&author=H.+Maoauthor=P.+J.+Hajdukauthor=R.+Craigauthor=R.+Bellauthor=T.+Borreauthor=S.+W.+Fesik&title=Rational+Design+of+Diflunisal+Analogues+with+Reduced+Affinity+for+Human+Serum+Albumin&doi=10.1021%2Fja015955b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja015955b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja015955b%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DR.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DRational%2520Design%2520of%2520Diflunisal%2520Analogues%2520with%2520Reduced%2520Affinity%2520for%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26issue%3D5%26spage%3D10429%26epage%3D10435%26doi%3D10.1021%2Fja015955b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Vallianatou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambrinidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantili-Kakoulidou, A.</span><span> </span><span class="NLM_article-title">In Silico Prediction of Human Serum Albumin Binding for Drug Leads</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span><span class="refDoi"> DOI: 10.1517/17460441.2013.777424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1517%2F17460441.2013.777424" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=583-595&issue=5&author=T.+Vallianatouauthor=G.+Lambrinidisauthor=A.+Tsantili-Kakoulidou&title=In+Silico+Prediction+of+Human+Serum+Albumin+Binding+for+Drug+Leads&doi=10.1517%2F17460441.2013.777424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.777424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.777424%26sid%3Dliteratum%253Aachs%26aulast%3DVallianatou%26aufirst%3DT.%26aulast%3DLambrinidis%26aufirst%3DG.%26aulast%3DTsantili-Kakoulidou%26aufirst%3DA.%26atitle%3DIn%2520Silico%2520Prediction%2520of%2520Human%2520Serum%2520Albumin%2520Binding%2520for%2520Drug%2520Leads%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D5%26spage%3D583%26epage%3D595%26doi%3D10.1517%2F17460441.2013.777424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hall, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, L.</span><span> </span><span class="NLM_article-title">Automated Ligand- and Structure-Based Protocol for in Silico Prediction of Human Serum Albumin Binding</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1021/ci3006098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci3006098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=907-922&issue=4&author=M.+L.+Hallauthor=W.+L.+Jorgensenauthor=L.+Whitehead&title=Automated+Ligand-+and+Structure-Based+Protocol+for+in+Silico+Prediction+of+Human+Serum+Albumin+Binding&doi=10.1021%2Fci3006098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Automated Ligand- and Structure-Based Protocol for in Silico Prediction of Human Serum Albumin Binding</span></div><div class="casAuthors">Hall, Michelle Lynn; Jorgensen, William L.; Whitehead, Lewis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-922</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasma protein binding has a profound impact on the pharmacokinetic and pharmacodynamic properties of many drug candidates and is thus an integral component of drug discovery.  Nevertheless, extant methods to examine small-mol. interactions with plasma protein have various limitations, thus creating a need for alternative methods.  Herein we present a comprehensive and cross-validated in silico workflow for the prediction of small-mol. binding to Human Serum Albumin (HSA), the most ubiquitous plasma protein.  This protocol reliably predicts small-mol. interactions with HSA, including a binding affinity calcn. using multiple linear regression methods, binding site prediction using a naive-Bayes classifier, and a three-dimensional binding pose using induced fit docking.  Furthermore, this workflow is implemented in a portable and automated format that can be downloaded and used by other end users, either as is or with customization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZSdhuCTKGibVg90H21EOLACvtfcHk0lhVf11eqAzQJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSntrg%253D&md5=d43e145e07ec4fb2dc114a03568aabe4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fci3006098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3006098%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BL.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DWhitehead%26aufirst%3DL.%26atitle%3DAutomated%2520Ligand-%2520and%2520Structure-Based%2520Protocol%2520for%2520in%2520Silico%2520Prediction%2520of%2520Human%2520Serum%2520Albumin%2520Binding%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26issue%3D4%26spage%3D907%26epage%3D922%26doi%3D10.1021%2Fci3006098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zhivkova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doytchinova, I.</span><span> </span><span class="NLM_article-title">Quantitative Structure—Plasma Protein Binding Relationships of Acidic Drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4627</span><span class="NLM_x">–</span> <span class="NLM_lpage">4641</span><span class="refDoi"> DOI: 10.1002/jps.23303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2Fjps.23303" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=4627-4641&issue=12&author=Z.+Zhivkovaauthor=I.+Doytchinova&title=Quantitative+Structure%E2%80%94Plasma+Protein+Binding+Relationships+of+Acidic+Drugs&doi=10.1002%2Fjps.23303"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjps.23303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23303%26sid%3Dliteratum%253Aachs%26aulast%3DZhivkova%26aufirst%3DZ.%26aulast%3DDoytchinova%26aufirst%3DI.%26atitle%3DQuantitative%2520Structure%25E2%2580%2594Plasma%2520Protein%2520Binding%2520Relationships%2520of%2520Acidic%2520Drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26issue%3D12%26spage%3D4627%26epage%3D4641%26doi%3D10.1002%2Fjps.23303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caris, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paasch, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, R. a.</span><span> </span><span class="NLM_article-title">Albumin Affinity Tags Increase Peptide Half-Life in Vivo</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">2883</span><span class="NLM_x">–</span> <span class="NLM_lpage">2886</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00610-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2FS0960-894X%2802%2900610-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2883-2886&issue=20&author=M.+F.+T.+Koehlerauthor=K.+Zobelauthor=M.+H.+Beresiniauthor=L.+D.+Carisauthor=D.+Combsauthor=B.+D.+Paaschauthor=R.+a.+Lazarus&title=Albumin+Affinity+Tags+Increase+Peptide+Half-Life+in+Vivo&doi=10.1016%2FS0960-894X%2802%2900610-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900610-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900610-8%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DCaris%26aufirst%3DL.%2BD.%26aulast%3DCombs%26aufirst%3DD.%26aulast%3DPaasch%26aufirst%3DB.%2BD.%26aulast%3DLazarus%26aufirst%3DR.%2Ba.%26atitle%3DAlbumin%2520Affinity%2520Tags%2520Increase%2520Peptide%2520Half-Life%2520in%2520Vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D20%26spage%3D2883%26epage%3D2886%26doi%3D10.1016%2FS0960-894X%2802%2900610-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caris, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D.</span><span> </span><span class="NLM_article-title">Phosphate Ester Serum Albumin Affinity Tags Greatly Improve Peptide Half-Life in Vivo</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00209-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2FS0960-894X%2803%2900209-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1513-1515&issue=9&author=K.+Zobelauthor=M.+F.+T.+Koehlerauthor=M.+H.+Beresiniauthor=L.+D.+Carisauthor=D.+Combs&title=Phosphate+Ester+Serum+Albumin+Affinity+Tags+Greatly+Improve+Peptide+Half-Life+in+Vivo&doi=10.1016%2FS0960-894X%2803%2900209-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900209-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900209-9%26sid%3Dliteratum%253Aachs%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DCaris%26aufirst%3DL.%2BD.%26aulast%3DCombs%26aufirst%3DD.%26atitle%3DPhosphate%2520Ester%2520Serum%2520Albumin%2520Affinity%2520Tags%2520Greatly%2520Improve%2520Peptide%2520Half-Life%2520in%2520Vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D9%26spage%3D1513%26epage%3D1515%26doi%3D10.1016%2FS0960-894X%2803%2900209-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Novel Dicoumarol Glucagon-like Peptide 1 Conjugates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">9955</span><span class="NLM_x">–</span> <span class="NLM_lpage">9968</span><span class="refDoi"> DOI: 10.1021/jm4017448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9955-9968&issue=24&author=J.+Hanauthor=L.+Sunauthor=Y.+Chuauthor=Z.+Liauthor=D.+Huangauthor=X.+Zhuauthor=H.+Qianauthor=W.+Huang&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Novel+Dicoumarol+Glucagon-like+Peptide+1+Conjugates&doi=10.1021%2Fjm4017448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm4017448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017448%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Novel%2520Dicoumarol%2520Glucagon-like%2520Peptide%25201%2520Conjugates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D24%26spage%3D9955%26epage%3D9968%26doi%3D10.1021%2Fjm4017448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dumelin, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trüssel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachsel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bootz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannocci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumea-Mirancea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeliger, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müggler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melkko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, D.</span><span> </span><span class="NLM_article-title">A Portable Albumin Binder from a DNA-Encoded Chemical Library</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">3196</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span><span class="refDoi"> DOI: 10.1002/anie.200704936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2Fanie.200704936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=3196-3201&issue=17&author=C.+E.+Dumelinauthor=S.+Tr%C3%BCsselauthor=F.+Bullerauthor=E.+Trachselauthor=F.+Bootzauthor=Y.+Zhangauthor=L.+Mannocciauthor=S.+C.+Beckauthor=M.+Drumea-Miranceaauthor=M.+W.+Seeligerauthor=C.+Baltesauthor=T.+M%C3%BCgglerauthor=F.+Kranzauthor=M.+Rudinauthor=S.+Melkkoauthor=J.+Scheuermannauthor=D.+Neri&title=A+Portable+Albumin+Binder+from+a+DNA-Encoded+Chemical+Library&doi=10.1002%2Fanie.200704936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A portable albumin binder from a DNA-encoded chemical library</span></div><div class="casAuthors">Dumelin, Christoph E.; Truessel, Sabrina; Buller, Fabian; Trachsel, Eveline; Bootz, Frank; Zhang, Yixin; Mannocci, Luca; Beck, Susanne C.; Drumea-Mirancea, Mihaela; Seeliger, Mathias W.; Baltes, Christof; Mueggler, Thomas; Kranz, Felicitas; Rudin, Markus; Melkko, Samu; Scheuermann, Joerg; Neri, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3196-3201</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Seeing eye to eye: Plasma-protein binding is effective in improving the pharmacokinetic properties of otherwise short-lived mols.  One compd. in a class of small portable albumin binders can be used to improve the in vivo circulatory half-life of two widely used contrast agents.  It improves the imaging performance of fluorescein in angiog. anal. of the retina of mice (see picture).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDJqApTpDdrVg90H21EOLACvtfcHk0ljPVvWQVBRUvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVWqtLw%253D&md5=d3f010e006b5c8e8292f43f3935d8762</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.200704936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200704936%26sid%3Dliteratum%253Aachs%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DTr%25C3%25BCssel%26aufirst%3DS.%26aulast%3DBuller%26aufirst%3DF.%26aulast%3DTrachsel%26aufirst%3DE.%26aulast%3DBootz%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMannocci%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DDrumea-Mirancea%26aufirst%3DM.%26aulast%3DSeeliger%26aufirst%3DM.%2BW.%26aulast%3DBaltes%26aufirst%3DC.%26aulast%3DM%25C3%25BCggler%26aufirst%3DT.%26aulast%3DKranz%26aufirst%3DF.%26aulast%3DRudin%26aufirst%3DM.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DScheuermann%26aufirst%3DJ.%26aulast%3DNeri%26aufirst%3DD.%26atitle%3DA%2520Portable%2520Albumin%2520Binder%2520from%2520a%2520DNA-Encoded%2520Chemical%2520Library%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26issue%3D17%26spage%3D3196%26epage%3D3201%26doi%3D10.1002%2Fanie.200704936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span> </span><span class="NLM_article-title">Coumaglutide, a Novel Long-Acting GLP-1 Analog, Inhibits β-Cell Apoptosis in Vitro and Invokes Sustained Glycemic Control in Vivo</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">767</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.ejphar.2015.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=26481165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=767&publication_year=2015&pages=211-219&author=L.+Sunauthor=C.+Wangauthor=Y.+Daiauthor=Y.+Chuauthor=J.+Hanauthor=J.+Zhouauthor=X.+Caiauthor=W.+Huangauthor=H.+Qian&title=Coumaglutide%2C+a+Novel+Long-Acting+GLP-1+Analog%2C+Inhibits+%CE%B2-Cell+Apoptosis+in+Vitro+and+Invokes+Sustained+Glycemic+Control+in+Vivo&doi=10.1016%2Fj.ejphar.2015.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Coumaglutide, a novel long-acting GLP-1 analog, inhibits β-cell apoptosis in vitro and invokes sustained glycemic control in vivo</span></div><div class="casAuthors">Sun, Lidan; Wang, Chuandong; Dai, Yuxuan; Chu, Yingying; Han, Jing; Zhou, Jie; Cai, Xingguang; Huang, Wenlong; Qian, Hai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">767</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glucagon-like peptide-1 (GLP-1) is a potential candidate for the treatment of type 2 diabetes.  However, native GLP-1 is not suitable for therapy of diabetes due to its short half-life (t1/2=2 min).  Our recent discovery of the novel long-acting GLP-1 analog, coumaglutide, elicits favorable hypoglycemic effects.  The present study was aimed at detg. the protection effect of β-cell from apoptosis and in vivo pharmacol. properties of coumaglutide in diabetic mice.  To det. the protective effect of coumaglutide on INS-1 cell viability and apoptosis, cells were exposed to 1 μM streptozotocin (STZ) and coumaglutide for 24 h.  Moreover, STZ-induced diabetic mice were treated daily with coumaglutide for 20 days and a range of pharmacol. parameters, including Hb A1c (HbA1C), i.p. glucose tolerance, food intake and body wt. were assessed before and after the treatment.  As with other glucagon-like peptide-1 receptor agonists, coumaglutide was able to protect β-cell from apoptosis in vitro and induce a durable restoration of glycemic control (normalization of both HbA1C and improvement of i.p. glucose tolerance) in diabetic mice.  It can be concluded that coumaglutide retains native GLP-1 activities and thus may serve as a promising hypoglycemic drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukJ7QBRMtlbVg90H21EOLACvtfcHk0ljQyrxl5xAHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWhsrfE&md5=46ddcf01590ae6c64d4ddad5ea0adc0f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DH.%26atitle%3DCoumaglutide%252C%2520a%2520Novel%2520Long-Acting%2520GLP-1%2520Analog%252C%2520Inhibits%2520%25CE%25B2-Cell%2520Apoptosis%2520in%2520Vitro%2520and%2520Invokes%2520Sustained%2520Glycemic%2520Control%2520in%2520Vivo%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D767%26spage%3D211%26epage%3D219%26doi%3D10.1016%2Fj.ejphar.2015.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Brabez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayasundera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chassaing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Multivalent Interactions: Synthesis and Evaluation of Melanotropin Multimers - Tools for Melanoma Targeting</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1021/ml300312b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300312b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=98-102&issue=1&author=N.+Brabezauthor=K.+Saundersauthor=K.+L.+Nguyenauthor=T.+Jayasunderaauthor=C.+Weberauthor=R.+M.+Lynchauthor=G.+Chassaingauthor=S.+Lavielleauthor=V.+J.+Hruby&title=Multivalent+Interactions%3A+Synthesis+and+Evaluation+of+Melanotropin+Multimers+-+Tools+for+Melanoma+Targeting&doi=10.1021%2Fml300312b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml300312b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300312b%26sid%3Dliteratum%253Aachs%26aulast%3DBrabez%26aufirst%3DN.%26aulast%3DSaunders%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DK.%2BL.%26aulast%3DJayasundera%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DR.%2BM.%26aulast%3DChassaing%26aufirst%3DG.%26aulast%3DLavielle%26aufirst%3DS.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DMultivalent%2520Interactions%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Melanotropin%2520Multimers%2520-%2520Tools%2520for%2520Melanoma%2520Targeting%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D1%26spage%3D98%26epage%3D102%26doi%3D10.1021%2Fml300312b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huusfeldt, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thøgersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agersø, H.</span><span> </span><span class="NLM_article-title">Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1669</span><span class="refDoi"> DOI: 10.1021/jm9909645</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9909645" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1664-1669&issue=9&author=L.+B.+Knudsenauthor=P.+F.+Nielsenauthor=P.+O.+Huusfeldtauthor=N.+L.+Johansenauthor=K.+Madsenauthor=F.+Z.+Pedersenauthor=H.+Th%C3%B8gersenauthor=M.+Wilkenauthor=H.+Agers%C3%B8&title=Potent+Derivatives+of+Glucagon-like+Peptide-1+with+Pharmacokinetic+Properties+Suitable+for+Once+Daily+Administration&doi=10.1021%2Fjm9909645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration</span></div><div class="casAuthors">Knudsen, Lotte B.; Nielsen, Per F.; Huusfeldt, Per O.; Johansen, Nils L.; Madsen, Kjeld; Pedersen, Freddy Z.; Thogersen, Henning; Wilken, Michael; Agerso, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1664-1669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of very potent derivs. of the 30-amino acid peptide hormone glucagon-like peptide-1 (GLP-1) is described.  The compds. were all derivatized with fatty acids in order to protract their action by facilitating binding to serum albumin. GLP-1 had a potency (EC50) of 55 pM for the cloned human GLP-1 receptor.  Many of the compds. had similar or even higher potencies, despite quite large substituents.  All compds. derivatized with fatty acids equal to or longer than 12 carbon atoms were very protracted compared to GLP-1 and thus seem suitable for once daily administration to type 2 diabetic patients.  A structure-activity relationship was obtained. GLP-1 could be derivatized with linear fatty acids up to the length of 16 carbon atoms, sometimes longer, almost anywhere in the C-terminal part without considerable loss of potency.  Derivatization with two fatty acid substituents led to a considerable loss of potency.  A structure-activity relationship on derivatization of specific amino acids generally was obtained.  It was found that the longer the fatty acid, the more potency was lost.  Simultaneous modification of the N-terminus (in order to obtain better metabolic stability) interfered with fatty acid derivatization and led to loss of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_iyZt3E6tG7Vg90H21EOLACvtfcHk0ljQyrxl5xAHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D&md5=d050c27dd6aea795191798254e2bf080</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm9909645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9909645%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DHuusfeldt%26aufirst%3DP.%2BO.%26aulast%3DJohansen%26aufirst%3DN.%2BL.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DPedersen%26aufirst%3DF.%2BZ.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DAgers%25C3%25B8%26aufirst%3DH.%26atitle%3DPotent%2520Derivatives%2520of%2520Glucagon-like%2520Peptide-1%2520with%2520Pharmacokinetic%2520Properties%2520Suitable%2520for%2520Once%2520Daily%2520Administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D9%26spage%3D1664%26epage%3D1669%26doi%3D10.1021%2Fjm9909645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Finan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habegger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriever, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Cáceres, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabra, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembree, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irmler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauvais-Jarvis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tilve, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfluger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarchi, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschöp, M. H.</span><span> </span><span class="NLM_article-title">Supplementary Information, Targeted Estrogen Delivery Reverses the Metabolic Syndrome</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1847</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span><span class="refDoi"> DOI: 10.1038/nm.3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1038%2Fnm.3009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=23142820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1847-1856&issue=12&author=B.+Finanauthor=B.+Yangauthor=N.+Ottawayauthor=K.+Stemmerauthor=T.+D.+M%C3%BCllerauthor=C.-X.+Yiauthor=K.+Habeggerauthor=S.+C.+Schrieverauthor=C.+Garc%C3%ADa-C%C3%A1ceresauthor=D.+G.+Kabraauthor=J.+Hembreeauthor=J.+Hollandauthor=C.+Raverauthor=R.+J.+Seeleyauthor=W.+Hansauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+H.+de+Angelisauthor=J.+P.+Tianoauthor=F.+Mauvais-Jarvisauthor=D.+Perez-Tilveauthor=P.+Pflugerauthor=L.+Zhangauthor=V.+Gelfanovauthor=R.+D.+DiMarchiauthor=M.+H.+Tsch%C3%B6p&title=Supplementary+Information%2C+Targeted+Estrogen+Delivery+Reverses+the+Metabolic+Syndrome&doi=10.1038%2Fnm.3009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted estrogen delivery reverses the metabolic syndrome</span></div><div class="casAuthors">Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; Hrabe de Angelis, Martin; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacol. while eliminating adverse effects in other tissues.  Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice.  The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metab., as shown by loss-of-function models and genetic action profiling.  Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity.  Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism.  This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small mols.  Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small mols. may offer equal promise for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQGspuH3IemrVg90H21EOLACvtfcHk0lg2r03BZMySHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F&md5=7c080cb982964af88163a9c505d0ee83</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnm.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3009%26sid%3Dliteratum%253Aachs%26aulast%3DFinan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOttaway%26aufirst%3DN.%26aulast%3DStemmer%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DYi%26aufirst%3DC.-X.%26aulast%3DHabegger%26aufirst%3DK.%26aulast%3DSchriever%26aufirst%3DS.%2BC.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1ceres%26aufirst%3DC.%26aulast%3DKabra%26aufirst%3DD.%2BG.%26aulast%3DHembree%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DRaver%26aufirst%3DC.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGelfanov%26aufirst%3DV.%26aulast%3DDiMarchi%26aufirst%3DR.%2BD.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DSupplementary%2520Information%252C%2520Targeted%2520Estrogen%2520Delivery%2520Reverses%2520the%2520Metabolic%2520Syndrome%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26issue%3D12%26spage%3D1847%26epage%3D1856%26doi%3D10.1038%2Fnm.3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sudlow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D. N.</span><span> </span><span class="NLM_article-title">The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">824</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1207674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADyaE28XmvFahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1975&pages=824-832&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=The+Characterization+of+Two+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of two specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">824-32</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The binding of a no. of fluorescent probe mols. to human serum albumin (HSA) has been studied.  Small changes in the amino acid moiety of the dansylamino acids resulted in large changes in the binding of these compds. to HSA.  It is suggested that electrostatic and dipolar forces play a role in the specificity and binding affinity of such compds.  Fluorescent probes which had 1 tight binding site were used for drug displacement studies.  Changes in probe fluorescence were shown, by equil. dialysis and by fluorescence titrations, to be a result of competitive displacement by drugs.  The pattern of displacement of probes by drugs enabled the identification of 2 specific drug binding sites.  The relative affinity of drugs for these binding sites was measured by their ability to displace fluorescent probes specific for the sites.  The method provides a rapid and simple means for detecting potential drug interactions based on competition for protein binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrEH3wzJ0z6LVg90H21EOLACvtfcHk0lg2r03BZMySHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFahsQ%253D%253D&md5=a13e1d6d3d0f4dd004d08d62e7b89613</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DThe%2520Characterization%2520of%2520Two%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1975%26volume%3D11%26spage%3D824%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sudlow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D. N.</span><span> </span><span class="NLM_article-title">Further Characterization of Specific Drug Binding Sites on Human Serum Albumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1004490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1976&pages=1052-1061&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=Further+Characterization+of+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1052-61</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The fluorescent probes, 5-dimethylaminonaphthalene-1-sulfonamide (I) [1431-39-6] and dansylsarcosine [1093-96-5] function as specific markers for 2 distinct binding sites for anionic drugs on human serum albumin (HSA).  The binding of drugs to site I or II was detected by measuring the displacement of these probes.  The results give an indication of some of the structural features required for binding at these sites.  Stearic acid [57-11-4] binding to HSA induced different conformational changes in the albumin at sites I and II, which were detected by changes in the fluorescence and/or strength of binding of probes specific for the 2 sites.  This provides further evidence for qual. differences between the 2 sites.  The specificity of the sites for particular drugs, even at high drug to albumin ratios, was established, and the specificity and characteristics of the 2 sites on human adult and neonatal sera were shown to be similar to those on cryst. HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMQN1NBrHM7Vg90H21EOLACvtfcHk0lgkV2cG3s63Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D&md5=5286ae0da826f2764eb595b22361fe80</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DFurther%2520Characterization%2520of%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1976%26volume%3D12%26spage%3D1052%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kragh-Hansen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, V. T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otagiri, M.</span><span> </span><span class="NLM_article-title">Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">June</span><span class="NLM_x">) </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span><span class="refDoi"> DOI: 10.1248/bpb.25.695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1248%2Fbpb.25.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=12081132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=695-704&issue=June&author=U.+Kragh-Hansenauthor=V.+T.+G.+Chuangauthor=M.+Otagiri&title=Practical+Aspects+of+the+Ligand-Binding+and+Enzymatic+Properties+of+Human+Serum+Albumin&doi=10.1248%2Fbpb.25.695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Practical aspects of the ligand-binding and enzymatic properties of human serum albumin</span></div><div class="casAuthors">Kragh-Hansen, Ulrich; Chuang, Victor Tuan Giam; Otagiri, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-704</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Recent work with approaches like recombinant mutants and x-ray crystallog. has given much new information about the ligand-binding properties of human serum albumin (HSA).  The information increases the understanding of this unique transport and depot protein and could give a structural basis for the possible construction of therapeutic agents with altered HSA-binding properties.  A tabulation of high-affinity binding sites for both endogenous and exogenous compds. has been made; it could be useful for the above-mentioned purpose, but it could also be of value when trying to predict potential drug interactions at the protein-binding level.  Drug displacement is not always a complication to therapy; it can be used to increase the biol. effect of a drug.  However, due to rebinding at other sites, the increase in the free concn. of a displaced ligand can be less than expected.  Drugs and drug metabolites can also interact covalently with HSA; thiol-contg. drugs often bind to the single free cysteine residue of HSA, and glucuronidated drugs react irreversibly with other residues of the protein.  Reversible binding of ligands is often stereospecific, and therefore immobilized HSA can be used to sep. drug isomers.  Albumin-contg. dialyzates are useful for extracorporeal removal of endogenous toxins and in the treatment of drug overdoses.  HSA has different types of hydrolytic activities, which also can be stereospecific.  The esterase-like property seems esp. useful in converting prodrugs to active drugs in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrmebO3fPwI7Vg90H21EOLACvtfcHk0lgkV2cG3s63Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D&md5=8de11b4e2c17851a6a69485437ab2cb1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1248%2Fbpb.25.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.25.695%26sid%3Dliteratum%253Aachs%26aulast%3DKragh-Hansen%26aufirst%3DU.%26aulast%3DChuang%26aufirst%3DV.%2BT.%2BG.%26aulast%3DOtagiri%26aufirst%3DM.%26atitle%3DPractical%2520Aspects%2520of%2520the%2520Ligand-Binding%2520and%2520Enzymatic%2520Properties%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2002%26volume%3D25%26issue%3DJune%26spage%3D695%26epage%3D704%26doi%3D10.1248%2Fbpb.25.695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, H.</span><span> </span><span class="NLM_article-title">Interactive Associations of Drug-Drug and Drug-Drug-Drug with Iia Subdomain of Human Serum Albumin</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">3259</span><span class="NLM_x">–</span> <span class="NLM_lpage">3265</span><span class="refDoi"> DOI: 10.1021/mp300322y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300322y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2rtrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=3259-3265&issue=11&author=F.+Yangauthor=J.+Yueauthor=L.+Maauthor=Z.+Maauthor=M.+Liauthor=X.+Wuauthor=H.+Liang&title=Interactive+Associations+of+Drug-Drug+and+Drug-Drug-Drug+with+Iia+Subdomain+of+Human+Serum+Albumin&doi=10.1021%2Fmp300322y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Interactive Associations of Drug-Drug and Drug-Drug-Drug with IIA Subdomain of Human Serum Albumin</span></div><div class="casAuthors">Yang, Feng; Yue, Jiping; Ma, Li; Ma, Zhiyuan; Li, Mei; Wu, Xiaoyang; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3259-3265</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Owing to advantageous biochem. and pharmacol. properties of human serum albumin (HSA), HSA-based drug carrier is playing an increasing role in the clin. setting.  Since the IIA subdomain of HSA is a big hydrophobic cavity, we proposed that HSA delivers multiple drugs simultaneously docking on the IIA subdomain and that drugs may influence each other's binding affinity to albumin when cobinding the HSA IIA subdomain.  Therefore, we studied the interactive assocn. of drugs with the IIA subdomain of HSA by fluorescence spectroscopy and X-ray crystallog., in order to elucidate the mol. mechanism and behavior of drugs cobinding the IIA subdomain of HSA, and develop a universal structure-based model for HSA carrier design.  We solved HSA-fatty acid-cinnamic acid, HSA-fatty acid-cinnamic acid-indomethacin and HSA-fatty acid-cinnamic acid-indomethacin-lamivudine complex structures, resp.  HSA complex structures and fluorescence quenching of HSA revealed that different drugs can regulate binding sites, binding mode and binding affinity of each other.  For example, indomethacin renders cinnamic acid to make reposition, and decreases binding affinity of HSA for cinnamic acid, but increases binding affinity of itself to HSA.  Lamivudine makes cinnamic acid and indomethacin to bind new subsites.  Cinnamic acid-indomethacin enhances binding affinity of lamivudine, and cinnamic acid-lamivudine increases binding affinity of indomethacin, but indomethacin-lamivudine decreases binding affinity of cinnamic acid to HSA.  The study provided a biochem. basis for structure-guided development of HSA delivery system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgnqaryPC5-7Vg90H21EOLACvtfcHk0li50N6gw0IRNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2rtrnM&md5=a5e8ae79b334ddaec4ce1041ac771cac</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fmp300322y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300322y%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DYue%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DInteractive%2520Associations%2520of%2520Drug-Drug%2520and%2520Drug-Drug-Drug%2520with%2520Iia%2520Subdomain%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26issue%3D11%26spage%3D3259%26epage%3D3265%26doi%3D10.1021%2Fmp300322y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hüll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebich, B. L.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Drugs: A Hope for Alzheimer’s Disease?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1517/13543784.9.4.671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1517%2F13543784.9.4.671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=671-683&issue=4&author=M.+H%C3%BCllauthor=K.+Liebauthor=B.+L.+Fiebich&title=Anti-Inflammatory+Drugs%3A+A+Hope+for+Alzheimer%E2%80%99s+Disease%3F&doi=10.1517%2F13543784.9.4.671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.4.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.4.671%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCll%26aufirst%3DM.%26aulast%3DLieb%26aufirst%3DK.%26aulast%3DFiebich%26aufirst%3DB.%2BL.%26atitle%3DAnti-Inflammatory%2520Drugs%253A%2520A%2520Hope%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26issue%3D4%26spage%3D671%26epage%3D683%26doi%3D10.1517%2F13543784.9.4.671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Haworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilling, A.</span><span> </span><span class="NLM_article-title">Differential Expression of COX-1 and COX-2 in the Gastrointestinal Tract of the Rat</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1080/01926230590906512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1080%2F01926230590906512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=15902967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1yksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=239-245&author=R.+Haworthauthor=K.+Oakleyauthor=N.+McCormackauthor=A.+Pilling&title=Differential+Expression+of+COX-1+and+COX-2+in+the+Gastrointestinal+Tract+of+the+Rat&doi=10.1080%2F01926230590906512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Expression of COX-1 and COX-2 in the Gastrointestinal Tract of the Rat</span></div><div class="casAuthors">Haworth, Richard; Oakley, Keli; McCormack, Nicola; Pilling, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-245</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The aim of this study was to use immunohistochem. with morphometry to investigate COX-1 and COX-2 expression in the normal rat gastrointestinal (GI) tract and examine if sites of ulceration previously obsd. with long-term COX-2 inhibitor administration in mice correlate with differential COX-1/COX-2 expression.  COX-2 pos. cells were obsd. predominantly in the apical lamina propria of intestinal villi with fewer cells in the mucosal epithelium.  The highest level of COX-2 expression was obsd. at the ileocaecal junction (ICJ).  COX-2 expression was also present in parasympathetic ganglia of the submucosa and muscularis.  In the stomach, the highest grade of COX-2 expression was obsd. in the apical lamina propria of the fundus adjacent to the junctional ridge.  In contrast, COX-1 pos. cells within the lamina propria were evenly distributed along the GI tract but were present in higher nos. than COX-2 pos. cells.  The mean level of COX-1 expression at the ICJ was not significantly different from the ileum and caecum.  Evidence that the highest level of COX-2 expression in normal rats is located on the ileal side of the ICJ provides the first mechanism to explain spontaneous ulceration and perforation of the distal ileum in COX-2-/-animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogBkRkZ9O9krVg90H21EOLACvtfcHk0li50N6gw0IRNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1yksg%253D%253D&md5=54a4e4087a7a4a2693fe7176e0dbaaff</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F01926230590906512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230590906512%26sid%3Dliteratum%253Aachs%26aulast%3DHaworth%26aufirst%3DR.%26aulast%3DOakley%26aufirst%3DK.%26aulast%3DMcCormack%26aufirst%3DN.%26aulast%3DPilling%26aufirst%3DA.%26atitle%3DDifferential%2520Expression%2520of%2520COX-1%2520and%2520COX-2%2520in%2520the%2520Gastrointestinal%2520Tract%2520of%2520the%2520Rat%26jtitle%3DToxicol.%2520Pathol.%26date%3D2005%26volume%3D33%26spage%3D239%26epage%3D245%26doi%3D10.1080%2F01926230590906512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Finan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habegger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriever, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Cáceres, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabra, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembree, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irmler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauvais-Jarvis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tilve, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfluger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarchi, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschöp, M. H.</span><span> </span><span class="NLM_article-title">Targeted Estrogen Delivery Reverses the Metabolic Syndrome</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1847</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span><span class="refDoi"> DOI: 10.1038/nm.3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1038%2Fnm.3009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=23142820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1847-1856&issue=12&author=B.+Finanauthor=B.+Yangauthor=N.+Ottawayauthor=K.+Stemmerauthor=T.+D.+M%C3%BCllerauthor=C.-X.+Yiauthor=K.+Habeggerauthor=S.+C.+Schrieverauthor=C.+Garc%C3%ADa-C%C3%A1ceresauthor=D.+G.+Kabraauthor=J.+Hembreeauthor=J.+Hollandauthor=C.+Raverauthor=R.+J.+Seeleyauthor=W.+Hansauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+H.+de+Angelisauthor=J.+P.+Tianoauthor=F.+Mauvais-Jarvisauthor=D.+Perez-Tilveauthor=P.+Pflugerauthor=L.+Zhangauthor=V.+Gelfanovauthor=R.+D.+DiMarchiauthor=M.+H.+Tsch%C3%B6p&title=Targeted+Estrogen+Delivery+Reverses+the+Metabolic+Syndrome&doi=10.1038%2Fnm.3009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted estrogen delivery reverses the metabolic syndrome</span></div><div class="casAuthors">Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; Hrabe de Angelis, Martin; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacol. while eliminating adverse effects in other tissues.  Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice.  The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metab., as shown by loss-of-function models and genetic action profiling.  Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity.  Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism.  This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small mols.  Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small mols. may offer equal promise for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQGspuH3IemrVg90H21EOLACvtfcHk0ljM39yosc2RmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F&md5=7c080cb982964af88163a9c505d0ee83</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3009%26sid%3Dliteratum%253Aachs%26aulast%3DFinan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOttaway%26aufirst%3DN.%26aulast%3DStemmer%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DYi%26aufirst%3DC.-X.%26aulast%3DHabegger%26aufirst%3DK.%26aulast%3DSchriever%26aufirst%3DS.%2BC.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1ceres%26aufirst%3DC.%26aulast%3DKabra%26aufirst%3DD.%2BG.%26aulast%3DHembree%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DRaver%26aufirst%3DC.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGelfanov%26aufirst%3DV.%26aulast%3DDiMarchi%26aufirst%3DR.%2BD.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DTargeted%2520Estrogen%2520Delivery%2520Reverses%2520the%2520Metabolic%2520Syndrome%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26issue%3D12%26spage%3D1847%26epage%3D1856%26doi%3D10.1038%2Fnm.3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span>Victoza (Liraglutide) Full Prescription Information; <span class="NLM_publisher-name">Nordisk Novo A/S</span>: <span class="NLM_publisher-loc">Bagsvaerd, Denmark</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span><a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022341lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022341lbl.pdf</a> (accessed Feb 22, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Victoza+%28Liraglutide%29+Full+Prescription+Information%3B+Nordisk+Novo+A%2FS%3A+Bagsvaerd%2C+Denmark%2C+2010%3B+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2010%2F022341lbl.pdf+%28accessed+Feb+22%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DVictoza%2520%2528Liraglutide%2529%2520Full%2520Prescription%2520Information%26pub%3DNordisk%2520Novo%2520A%252FS%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span>Indocin (Indomethacin) Oral Suspension; <span class="NLM_publisher-name">IROKO Pharmaceuticals, LLC</span>: <span class="NLM_publisher-loc">Philadelphia</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018332s032lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018332s032lbl.pdf</a> (accessed Jan 22, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Indocin+%28Indomethacin%29+Oral+Suspension%3B+IROKO+Pharmaceuticals%2C+LLC%3A+Philadelphia%2C+2008%3B+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2009%2F018332s032lbl.pdf+%28accessed+Jan+22%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DIndocin%2520%2528Indomethacin%2529%2520Oral%2520Suspension%26pub%3DIROKO%2520Pharmaceuticals%252C%2520LLC%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span>Dolobid (Diflunisal) Tablets; <span class="NLM_publisher-name">Merck & Co. Inc.</span>: <span class="NLM_publisher-loc">Whitehouse Station, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://www.accessdata.fda.gov/drugsatfda_docs/.../018445s058lbl.pdf" class="extLink">www.accessdata.fda.gov/drugsatfda_docs/2007/018445s058lbl.pdf</a> (accessed Feb 22, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dolobid+%28Diflunisal%29+Tablets%3B+Merck+%26+Co.+Inc.%3A+Whitehouse+Station%2C+NJ%2C+2007%3B+www.accessdata.fda.gov%2Fdrugsatfda_docs%2F2007%2F018445s058lbl.pdf+%28accessed+Feb+22%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDolobid%2520%2528Diflunisal%2529%2520Tablets%26pub%3DMerck%2520%2526%2520Co.%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Laue, T.; Plagens, A.</span><span> </span><span class="NLM_article-title">Williamson Ether Synthesis</span>. In  <span class="citation_source-book">Named Organic Reactions</span>; <span class="NLM_publisher-name">John Wiley and Sons, Ltd</span>: <span class="NLM_publisher-loc">Chichester, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2F0470010428.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=19-49&author=T.+Laue&author=A.+Plagens&title=Named+Organic+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F0470010428.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470010428.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DLaue%26aufirst%3DT.%26atitle%3DWilliamson%2520Ether%2520Synthesis%26btitle%3DNamed%2520Organic%2520Reactions%26pub%3DJohn%2520Wiley%2520and%2520Sons%252C%2520Ltd%26date%3D2005%26spage%3D19%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Steensgaard, D. B.; Thomsen, J. K.; Olsen, H. B.; Knudsen, L. B.</span><span> </span><span class="NLM_article-title">The Molecular Basis for the Delayed Absorption of the Once-Daily Human GLP-1 Analog, Liraglutide</span>.  In Diabetes: American Diabetes Association’s (ADA) 68th Scientific Sessions, San Francisco, 2008,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">57</span>, p  <span class="NLM_fpage">A157</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=A157&author=D.+B.+Steensgaard&author=J.+K.+Thomsen&author=H.+B.+Olsen&author=L.+B.+Knudsen&title=The+Molecular+Basis+for+the+Delayed+Absorption+of+the+Once-Daily+Human+GLP-1+Analog%2C+Liraglutide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26atitle%3DThe%2520Molecular%2520Basis%2520for%2520the%2520Delayed%2520Absorption%2520of%2520the%2520Once-Daily%2520Human%2520GLP-1%2520Analog%252C%2520Liraglutide%26jtitle%3DDiabetes%253A%2520American%2520Diabetes%2520Association%25E2%2580%2599s%2520%2528ADA%2529%252068th%2520Scientific%2520Sessions%252C%2520San%2520Francisco%252C%25202008%26date%3D2008%26volume%3D57%26spage%3DA157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">Grading the Commercial Optical Biosensor Literature-Class of 2008: “The Mighty Binders.</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1002/jmr.1004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2Fjmr.1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=20017116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2it7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=1-64&issue=1&author=R.+L.+Richauthor=D.+G.+Myszka&title=Grading+the+Commercial+Optical+Biosensor+Literature-Class+of+2008%3A+%E2%80%9CThe+Mighty+Binders.&doi=10.1002%2Fjmr.1004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Grading the commercial optical biosensor literature-Class of 2008: The Mighty Binders'</span></div><div class="casAuthors">Rich, Rebecca L.; Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-64</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Optical biosensor technol. continues to be the method of choice for label-free, real-time interaction anal.  But when it comes to improving the quality of the biosensor literature, education should be fundamental.  Of the 1413 articles published in 2008, less than 30% would pass the requirements for high-school chem.  To teach by example, we spotlight 10 papers that illustrate how to implement the technol. properly.  Then we grade every paper published in 2008 on a scale from A to F and outline what features make a biosensor article fabulous, middling or abysmal.  To help improve the quality of published data, we focus on a few exptl., anal. and presentation mistakes that are alarmingly common.  With the literature as a guide, we want to ensure that no user is left behind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEHOQqiaPHALVg90H21EOLACvtfcHk0ljUFdU6YNCGqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2it7nK&md5=e24281c83d0524eeeec82e0f18bf06fc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fjmr.1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.1004%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DGrading%2520the%2520Commercial%2520Optical%2520Biosensor%2520Literature-Class%2520of%25202008%253A%2520%25E2%2580%259CThe%2520Mighty%2520Binders.%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2010%26volume%3D23%26issue%3D1%26spage%3D1%26epage%3D64%26doi%3D10.1002%2Fjmr.1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Jonassen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havelund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeg-Jensen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensgaard, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlund, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribel, U.</span><span> </span><span class="NLM_article-title">Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2104</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span><span class="refDoi"> DOI: 10.1007/s11095-012-0739-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1007%2Fs11095-012-0739-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=22485010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38XltF2jsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2104-2114&issue=8&author=I.+Jonassenauthor=S.+Havelundauthor=T.+Hoeg-Jensenauthor=D.+B.+Steensgaardauthor=P.+O.+Wahlundauthor=U.+Ribel&title=Design+of+the+Novel+Protraction+Mechanism+of+Insulin+Degludec%2C+an+Ultra-Long-Acting+Basal+Insulin&doi=10.1007%2Fs11095-012-0739-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin</span></div><div class="casAuthors">Jonassen, Ib; Havelund, Svend; Hoeg-Jensen, Thomas; Steensgaard, Dorte Bjerre; Wahlund, Per-Olof; Ribel, Ulla</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2104-2114</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Basal insulins with improved kinetic properties can potentially be produced using acylation by fatty acids that enable sol., high-mol. wt. complexes to form post-injection.  A series of insulins, acylated at B29 with fatty acids via glutamic acid spacers, were examd. to deduce the structural requirements.  Methods: Self-assocn., mol. masses and hexameric conformations of the insulins were studied using size exclusion chromatog. monitored by UV or multi-angle light scattering and dynamic light scattering, and CD spectroscopy (CDS) in environments (changing phenol and zinc concn.) simulating a pharmaceutical formulation and changes following s.c. injection.  Results: With depletion of phenol, insulin degludec and another fatty diacid-insulin analog formed high mol. mass filament-like complexes, which disintegrated with depletion of zinc.  CDS showed these analogs adopting stable T3R3 conformation in presence of phenol and zinc, changing to T6 with depletion of phenol.  These findings suggest insulin degludec is dihexameric in pharmaceutical formulation becoming multihexameric after injection.  The analogs showed weak dimeric assocn., indicating rapid release of monomers following hexamer disassembly.  Conclusions: Insulins can be engineered that remain sol. but become highly self-assocd. after injection, slowly releasing monomers; this is critically dependent on the acylation moiety.  One such analog, insulin degludec, has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7r6MuzFE1K7Vg90H21EOLACvtfcHk0ljUFdU6YNCGqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltF2jsrc%253D&md5=32352bc327770e3c54bae7f3277329fe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0739-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0739-z%26sid%3Dliteratum%253Aachs%26aulast%3DJonassen%26aufirst%3DI.%26aulast%3DHavelund%26aufirst%3DS.%26aulast%3DHoeg-Jensen%26aufirst%3DT.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DWahlund%26aufirst%3DP.%2BO.%26aulast%3DRibel%26aufirst%3DU.%26atitle%3DDesign%2520of%2520the%2520Novel%2520Protraction%2520Mechanism%2520of%2520Insulin%2520Degludec%252C%2520an%2520Ultra-Long-Acting%2520Basal%2520Insulin%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26issue%3D8%26spage%3D2104%26epage%3D2114%26doi%3D10.1007%2Fs11095-012-0739-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Younis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen-Jones, D.</span><span> </span><span class="NLM_article-title">Insulin Glargine: A New Basal Insulin Analogue</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span><span class="refDoi"> DOI: 10.1345/aph.1A301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1345%2Faph.1A301" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=1019-1027&author=N.+Younisauthor=H.+Soranauthor=D.+Bowen-Jones&title=Insulin+Glargine%3A+A+New+Basal+Insulin+Analogue&doi=10.1345%2Faph.1A301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1345%2Faph.1A301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1A301%26sid%3Dliteratum%253Aachs%26aulast%3DYounis%26aufirst%3DN.%26aulast%3DSoran%26aufirst%3DH.%26aulast%3DBowen-Jones%26aufirst%3DD.%26atitle%3DInsulin%2520Glargine%253A%2520A%2520New%2520Basal%2520Insulin%2520Analogue%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2002%26volume%3D36%26spage%3D1019%26epage%3D1027%26doi%3D10.1345%2Faph.1A301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agersoe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thøgersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, N. L.</span><span> </span><span class="NLM_article-title">Structure-Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives: Importance of Fatty Acid Length, Polarity, and Bulkiness</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6132</span><span class="refDoi"> DOI: 10.1021/jm070861j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070861j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KisbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6126-6132&issue=24&author=K.+Madsenauthor=L.+B.+Knudsenauthor=H.+Agersoeauthor=P.+F.+Nielsenauthor=H.+Th%C3%B8gersenauthor=M.+Wilkenauthor=N.+L.+Johansen&title=Structure-Activity+and+Protraction+Relationship+of+Long-Acting+Glucagon-like+Peptide-1+Derivatives%3A+Importance+of+Fatty+Acid+Length%2C+Polarity%2C+and+Bulkiness&doi=10.1021%2Fjm070861j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives: Importance of Fatty Acid Length, Polarity, and Bulkiness</span></div><div class="casAuthors">Madsen, Kjeld; Knudsen, Lotte Bjerre; Agersoe, Henrik; Nielsen, Per Franklin; Thogersen, Henning; Wilken, Michael; Johansen, Nils Langeland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6126-6132</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We here report a series of derivs. describing the structure-activity relation around liraglutide, a once-daily human glucagon-like peptide-1 fatty acid deriv., with respect to potency as well as protraction in vivo.  The spacer region between the fatty acid and the peptide is mostly important for potency, whereas the fatty acid or fatty acid mimetic is important for both potency and protraction.  The length of the fatty acid is the most important parameter for protraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosAuWJXGV4jrVg90H21EOLACvtfcHk0lhLRyrzgxgV2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KisbnJ&md5=ded10166177422e5e318b767205eb8c9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070861j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070861j%26sid%3Dliteratum%253Aachs%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DAgersoe%26aufirst%3DH.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DN.%2BL.%26atitle%3DStructure-Activity%2520and%2520Protraction%2520Relationship%2520of%2520Long-Acting%2520Glucagon-like%2520Peptide-1%2520Derivatives%253A%2520Importance%2520of%2520Fatty%2520Acid%2520Length%252C%2520Polarity%252C%2520and%2520Bulkiness%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D24%26spage%3D6126%26epage%3D6132%26doi%3D10.1021%2Fjm070861j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäffer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spetzler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofoed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensgaard, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thygesen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedtz-Runge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, T.</span><span> </span><span class="NLM_article-title">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7370</span><span class="NLM_x">–</span> <span class="NLM_lpage">7380</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00726</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00726" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7370-7380&issue=18&author=J.+Lauauthor=P.+Blochauthor=L.+Sch%C3%A4fferauthor=I.+Petterssonauthor=J.+Spetzlerauthor=J.+Kofoedauthor=K.+Madsenauthor=L.+B.+Knudsenauthor=J.+McGuireauthor=D.+B.+Steensgaardauthor=H.+M.+Straussauthor=D.+X.+Gramauthor=S.+M.+Knudsenauthor=F.+S.+Nielsenauthor=P.+Thygesenauthor=S.+Reedtz-Rungeauthor=T.+Kruse&title=Discovery+of+the+Once-Weekly+Glucagon-Like+Peptide-1+%28GLP-1%29+Analogue+Semaglutide&doi=10.1021%2Facs.jmedchem.5b00726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span></div><div class="casAuthors">Lau, Jesper; Bloch, Paw; Schaffer, Lauge; Pettersson, Ingrid; Spetzler, Jane; Kofoed, Jacob; Madsen, Kjeld; Knudsen, Lotte Bjerre; McGuire, James; Steensgaard, Dorte Bjerre; Strauss, Holger Martin; Gram, Dorte X.; Knudsen, Sanne Moeller; Nielsen, Flemming Seier; Thygesen, Peter; Reedtz-Runge, Steffen; Kruse, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7370-7380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analog that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity.  The aim of the present studies was to design a once weekly GLP-1 analog by increasing albumin affinity and secure full stability against metabolic degrdn.  The fatty acid moiety and the linking chem. to GLP-1 were the key features to secure high albumin affinity and GLP-1 receptor (GLP-1R) potency and in obtaining a prolonged exposure and action of the GLP-1 analog.  Semaglutide was selected as the optimal once weekly candidate.  Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26.  The GLP-1R affinity of semaglutide (0.38 ± 0.06 nM) was three-fold decreased compared to liraglutide, whereas the albumin affinity was increased.  The plasma half-life was 46.1 h in mini-pigs following i.v. administration, and semaglutide has an MRT of 63.6 h after s.c. dosing to mini-pigs.  Semaglutide is currently in phase 3 clin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tFc0FzEro7Vg90H21EOLACvtfcHk0lhLRyrzgxgV2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM&md5=0478fe17f9f4dcc0cb58919b1c55869a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00726%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DBloch%26aufirst%3DP.%26aulast%3DSch%25C3%25A4ffer%26aufirst%3DL.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DSpetzler%26aufirst%3DJ.%26aulast%3DKofoed%26aufirst%3DJ.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DMcGuire%26aufirst%3DJ.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DStrauss%26aufirst%3DH.%2BM.%26aulast%3DGram%26aufirst%3DD.%2BX.%26aulast%3DKnudsen%26aufirst%3DS.%2BM.%26aulast%3DNielsen%26aufirst%3DF.%2BS.%26aulast%3DThygesen%26aufirst%3DP.%26aulast%3DReedtz-Runge%26aufirst%3DS.%26aulast%3DKruse%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520the%2520Once-Weekly%2520Glucagon-Like%2520Peptide-1%2520%2528GLP-1%2529%2520Analogue%2520Semaglutide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7370%26epage%3D7380%26doi%3D10.1021%2Facs.jmedchem.5b00726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Russell-Jones, D.</span><span> </span><span class="NLM_article-title">Molecular, Pharmacological and Clinical Aspects of Liraglutide, a Once-Daily Human GLP-1 Analogue</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.mce.2008.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.mce.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=19041364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=137-140&author=D.+Russell-Jones&title=Molecular%2C+Pharmacological+and+Clinical+Aspects+of+Liraglutide%2C+a+Once-Daily+Human+GLP-1+Analogue&doi=10.1016%2Fj.mce.2008.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular, pharmacological and clinical aspects of Liraglutide, a once-daily human GLP-1 analogue</span></div><div class="casAuthors">Russell-Jones, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">137-140</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Liraglutide, a human glucagon-like peptide 1 (GLP-1) analog with high homol. to native GLP-1, has structural modifications sufficient to amend pharmacokinetics for once-daily administration without compromising biol. activity.  Data from large, controlled, clin. studies have confirmed the therapeutic profile of Liraglutide, with robust redns. in HbA1c, low risk of hypoglycemia and clin. relevant redns. in body wt. and systolic blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowKOB67do2d7Vg90H21EOLACvtfcHk0lg16jWu8mxTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73I&md5=f69909ac99dde6cfcd765e0c046b9e13</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DRussell-Jones%26aufirst%3DD.%26atitle%3DMolecular%252C%2520Pharmacological%2520and%2520Clinical%2520Aspects%2520of%2520Liraglutide%252C%2520a%2520Once-Daily%2520Human%2520GLP-1%2520Analogue%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D297%26spage%3D137%26epage%3D140%26doi%3D10.1016%2Fj.mce.2008.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Deryabina, M. A.; Daugaard, J. R.; Knudsen, C. B.; Shelton, P. T.; Fog, J. U.; Jessen, L.; Noerregaard, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and Pharmacodynamics of GLP-1-GIP Receptor Dual Agonist Peptides: From Once-Daily to Once-Weekly</span>. In Integrated Physiology - Other Hormones: The American Diabetes Association’s (ADA) 75th Scientific Sessions, Boston, 2015,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">2086-P</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=2086-P&author=M.+A.+Deryabina&author=J.+R.+Daugaard&author=C.+B.+Knudsen&author=P.+T.+Shelton&author=J.+U.+Fog&author=L.+Jessen&author=P.+Noerregaard&title=Pharmacokinetics+and+Pharmacodynamics+of+GLP-1-GIP+Receptor+Dual+Agonist+Peptides%3A+From+Once-Daily+to+Once-Weekly"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDeryabina%26aufirst%3DM.%2BA.%26atitle%3DPharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520GLP-1-GIP%2520Receptor%2520Dual%2520Agonist%2520Peptides%253A%2520From%2520Once-Daily%2520to%2520Once-Weekly%26jtitle%3DIntegrated%2520Physiology%2520-%2520Other%2520Hormones%253A%2520The%2520American%2520Diabetes%2520Association%25E2%2580%2599s%2520%2528ADA%2529%252075th%2520Scientific%2520Sessions%252C%2520Boston%252C%25202015%26date%3D2015%26spage%3D2086-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Tofteng Shelton, P.; J. Jensen, K.</span><span> </span><span class="NLM_article-title">Linkers, Resins, and General Procedures for Solid-Phase Peptide Synthesis</span>. In  <span class="citation_source-book">Peptide Synthesis and Applications</span>; <span class="NLM_contrib-group">J. Jensen, K.; Tofteng Shelton, P.; L. Pedersen, S.</span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1007%2F978-1-62703-544-6_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=23-43&author=P.+Tofteng+Shelton&author=K.+J.+Jensenauthor=K.+J.+Jensen&author=P.+Tofteng+Shelton&author=S.+L.+Pedersen&title=Peptide+Synthesis+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-544-6_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-62703-544-6_2%26sid%3Dliteratum%253Aachs%26aulast%3DTofteng%2BShelton%26aufirst%3DP.%26atitle%3DLinkers%252C%2520Resins%252C%2520and%2520General%2520Procedures%2520for%2520Solid-Phase%2520Peptide%2520Synthesis%26btitle%3DPeptide%2520Synthesis%2520and%2520Applications%26aulast%3DJ.%2BJensen%26aufirst%3DK.%26pub%3DHumana%2520Press%26date%3D2013%26spage%3D23%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Mathiesen, J. M.; Vedel, L.; Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">cAMP Biosensors Applied in Molecular Pharmacological Studies of G Protein-Coupled Receptors</span>. In  <span class="citation_source-book">Methods Enzymol.</span>. <span class="NLM_contrib-group">Pyle, A. M.; Christianson, D. W.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">522</span>, pp  <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2FB978-0-12-407865-9.00011-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=191-207&author=J.+M.+Mathiesen&author=L.+Vedel&author=H.+Br%C3%A4uner-Osborneauthor=A.+M.+Pyle&author=D.+W.+Christianson&title=Methods+Enzymol."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-407865-9.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-407865-9.00011-X%26sid%3Dliteratum%253Aachs%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26atitle%3DcAMP%2520Biosensors%2520Applied%2520in%2520Molecular%2520Pharmacological%2520Studies%2520of%2520G%2520Protein-Coupled%2520Receptors%26btitle%3DMethods%2520Enzymol.%26aulast%3DPyle%26aufirst%3DA.%2BM.%26pub%3DElsevier%26date%3D2013%26volume%3D522%26spage%3D191%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">High-Resolution and High-Throughput Protocols for Measuring Drug/human Serum Albumin Interactions Using BIACORE</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1006/abio.2001.5314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1006%2Fabio.2001.5314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=11554715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms12rsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2001&pages=197-207&author=R.+L.+Richauthor=Y.+S.+Dayauthor=T.+A.+Mortonauthor=D.+G.+Myszka&title=High-Resolution+and+High-Throughput+Protocols+for+Measuring+Drug%2Fhuman+Serum+Albumin+Interactions+Using+BIACORE&doi=10.1006%2Fabio.2001.5314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution and High-Throughput Protocols for Measuring Drug/Human Serum Albumin Interactions Using BIACORE</span></div><div class="casAuthors">Rich, Rebecca L.; Day, Yasmina S. N.; Morton, Thomas A.; Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Characterizing how chem. compds. bind to human serum albumin (HSA) is essential in evaluating drug candidates.  Using warfarin as a test system, we validate the application of BIACORE SPR biosensors to reliably det. binding consts. for drug/HSA interactions.  The binding responses for warfarin over HSA surfaces were extremely reproducible even though warfarin is small compared to the size of the immobilized protein.  At high concns., warfarin bound at more than one site on HSA, which is consistent with its known binding properties.  The affinity we detd. for the high-affinity site (K25°Cd = 3.7±1.2 μM), as well as the dissocn. rate const. (k25°Cd = 1.2 s-1), are also consistent with binding consts. detd. previously.  These results validate the biosensor technol. and illustrate how BIACORE can be used to study drug/HSA interactions in a high-resoln. mode.  Using a set of 10 test compds., we present a protocol for detg. equil. dissocn. consts. for HSA in a high-throughput mode.  Our method involves working at low compd. concns. and fitting the equil. data for all compds. simultaneously.  We show that the % bound values detd. by SPR correlate with the values detd. by soln.-based methods.  The ability to examine directly the binding of small mols. (130-800 Da), coupled with minimal sample requirements and automated instrumentation, makes BIACORE technol. applicable for evaluating drug/HSA interactions.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol1RkwlH6QBbVg90H21EOLACvtfcHk0lg16jWu8mxTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms12rsLg%253D&md5=2a6ec9d23dd6a2c54db703b546cdf2b9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5314%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DDay%26aufirst%3DY.%2BS.%26aulast%3DMorton%26aufirst%3DT.%2BA.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DHigh-Resolution%2520and%2520High-Throughput%2520Protocols%2520for%2520Measuring%2520Drug%252Fhuman%2520Serum%2520Albumin%2520Interactions%2520Using%2520BIACORE%26jtitle%3DAnal.%2520Biochem.%26date%3D2001%26volume%3D296%26spage%3D197%26epage%3D207%26doi%3D10.1006%2Fabio.2001.5314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Julien C. Vantourout, Andrew M. Mason, Josephine Yuen, Graham L. Simpson, Ghotas Evindar, Letian Kuai, Michael Hobbs, Emma Edgar, Saul Needle, Xiaopeng Bai, Steve Wilson, Paul Scott-Stevens, William Traylen, Kim Lambert, Neil Young, Shenaz Bunally, Scott G. Summerfield, Richard Snell, Rakesh Lad, Eric Shi, Steven Skinner, Lisa Shewchuk, Allan J.B. Watson, Chun-wa Chung, Sandeep Pal, Dennis A. Holt, Lara S. Kallander, Joanne Prendergast, Katrina Rivera, David G. Washburn, Mark R. Harpel, Christopher Arico-Muendel, <span class="NLM_string-name hlFld-ContribAuthor">Albert Isidro-Llobet</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin Binders. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (2)
                                     , 279-289. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00662" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00662%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DIn%252BVivo%252BHalf-Life%252BExtension%252Bof%252BBMP1%25252FTLL%252BMetalloproteinase%252BInhibitors%252BUsing%252BSmall-Molecule%252BHuman%252BSerum%252BAlbumin%252BBinders%26aulast%3DVantourout%26aufirst%3DJulien%2BC.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D02122020%26date%3D20012021%26date%3D01022021%26volume%3D32%26issue%3D2%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinyu Chen, Junjie Fu, Feng Zhou, Qimeng Yang, Jialing Wang, Hui Feng, Wen Jiang, Luofan Jin, Xuelin Tang, Neng Jiang, Jian Yin, <span class="NLM_string-name hlFld-ContribAuthor">Jing Han</span>. </span><span class="cited-content_cbyCitation_article-title">Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12595-12613. <a href="https://doi.org/10.1021/acs.jmedchem.0c00736" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00736%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStapled%252Band%252BXenopus%252BGlucagon-Like%252BPeptide%252B1%252B%252528GLP-1%252529-Based%252BDual%252BGLP-1%25252FGastrin%252BReceptor%252BAgonists%252Bwith%252BImproved%252BMetabolic%252BBenefits%252Bin%252BRodent%252BModels%252Bof%252BObesity%252Band%252BDiabetes%26aulast%3DChen%26aufirst%3DXinyu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02052020%26date%3D30102020%26volume%3D63%26issue%3D21%26spage%3D12595%26epage%3D12613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Esben
M. Bech, Søren L. Pedersen, <span class="NLM_string-name hlFld-ContribAuthor">Knud J. Jensen</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its Alternatives. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 577-580. <a href="https://doi.org/10.1021/acsmedchemlett.8b00226" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00226%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DChemical%252BStrategies%252Bfor%252BHalf-Life%252BExtension%252Bof%252BBiopharmaceuticals%25253A%252BLipidation%252Band%252BIts%252BAlternatives%26aulast%3DBech%26aufirst%3DEsben%2BM.%26date%3D2018%26date%3D2018%26date%3D15062018%26volume%3D9%26issue%3D7%26spage%3D577%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jing Han, Xinyu Chen, Liming Zhao, Junjie Fu, Lidan Sun, Ying Zhang, Feng Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Yingying Fei</span>. </span><span class="cited-content_cbyCitation_article-title">Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (7)
                                     , 2840-2856. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00336" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00336%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DLithocholic%252BAcid-Based%252BPeptide%252BDelivery%252BSystem%252Bfor%252Ban%252BEnhanced%252BPharmacological%252Band%252BPharmacokinetic%252BProfile%252Bof%252BXenopus%252BGLP-1%252BAnalogs%26aulast%3DHan%26aufirst%3DJing%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29032018%26date%3D25052018%26date%3D04052018%26date%3D04062018%26date%3D25052018%26volume%3D15%26issue%3D7%26spage%3D2840%26epage%3D2856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasper K.  Sørensen</span>, <span class="hlFld-ContribAuthor ">Narendra K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Maciej P.  Paprocki</span>, <span class="hlFld-ContribAuthor ">Amit  Mehrotra</span>, <span class="hlFld-ContribAuthor ">Knud J.  Jensen</span>. </span><span class="cited-content_cbyCitation_article-title">High‐Performance Reversed‐Phase Flash Chromatography Purification of Peptides and Chemically Modified Insulins. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (10)
                                     , 1818-1822. <a href="https://doi.org/10.1002/cbic.202000826" title="DOI URL">https://doi.org/10.1002/cbic.202000826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000826%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DHigh%2525E2%252580%252590Performance%252BReversed%2525E2%252580%252590Phase%252BFlash%252BChromatography%252BPurification%252Bof%252BPeptides%252Band%252BChemically%252BModified%252BInsulins%26aulast%3DS%25C3%25B8rensen%26aufirst%3DKasper%2BK.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D10%26spage%3D1818%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuteng  Wu</span>, <span class="hlFld-ContribAuthor ">Jack  Williams</span>, <span class="hlFld-ContribAuthor ">Ewen D. D.  Calder</span>, <span class="hlFld-ContribAuthor ">Louise J.  Walport</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to expand peptide functionality through hybridisation with a small molecule component. </span><span class="cited-content_cbyCitation_journal-name">RSC Chemical Biology</span><span> <strong>2021,</strong> <em>2 </em>
                                    (1)
                                     , 151-165. <a href="https://doi.org/10.1039/D0CB00167H" title="DOI URL">https://doi.org/10.1039/D0CB00167H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CB00167H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CB00167H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Chemical%2520Biology%26atitle%3DStrategies%252Bto%252Bexpand%252Bpeptide%252Bfunctionality%252Bthrough%252Bhybridisation%252Bwith%252Ba%252Bsmall%252Bmolecule%252Bcomponent%26aulast%3DWu%26aufirst%3DYuteng%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D1%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Abdallah</span>, <span class="hlFld-ContribAuthor ">Olivia O.  Müllertz</span>, <span class="hlFld-ContribAuthor ">Ian K.  Styles</span>, <span class="hlFld-ContribAuthor ">Alexander  Mörsdorf</span>, <span class="hlFld-ContribAuthor ">John F.  Quinn</span>, <span class="hlFld-ContribAuthor ">Michael R.  Whittaker</span>, <span class="hlFld-ContribAuthor ">Natalie L.  Trevaskis</span>. </span><span class="cited-content_cbyCitation_article-title">Lymphatic targeting by albumin-hitchhiking: Applications and optimisation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2020,</strong> <em>327 </em>, 117-128. <a href="https://doi.org/10.1016/j.jconrel.2020.07.046" title="DOI URL">https://doi.org/10.1016/j.jconrel.2020.07.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2020.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2020.07.046%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DLymphatic%252Btargeting%252Bby%252Balbumin-hitchhiking%25253A%252BApplications%252Band%252Boptimisation%26aulast%3DAbdallah%26aufirst%3DMohammad%26date%3D2020%26volume%3D327%26spage%3D117%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Junjie  Fu</span>, <span class="hlFld-ContribAuthor ">Qimeng  Yang</span>, <span class="hlFld-ContribAuthor ">Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Xinyu  Chen</span>, <span class="hlFld-ContribAuthor ">Chenglin  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112389. <a href="https://doi.org/10.1016/j.ejmech.2020.112389" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112389%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%252Band%252Bbiological%252Bevaluation%252Bof%252Bgemfibrozil%252Bmodified%252BXenopus%252BGLP-1%252Bderivatives%252Bas%252Blong-acting%252Bhypoglycemic%252Bagents%26aulast%3DHan%26aufirst%3DJing%26date%3D2020%26volume%3D198%26spage%3D112389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunli  Tang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Deng</span>, <span class="hlFld-ContribAuthor ">Weiwei  Wu</span>, <span class="hlFld-ContribAuthor ">Liufeng  Liao</span>, <span class="hlFld-ContribAuthor ">Kai  Liang</span>, <span class="hlFld-ContribAuthor ">Rongrui  Huo</span>, <span class="hlFld-ContribAuthor ">Chenglin  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Weizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of lixisenatide analogues as long-acting hypoglycemic agents using novel peptide half-life extension technology based on mycophenolic acid. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (20)
                                     , 12089-12104. <a href="https://doi.org/10.1039/D0RA01002B" title="DOI URL">https://doi.org/10.1039/D0RA01002B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA01002B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA01002B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Bof%252Blixisenatide%252Banalogues%252Bas%252Blong-acting%252Bhypoglycemic%252Bagents%252Busing%252Bnovel%252Bpeptide%252Bhalf-life%252Bextension%252Btechnology%252Bbased%252Bon%252Bmycophenolic%252Bacid%26aulast%3DTang%26aufirst%3DChunli%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D20%26spage%3D12089%26epage%3D12104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Kwiatkowska</span>, <span class="hlFld-ContribAuthor ">Frédéric  Couture</span>, <span class="hlFld-ContribAuthor ">Samia  Ait-Mohand</span>, <span class="hlFld-ContribAuthor ">Roxane  Desjardins</span>, <span class="hlFld-ContribAuthor ">Yves L.  Dory</span>, <span class="hlFld-ContribAuthor ">Brigitte  Guérin</span>, <span class="hlFld-ContribAuthor ">Robert  Day</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-37568-6" title="DOI URL">https://doi.org/10.1038/s41598-018-37568-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-37568-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-37568-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DEnhanced%252Banti-tumor%252Bactivity%252Bof%252Bthe%252BMulti-Leu%252Bpeptide%252BPACE4%252Binhibitor%252Btransformed%252Binto%252Ban%252Balbumin-bound%252Btumor-targeting%252Bprodrug%26aulast%3DKwiatkowska%26aufirst%3DAnna%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Zorzi</span>, <span class="hlFld-ContribAuthor ">Sara  Linciano</span>, <span class="hlFld-ContribAuthor ">Alessandro  Angelini</span>. </span><span class="cited-content_cbyCitation_article-title">Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (7)
                                     , 1068-1081. <a href="https://doi.org/10.1039/C9MD00018F" title="DOI URL">https://doi.org/10.1039/C9MD00018F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00018F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00018F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNon-covalent%252Balbumin-binding%252Bligands%252Bfor%252Bextending%252Bthe%252Bcirculating%252Bhalf-life%252Bof%252Bsmall%252Bbiotherapeutics%26aulast%3DZorzi%26aufirst%3DAlessandro%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D7%26spage%3D1068%26epage%3D1081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Tingting  Meng</span>, <span class="hlFld-ContribAuthor ">Xinyu  Chen</span>, <span class="hlFld-ContribAuthor ">Yue  Han</span>, <span class="hlFld-ContribAuthor ">Junjie  Fu</span>, <span class="hlFld-ContribAuthor ">Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Yingying  Fei</span>, <span class="hlFld-ContribAuthor ">Chenglin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">The chronic administration of two novel long‐acting
              Xenopus
              glucagon‐like peptide‐1 analogs xGLP159 and XGLP296 potently improved systemic metabolism and glycemic control in rodent models. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2019,</strong> <em>33 </em>
                                    (6)
                                     , 7113-7125. <a href="https://doi.org/10.1096/fj.201801479R" title="DOI URL">https://doi.org/10.1096/fj.201801479R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.201801479R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.201801479R%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DThe%252Bchronic%252Badministration%252Bof%252Btwo%252Bnovel%252Blong%2525E2%252580%252590acting%252BXenopus%252Bglucagon%2525E2%252580%252590like%252Bpeptide%2525E2%252580%2525901%252Banalogs%252BxGLP159%252Band%252BXGLP296%252Bpotently%252Bimproved%252Bsystemic%252Bmetabolism%252Band%252Bglycemic%252Bcontrol%252Bin%252Brodent%252Bmodels%26aulast%3DHan%26aufirst%3DJing%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D6%26spage%3D7113%26epage%3D7125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Li</span>, <span class="hlFld-ContribAuthor ">Shijie  Dai</span>, <span class="hlFld-ContribAuthor ">Aijie  Cao</span>, <span class="hlFld-ContribAuthor ">Zhifang  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhimeng  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of rhamnose-modified exenatide conjugate by sortase A-mediated ligation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Carbohydrate Chemistry</span><span> <strong>2019,</strong> <em>38 </em>
                                    (3)
                                     , 167-178. <a href="https://doi.org/10.1080/07328303.2019.1609021" title="DOI URL">https://doi.org/10.1080/07328303.2019.1609021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07328303.2019.1609021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07328303.2019.1609021%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Carbohydrate%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Brhamnose-modified%252Bexenatide%252Bconjugate%252Bby%252Bsortase%252BA-mediated%252Bligation%26aulast%3DLi%26aufirst%3DChen%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D3%26spage%3D167%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Yue  Huang</span>, <span class="hlFld-ContribAuthor ">Xinyu  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Yingying  Fei</span>, <span class="hlFld-ContribAuthor ">Junjie  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Lipidation and conformational constraining for prolonging the effects of peptides: Xenopus glucagon-like peptide 1 analogues with potent and long-acting hypoglycemic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2018,</strong> <em>123 </em>, 111-123. <a href="https://doi.org/10.1016/j.ejps.2018.07.032" title="DOI URL">https://doi.org/10.1016/j.ejps.2018.07.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2018.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2018.07.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DLipidation%252Band%252Bconformational%252Bconstraining%252Bfor%252Bprolonging%252Bthe%252Beffects%252Bof%252Bpeptides%25253A%252BXenopus%252Bglucagon-like%252Bpeptide%252B1%252Banalogues%252Bwith%252Bpotent%252Band%252Blong-acting%252Bhypoglycemic%252Bactivity%26aulast%3DHan%26aufirst%3DJing%26date%3D2018%26volume%3D123%26spage%3D111%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Yue  Huang</span>, <span class="hlFld-ContribAuthor ">Xinyu  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Yingying  Fei</span>, <span class="hlFld-ContribAuthor ">Junjie  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 177-187. <a href="https://doi.org/10.1016/j.ejmech.2018.07.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%252Bof%252Bdimeric%252Blipidated%252BXenopus%252Bglucagon-like%252Bpeptide%252B1%252Banalogues%252Bas%252Blong-acting%252Bantihyperglycaemic%252Bagents%26aulast%3DHan%26aufirst%3DJing%26date%3D2018%26volume%3D157%26spage%3D177%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-wen  Su</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Surface plasmon resonance sensing: from purified biomolecules to intact cells. </span><span class="cited-content_cbyCitation_journal-name">Analytical and Bioanalytical Chemistry</span><span> <strong>2018,</strong> <em>410 </em>
                                    (17)
                                     , 3943-3951. <a href="https://doi.org/10.1007/s00216-018-1008-8" title="DOI URL">https://doi.org/10.1007/s00216-018-1008-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00216-018-1008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00216-018-1008-8%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520and%2520Bioanalytical%2520Chemistry%26atitle%3DSurface%252Bplasmon%252Bresonance%252Bsensing%25253A%252Bfrom%252Bpurified%252Bbiomolecules%252Bto%252Bintact%252Bcells%26aulast%3DSu%26aufirst%3DYu-wen%26date%3D2018%26date%3D2018%26volume%3D410%26issue%3D17%26spage%3D3943%26epage%3D3951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Junjie  Fu</span>, <span class="hlFld-ContribAuthor ">Lidan  Sun</span>, <span class="hlFld-ContribAuthor ">Yue  Han</span>, <span class="hlFld-ContribAuthor ">Qiuyi  Mao</span>, <span class="hlFld-ContribAuthor ">Fang  Liao</span>, <span class="hlFld-ContribAuthor ">Xinshi  Zheng</span>, <span class="hlFld-ContribAuthor ">Ke  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmaceutical characterization of site specific mycophenolic acid-modified
              Xenopus
              glucagon-like peptide-1 analogs. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     , 67-80. <a href="https://doi.org/10.1039/C7MD00471K" title="DOI URL">https://doi.org/10.1039/C7MD00471K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00471K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00471K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bpharmaceutical%252Bcharacterization%252Bof%252Bsite%252Bspecific%252Bmycophenolic%252Bacid-modified%252BXenopus%252Bglucagon-like%252Bpeptide-1%252Banalogs%26aulast%3DHan%26aufirst%3DJing%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D67%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>11</b>: Preparation of Diflunisal for Solid-Phase Peptide Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Strategy for Creating GLP-1 Analogues Containing Small-Molecule Albumin Binders<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(A) Fully protected Boc-[K34R]-GLP-1(7-37)-OH was synthesized by Fmoc-SPPS. Next, Lys26 ε-amine was selectively deprotected and subsequently modified for HSA mono- or divalency. Finally, TFA was used to deprotect- and release GLP-1 analogues <b>3</b>–<b>7</b>. <b>R</b> denotes either of the ligands shown in (B).</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Size exclusion chromatograms of GLP-1 analogues (100 μL, 1 mg/mL) divided into three separate chromatograms; the controls, <b>2</b>, and liraglutide are displayed to the left, monovalent GLP-1 analogues at the center, and divalent <b>6</b> to the right. Compound <b>8</b> was used as an analogue of <b>3</b>. The <i>x</i>-axis marks the retention volume, while the <i>y</i>-axis marks the eluate absorption at 280 nm normalized for clarity. Retention volume and apparent size of molecular markers are depicted by dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HSA interactions with GLP-1 analogues <b>2</b>–<b>7</b>. Sensorgrams were obtained from triple injections of peptides <b>3</b>–<b>7</b> (5–25 μM) and double/triple injections of <b>2</b> (1–100 μM) over a surface of 3555 RU immobilized HSA. Double referencing was used in all experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oral glucose tolerance test on lean mice administered sc with vehicle, liraglutide, <b>4</b>, or <b>6</b>. Each group (<i>n</i> = 7) was dosed at <i>t</i> = −45 min (5 mL/kg, 10 nmol/mL). (left) Blood glucose in mmol/L ± SEM. (right) Area under the curve for the OGTT from 0 to 120 min. Asterisks represents <i>P</i> values below 0.001 derived from a one-way ANOVA analysis with Bonferroni’s posthoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cumulated food intake of mice (g/mouse) administered sc with vehicle or a GLP-1 analogue (5 mL/kg, 10 nmol/mL). (A–C) Three separate experiments. Two-way ANOVA with Bonferroni’s posthoc test was used to compare food intake of treatment groups against the vehicle group. The asterisks *, **, and *** represents <i>P</i> values below or equal to 0.05, 0.01, and 0.001, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Twenty hours of cumulated food intake of mice (g/mouse ± SEM) administered sc with vehicle or a GLP-1 analogue (5 mL/kg, 10 nmol/mL). A one-way ANOVA analysis with Bonferroni’s posthoc test was used to compare treatment groups to the vehicle animals. The asterisks represent <i>P</i> values below or equal to 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/medium/jm-2017-00787h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacokinetic profiles of <b>4</b> and <b>6</b> administered sc in C57bl/6 mice (5 mL/kg, 10 nmol/mL). Each time point equals three mice, and peptide concentrations were measured in triplicate. Error bars are shown when larger than the symbols representing data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00787/20170908/images/large/jm-2017-00787h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00787&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Fasano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galliano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanali, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narciso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascenzi, P.</span><span> </span><span class="NLM_article-title">The Extraordinary Ligand Binding Properties of Human Serum Albumin</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1080/15216540500404093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1080%2F15216540500404093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=16393781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGhtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=787-796&issue=12&author=M.+Fasanoauthor=S.+Curryauthor=E.+Terrenoauthor=M.+Gallianoauthor=G.+Fanaliauthor=P.+Narcisoauthor=S.+Notariauthor=P.+Ascenzi&title=The+Extraordinary+Ligand+Binding+Properties+of+Human+Serum+Albumin&doi=10.1080%2F15216540500404093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The extraordinary ligand binding properties of human serum albumin</span></div><div class="casAuthors">Fasano, Mauro; Curry, Stephen; Terreno, Enzo; Galliano, Monica; Fanali, Gabriella; Narciso, Pasquale; Notari, Stefania; Ascenzi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Human serum albumin (HSA), the most prominent protein in plasma, binds different classes of ligands at multiple sites.  HSA provides a depot for many compds., affects pharmacokinetics of many drugs, holds some ligands in a strained orientation by providing their metabolic modification, renders potential toxins harmless by transporting them to disposal sites, accounts for most of the antioxidant capacity of human serum, and acts as a NO carrier.  The globular domain structural organization of monomeric HSA is at the root of its allosteric properties which are reminiscent of those of multimeric proteins.  Here, structural, functional, biotechnol., and biomedical aspects of ligand binding to HSA are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcmxLuwoq-vrVg90H21EOLACvtfcHk0lgT5cY2tiiihw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGhtbnN&md5=451c58473be47c2561f830fe23c0bd3d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1080%2F15216540500404093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15216540500404093%26sid%3Dliteratum%253Aachs%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DTerreno%26aufirst%3DE.%26aulast%3DGalliano%26aufirst%3DM.%26aulast%3DFanali%26aufirst%3DG.%26aulast%3DNarciso%26aufirst%3DP.%26aulast%3DNotari%26aufirst%3DS.%26aulast%3DAscenzi%26aufirst%3DP.%26atitle%3DThe%2520Extraordinary%2520Ligand%2520Binding%2520Properties%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DIUBMB%2520Life%26date%3D2005%26volume%3D57%26issue%3D12%26spage%3D787%26epage%3D796%26doi%3D10.1080%2F15216540500404093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>Victoza (Liraglutide) EPAR Assessment Report; <span class="NLM_publisher-name">European Medicines Agency</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><a href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016.pdf" class="extLink">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016.pdf</a> (accessed Mar 1, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Victoza+%28Liraglutide%29+EPAR+Assessment+Report%3B+European+Medicines+Agency%3A+London%2C+2009%3B+http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_library%2FEPAR_-_Public_assessment_report%2Fhuman%2F001026%2FWC500050016.pdf+%28accessed+Mar+1%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DVictoza%2520%2528Liraglutide%2529%2520EPAR%2520Assessment%2520Report%26pub%3DEuropean%2520Medicines%2520Agency%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Agersø, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrønd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdravkovic, M.</span><span> </span><span class="NLM_article-title">The Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of NN2211, a New Long-Acting GLP-1 Derivative, in Healthy Men</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1007/s00125-001-0719-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1007%2Fs00125-001-0719-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=195-202&author=H.+Agers%C3%B8author=L.+B.+Jensenauthor=B.+Elbr%C3%B8ndauthor=P.+Rolanauthor=M.+Zdravkovic&title=The+Pharmacokinetics%2C+Pharmacodynamics%2C+Safety+and+Tolerability+of+NN2211%2C+a+New+Long-Acting+GLP-1+Derivative%2C+in+Healthy+Men&doi=10.1007%2Fs00125-001-0719-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00125-001-0719-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-001-0719-z%26sid%3Dliteratum%253Aachs%26aulast%3DAgers%25C3%25B8%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DL.%2BB.%26aulast%3DElbr%25C3%25B8nd%26aufirst%3DB.%26aulast%3DRolan%26aufirst%3DP.%26aulast%3DZdravkovic%26aufirst%3DM.%26atitle%3DThe%2520Pharmacokinetics%252C%2520Pharmacodynamics%252C%2520Safety%2520and%2520Tolerability%2520of%2520NN2211%252C%2520a%2520New%2520Long-Acting%2520GLP-1%2520Derivative%252C%2520in%2520Healthy%2520Men%26jtitle%3DDiabetologia%26date%3D2002%26volume%3D45%26spage%3D195%26epage%3D202%26doi%3D10.1007%2Fs00125-001-0719-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Sleep, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, L. R.</span><span> </span><span class="NLM_article-title">Albumin as a Versatile Platform for Drug Half-Life Extension</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1830</span><span class="NLM_x">, </span> <span class="NLM_fpage">5526</span><span class="NLM_x">–</span> <span class="NLM_lpage">5534</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2013.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.bbagen.2013.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=23639804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=5526-5534&author=D.+Sleepauthor=J.+Cameronauthor=L.+R.+Evans&title=Albumin+as+a+Versatile+Platform+for+Drug+Half-Life+Extension&doi=10.1016%2Fj.bbagen.2013.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin as a versatile platform for drug half-life extension</span></div><div class="casAuthors">Sleep, Darrell; Cameron, Jason; Evans, Leslie R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5526-5534</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Albumin is the most abundant plasma protein, is highly sol., very stable and has an extraordinarily long circulatory half-life as a direct result of its size and interaction with the FcRn mediated recycling pathway.  In contrast, many therapeutic mols. are smaller than the renal filtration threshold and are rapidly lost from the circulation thereby limiting their therapeutic potential.  Albumin can be used in a variety of ways to increase the circulatory half-life of such mols.  This article will review the mechanisms which underpin albumin's extraordinarily long circulatory half-life and how the understanding of these processes are currently being employed to extend the circulatory half-life of drugs which can be engineered to bind to albumin, or are conjugated to, or genetically fused to, albumin.  The recent and growing understanding of the pivotal role of FcRn in maintaining the extended circulatory half-life of albumin will necessitate a greater and more thorough investigation of suitable pre-clin. model systems for assessing the pharmacokinetic profiles of drugs assocd., conjugated or fused to albumin.  Assocn., conjugation or fusion of therapeutic drugs to albumin is a well-accepted and established half-life extension technol.  The manipulation of the albumin-FcRn interaction will facilitate the modulation of the circulatory half-life of albumin-enabled drugs, leading to superior pharmacokinetics tailored to the disease state and increased patient compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExYMlo75ySLVg90H21EOLACvtfcHk0lgT5cY2tiiihw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cjsr4%253D&md5=0e4c382f353eef14774c423dcb3d1963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DSleep%26aufirst%3DD.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DL.%2BR.%26atitle%3DAlbumin%2520as%2520a%2520Versatile%2520Platform%2520for%2520Drug%2520Half-Life%2520Extension%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2013%26volume%3D1830%26spage%3D5526%26epage%3D5534%26doi%3D10.1016%2Fj.bbagen.2013.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ghuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunszain, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitpas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otagiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, S.</span><span> </span><span class="NLM_article-title">Structural Basis of the Drug-Binding Specificity of Human Serum Albumin</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.jmb.2005.07.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.jmb.2005.07.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=16169013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=38-52&author=J.+Ghumanauthor=P.+A.+Zunszainauthor=I.+Petitpasauthor=A.+A.+Bhattacharyaauthor=M.+Otagiriauthor=S.+Curry&title=Structural+Basis+of+the+Drug-Binding+Specificity+of+Human+Serum+Albumin&doi=10.1016%2Fj.jmb.2005.07.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Drug-binding Specificity of Human Serum Albumin</span></div><div class="casAuthors">Ghuman, Jamie; Zunszain, Patricia A.; Petitpas, Isabelle; Bhattacharya, Ananyo A.; Otagiri, Masaki; Curry, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-52</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concns.  The problem of overcoming the binding affinity of lead compds. for HSA represents a major challenge in drug development.  Crystallog. anal. of 17 different complexes of HSA with a wide variety of drugs and small-mol. toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation.  Numerous secondary binding sites for drugs distributed across the protein have also been identified.  The binding of fatty acids, the primary physiol. ligand for the protein, is shown to alter the polarity and increase the vol. of drug site 1.  These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKWUfReJZ-bVg90H21EOLACvtfcHk0lhMfNdin8-N8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensrbJ&md5=d82105920c360292329bf509667df42f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.07.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.07.075%26sid%3Dliteratum%253Aachs%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DZunszain%26aufirst%3DP.%2BA.%26aulast%3DPetitpas%26aufirst%3DI.%26aulast%3DBhattacharya%26aufirst%3DA.%2BA.%26aulast%3DOtagiri%26aufirst%3DM.%26aulast%3DCurry%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520of%2520the%2520Drug-Binding%2520Specificity%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D38%26epage%3D52%26doi%3D10.1016%2Fj.jmb.2005.07.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Rational Design of Diflunisal Analogues with Reduced Affinity for Human Serum Albumin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">10429</span><span class="NLM_x">–</span> <span class="NLM_lpage">10435</span><span class="refDoi"> DOI: 10.1021/ja015955b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja015955b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=10429-10435&issue=5&author=H.+Maoauthor=P.+J.+Hajdukauthor=R.+Craigauthor=R.+Bellauthor=T.+Borreauthor=S.+W.+Fesik&title=Rational+Design+of+Diflunisal+Analogues+with+Reduced+Affinity+for+Human+Serum+Albumin&doi=10.1021%2Fja015955b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja015955b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja015955b%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DR.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DRational%2520Design%2520of%2520Diflunisal%2520Analogues%2520with%2520Reduced%2520Affinity%2520for%2520Human%2520Serum%2520Albumin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26issue%3D5%26spage%3D10429%26epage%3D10435%26doi%3D10.1021%2Fja015955b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Vallianatou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambrinidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantili-Kakoulidou, A.</span><span> </span><span class="NLM_article-title">In Silico Prediction of Human Serum Albumin Binding for Drug Leads</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span><span class="refDoi"> DOI: 10.1517/17460441.2013.777424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1517%2F17460441.2013.777424" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=583-595&issue=5&author=T.+Vallianatouauthor=G.+Lambrinidisauthor=A.+Tsantili-Kakoulidou&title=In+Silico+Prediction+of+Human+Serum+Albumin+Binding+for+Drug+Leads&doi=10.1517%2F17460441.2013.777424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.777424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.777424%26sid%3Dliteratum%253Aachs%26aulast%3DVallianatou%26aufirst%3DT.%26aulast%3DLambrinidis%26aufirst%3DG.%26aulast%3DTsantili-Kakoulidou%26aufirst%3DA.%26atitle%3DIn%2520Silico%2520Prediction%2520of%2520Human%2520Serum%2520Albumin%2520Binding%2520for%2520Drug%2520Leads%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D5%26spage%3D583%26epage%3D595%26doi%3D10.1517%2F17460441.2013.777424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hall, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, L.</span><span> </span><span class="NLM_article-title">Automated Ligand- and Structure-Based Protocol for in Silico Prediction of Human Serum Albumin Binding</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1021/ci3006098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci3006098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=907-922&issue=4&author=M.+L.+Hallauthor=W.+L.+Jorgensenauthor=L.+Whitehead&title=Automated+Ligand-+and+Structure-Based+Protocol+for+in+Silico+Prediction+of+Human+Serum+Albumin+Binding&doi=10.1021%2Fci3006098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Automated Ligand- and Structure-Based Protocol for in Silico Prediction of Human Serum Albumin Binding</span></div><div class="casAuthors">Hall, Michelle Lynn; Jorgensen, William L.; Whitehead, Lewis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-922</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasma protein binding has a profound impact on the pharmacokinetic and pharmacodynamic properties of many drug candidates and is thus an integral component of drug discovery.  Nevertheless, extant methods to examine small-mol. interactions with plasma protein have various limitations, thus creating a need for alternative methods.  Herein we present a comprehensive and cross-validated in silico workflow for the prediction of small-mol. binding to Human Serum Albumin (HSA), the most ubiquitous plasma protein.  This protocol reliably predicts small-mol. interactions with HSA, including a binding affinity calcn. using multiple linear regression methods, binding site prediction using a naive-Bayes classifier, and a three-dimensional binding pose using induced fit docking.  Furthermore, this workflow is implemented in a portable and automated format that can be downloaded and used by other end users, either as is or with customization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZSdhuCTKGibVg90H21EOLACvtfcHk0lhMfNdin8-N8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSntrg%253D&md5=d43e145e07ec4fb2dc114a03568aabe4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fci3006098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3006098%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%2BL.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DWhitehead%26aufirst%3DL.%26atitle%3DAutomated%2520Ligand-%2520and%2520Structure-Based%2520Protocol%2520for%2520in%2520Silico%2520Prediction%2520of%2520Human%2520Serum%2520Albumin%2520Binding%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26issue%3D4%26spage%3D907%26epage%3D922%26doi%3D10.1021%2Fci3006098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zhivkova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doytchinova, I.</span><span> </span><span class="NLM_article-title">Quantitative Structure—Plasma Protein Binding Relationships of Acidic Drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4627</span><span class="NLM_x">–</span> <span class="NLM_lpage">4641</span><span class="refDoi"> DOI: 10.1002/jps.23303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2Fjps.23303" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=4627-4641&issue=12&author=Z.+Zhivkovaauthor=I.+Doytchinova&title=Quantitative+Structure%E2%80%94Plasma+Protein+Binding+Relationships+of+Acidic+Drugs&doi=10.1002%2Fjps.23303"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjps.23303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23303%26sid%3Dliteratum%253Aachs%26aulast%3DZhivkova%26aufirst%3DZ.%26aulast%3DDoytchinova%26aufirst%3DI.%26atitle%3DQuantitative%2520Structure%25E2%2580%2594Plasma%2520Protein%2520Binding%2520Relationships%2520of%2520Acidic%2520Drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26issue%3D12%26spage%3D4627%26epage%3D4641%26doi%3D10.1002%2Fjps.23303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caris, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paasch, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, R. a.</span><span> </span><span class="NLM_article-title">Albumin Affinity Tags Increase Peptide Half-Life in Vivo</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">2883</span><span class="NLM_x">–</span> <span class="NLM_lpage">2886</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00610-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2FS0960-894X%2802%2900610-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2883-2886&issue=20&author=M.+F.+T.+Koehlerauthor=K.+Zobelauthor=M.+H.+Beresiniauthor=L.+D.+Carisauthor=D.+Combsauthor=B.+D.+Paaschauthor=R.+a.+Lazarus&title=Albumin+Affinity+Tags+Increase+Peptide+Half-Life+in+Vivo&doi=10.1016%2FS0960-894X%2802%2900610-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900610-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900610-8%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DCaris%26aufirst%3DL.%2BD.%26aulast%3DCombs%26aufirst%3DD.%26aulast%3DPaasch%26aufirst%3DB.%2BD.%26aulast%3DLazarus%26aufirst%3DR.%2Ba.%26atitle%3DAlbumin%2520Affinity%2520Tags%2520Increase%2520Peptide%2520Half-Life%2520in%2520Vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D20%26spage%3D2883%26epage%3D2886%26doi%3D10.1016%2FS0960-894X%2802%2900610-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caris, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D.</span><span> </span><span class="NLM_article-title">Phosphate Ester Serum Albumin Affinity Tags Greatly Improve Peptide Half-Life in Vivo</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00209-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2FS0960-894X%2803%2900209-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1513-1515&issue=9&author=K.+Zobelauthor=M.+F.+T.+Koehlerauthor=M.+H.+Beresiniauthor=L.+D.+Carisauthor=D.+Combs&title=Phosphate+Ester+Serum+Albumin+Affinity+Tags+Greatly+Improve+Peptide+Half-Life+in+Vivo&doi=10.1016%2FS0960-894X%2803%2900209-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900209-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900209-9%26sid%3Dliteratum%253Aachs%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DCaris%26aufirst%3DL.%2BD.%26aulast%3DCombs%26aufirst%3DD.%26atitle%3DPhosphate%2520Ester%2520Serum%2520Albumin%2520Affinity%2520Tags%2520Greatly%2520Improve%2520Peptide%2520Half-Life%2520in%2520Vivo%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D9%26spage%3D1513%26epage%3D1515%26doi%3D10.1016%2FS0960-894X%2803%2900209-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Novel Dicoumarol Glucagon-like Peptide 1 Conjugates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">9955</span><span class="NLM_x">–</span> <span class="NLM_lpage">9968</span><span class="refDoi"> DOI: 10.1021/jm4017448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9955-9968&issue=24&author=J.+Hanauthor=L.+Sunauthor=Y.+Chuauthor=Z.+Liauthor=D.+Huangauthor=X.+Zhuauthor=H.+Qianauthor=W.+Huang&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Novel+Dicoumarol+Glucagon-like+Peptide+1+Conjugates&doi=10.1021%2Fjm4017448"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm4017448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017448%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Novel%2520Dicoumarol%2520Glucagon-like%2520Peptide%25201%2520Conjugates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D24%26spage%3D9955%26epage%3D9968%26doi%3D10.1021%2Fjm4017448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dumelin, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trüssel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachsel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bootz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannocci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumea-Mirancea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeliger, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müggler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melkko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, D.</span><span> </span><span class="NLM_article-title">A Portable Albumin Binder from a DNA-Encoded Chemical Library</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">3196</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span><span class="refDoi"> DOI: 10.1002/anie.200704936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2Fanie.200704936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=3196-3201&issue=17&author=C.+E.+Dumelinauthor=S.+Tr%C3%BCsselauthor=F.+Bullerauthor=E.+Trachselauthor=F.+Bootzauthor=Y.+Zhangauthor=L.+Mannocciauthor=S.+C.+Beckauthor=M.+Drumea-Miranceaauthor=M.+W.+Seeligerauthor=C.+Baltesauthor=T.+M%C3%BCgglerauthor=F.+Kranzauthor=M.+Rudinauthor=S.+Melkkoauthor=J.+Scheuermannauthor=D.+Neri&title=A+Portable+Albumin+Binder+from+a+DNA-Encoded+Chemical+Library&doi=10.1002%2Fanie.200704936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A portable albumin binder from a DNA-encoded chemical library</span></div><div class="casAuthors">Dumelin, Christoph E.; Truessel, Sabrina; Buller, Fabian; Trachsel, Eveline; Bootz, Frank; Zhang, Yixin; Mannocci, Luca; Beck, Susanne C.; Drumea-Mirancea, Mihaela; Seeliger, Mathias W.; Baltes, Christof; Mueggler, Thomas; Kranz, Felicitas; Rudin, Markus; Melkko, Samu; Scheuermann, Joerg; Neri, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3196-3201</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Seeing eye to eye: Plasma-protein binding is effective in improving the pharmacokinetic properties of otherwise short-lived mols.  One compd. in a class of small portable albumin binders can be used to improve the in vivo circulatory half-life of two widely used contrast agents.  It improves the imaging performance of fluorescein in angiog. anal. of the retina of mice (see picture).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDJqApTpDdrVg90H21EOLACvtfcHk0ljdDXAijUcaJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVWqtLw%253D&md5=d3f010e006b5c8e8292f43f3935d8762</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.200704936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200704936%26sid%3Dliteratum%253Aachs%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DTr%25C3%25BCssel%26aufirst%3DS.%26aulast%3DBuller%26aufirst%3DF.%26aulast%3DTrachsel%26aufirst%3DE.%26aulast%3DBootz%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMannocci%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DDrumea-Mirancea%26aufirst%3DM.%26aulast%3DSeeliger%26aufirst%3DM.%2BW.%26aulast%3DBaltes%26aufirst%3DC.%26aulast%3DM%25C3%25BCggler%26aufirst%3DT.%26aulast%3DKranz%26aufirst%3DF.%26aulast%3DRudin%26aufirst%3DM.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DScheuermann%26aufirst%3DJ.%26aulast%3DNeri%26aufirst%3DD.%26atitle%3DA%2520Portable%2520Albumin%2520Binder%2520from%2520a%2520DNA-Encoded%2520Chemical%2520Library%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26issue%3D17%26spage%3D3196%26epage%3D3201%26doi%3D10.1002%2Fanie.200704936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span> </span><span class="NLM_article-title">Coumaglutide, a Novel Long-Acting GLP-1 Analog, Inhibits β-Cell Apoptosis in Vitro and Invokes Sustained Glycemic Control in Vivo</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">767</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.ejphar.2015.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=26481165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=767&publication_year=2015&pages=211-219&author=L.+Sunauthor=C.+Wangauthor=Y.+Daiauthor=Y.+Chuauthor=J.+Hanauthor=J.+Zhouauthor=X.+Caiauthor=W.+Huangauthor=H.+Qian&title=Coumaglutide%2C+a+Novel+Long-Acting+GLP-1+Analog%2C+Inhibits+%CE%B2-Cell+Apoptosis+in+Vitro+and+Invokes+Sustained+Glycemic+Control+in+Vivo&doi=10.1016%2Fj.ejphar.2015.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Coumaglutide, a novel long-acting GLP-1 analog, inhibits β-cell apoptosis in vitro and invokes sustained glycemic control in vivo</span></div><div class="casAuthors">Sun, Lidan; Wang, Chuandong; Dai, Yuxuan; Chu, Yingying; Han, Jing; Zhou, Jie; Cai, Xingguang; Huang, Wenlong; Qian, Hai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">767</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glucagon-like peptide-1 (GLP-1) is a potential candidate for the treatment of type 2 diabetes.  However, native GLP-1 is not suitable for therapy of diabetes due to its short half-life (t1/2=2 min).  Our recent discovery of the novel long-acting GLP-1 analog, coumaglutide, elicits favorable hypoglycemic effects.  The present study was aimed at detg. the protection effect of β-cell from apoptosis and in vivo pharmacol. properties of coumaglutide in diabetic mice.  To det. the protective effect of coumaglutide on INS-1 cell viability and apoptosis, cells were exposed to 1 μM streptozotocin (STZ) and coumaglutide for 24 h.  Moreover, STZ-induced diabetic mice were treated daily with coumaglutide for 20 days and a range of pharmacol. parameters, including Hb A1c (HbA1C), i.p. glucose tolerance, food intake and body wt. were assessed before and after the treatment.  As with other glucagon-like peptide-1 receptor agonists, coumaglutide was able to protect β-cell from apoptosis in vitro and induce a durable restoration of glycemic control (normalization of both HbA1C and improvement of i.p. glucose tolerance) in diabetic mice.  It can be concluded that coumaglutide retains native GLP-1 activities and thus may serve as a promising hypoglycemic drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukJ7QBRMtlbVg90H21EOLACvtfcHk0ljdDXAijUcaJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWhsrfE&md5=46ddcf01590ae6c64d4ddad5ea0adc0f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DH.%26atitle%3DCoumaglutide%252C%2520a%2520Novel%2520Long-Acting%2520GLP-1%2520Analog%252C%2520Inhibits%2520%25CE%25B2-Cell%2520Apoptosis%2520in%2520Vitro%2520and%2520Invokes%2520Sustained%2520Glycemic%2520Control%2520in%2520Vivo%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D767%26spage%3D211%26epage%3D219%26doi%3D10.1016%2Fj.ejphar.2015.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Brabez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayasundera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chassaing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Multivalent Interactions: Synthesis and Evaluation of Melanotropin Multimers - Tools for Melanoma Targeting</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1021/ml300312b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300312b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=98-102&issue=1&author=N.+Brabezauthor=K.+Saundersauthor=K.+L.+Nguyenauthor=T.+Jayasunderaauthor=C.+Weberauthor=R.+M.+Lynchauthor=G.+Chassaingauthor=S.+Lavielleauthor=V.+J.+Hruby&title=Multivalent+Interactions%3A+Synthesis+and+Evaluation+of+Melanotropin+Multimers+-+Tools+for+Melanoma+Targeting&doi=10.1021%2Fml300312b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml300312b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300312b%26sid%3Dliteratum%253Aachs%26aulast%3DBrabez%26aufirst%3DN.%26aulast%3DSaunders%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DK.%2BL.%26aulast%3DJayasundera%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DR.%2BM.%26aulast%3DChassaing%26aufirst%3DG.%26aulast%3DLavielle%26aufirst%3DS.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DMultivalent%2520Interactions%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Melanotropin%2520Multimers%2520-%2520Tools%2520for%2520Melanoma%2520Targeting%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D1%26spage%3D98%26epage%3D102%26doi%3D10.1021%2Fml300312b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huusfeldt, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thøgersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agersø, H.</span><span> </span><span class="NLM_article-title">Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1669</span><span class="refDoi"> DOI: 10.1021/jm9909645</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9909645" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1664-1669&issue=9&author=L.+B.+Knudsenauthor=P.+F.+Nielsenauthor=P.+O.+Huusfeldtauthor=N.+L.+Johansenauthor=K.+Madsenauthor=F.+Z.+Pedersenauthor=H.+Th%C3%B8gersenauthor=M.+Wilkenauthor=H.+Agers%C3%B8&title=Potent+Derivatives+of+Glucagon-like+Peptide-1+with+Pharmacokinetic+Properties+Suitable+for+Once+Daily+Administration&doi=10.1021%2Fjm9909645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration</span></div><div class="casAuthors">Knudsen, Lotte B.; Nielsen, Per F.; Huusfeldt, Per O.; Johansen, Nils L.; Madsen, Kjeld; Pedersen, Freddy Z.; Thogersen, Henning; Wilken, Michael; Agerso, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1664-1669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of very potent derivs. of the 30-amino acid peptide hormone glucagon-like peptide-1 (GLP-1) is described.  The compds. were all derivatized with fatty acids in order to protract their action by facilitating binding to serum albumin. GLP-1 had a potency (EC50) of 55 pM for the cloned human GLP-1 receptor.  Many of the compds. had similar or even higher potencies, despite quite large substituents.  All compds. derivatized with fatty acids equal to or longer than 12 carbon atoms were very protracted compared to GLP-1 and thus seem suitable for once daily administration to type 2 diabetic patients.  A structure-activity relationship was obtained. GLP-1 could be derivatized with linear fatty acids up to the length of 16 carbon atoms, sometimes longer, almost anywhere in the C-terminal part without considerable loss of potency.  Derivatization with two fatty acid substituents led to a considerable loss of potency.  A structure-activity relationship on derivatization of specific amino acids generally was obtained.  It was found that the longer the fatty acid, the more potency was lost.  Simultaneous modification of the N-terminus (in order to obtain better metabolic stability) interfered with fatty acid derivatization and led to loss of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_iyZt3E6tG7Vg90H21EOLACvtfcHk0li8NASAHQMOqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D&md5=d050c27dd6aea795191798254e2bf080</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm9909645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9909645%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DHuusfeldt%26aufirst%3DP.%2BO.%26aulast%3DJohansen%26aufirst%3DN.%2BL.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DPedersen%26aufirst%3DF.%2BZ.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DAgers%25C3%25B8%26aufirst%3DH.%26atitle%3DPotent%2520Derivatives%2520of%2520Glucagon-like%2520Peptide-1%2520with%2520Pharmacokinetic%2520Properties%2520Suitable%2520for%2520Once%2520Daily%2520Administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D9%26spage%3D1664%26epage%3D1669%26doi%3D10.1021%2Fjm9909645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Finan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habegger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriever, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Cáceres, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabra, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembree, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irmler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauvais-Jarvis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tilve, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfluger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarchi, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschöp, M. H.</span><span> </span><span class="NLM_article-title">Supplementary Information, Targeted Estrogen Delivery Reverses the Metabolic Syndrome</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1847</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span><span class="refDoi"> DOI: 10.1038/nm.3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1038%2Fnm.3009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=23142820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1847-1856&issue=12&author=B.+Finanauthor=B.+Yangauthor=N.+Ottawayauthor=K.+Stemmerauthor=T.+D.+M%C3%BCllerauthor=C.-X.+Yiauthor=K.+Habeggerauthor=S.+C.+Schrieverauthor=C.+Garc%C3%ADa-C%C3%A1ceresauthor=D.+G.+Kabraauthor=J.+Hembreeauthor=J.+Hollandauthor=C.+Raverauthor=R.+J.+Seeleyauthor=W.+Hansauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+H.+de+Angelisauthor=J.+P.+Tianoauthor=F.+Mauvais-Jarvisauthor=D.+Perez-Tilveauthor=P.+Pflugerauthor=L.+Zhangauthor=V.+Gelfanovauthor=R.+D.+DiMarchiauthor=M.+H.+Tsch%C3%B6p&title=Supplementary+Information%2C+Targeted+Estrogen+Delivery+Reverses+the+Metabolic+Syndrome&doi=10.1038%2Fnm.3009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted estrogen delivery reverses the metabolic syndrome</span></div><div class="casAuthors">Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; Hrabe de Angelis, Martin; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacol. while eliminating adverse effects in other tissues.  Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice.  The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metab., as shown by loss-of-function models and genetic action profiling.  Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity.  Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism.  This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small mols.  Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small mols. may offer equal promise for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQGspuH3IemrVg90H21EOLACvtfcHk0li8NASAHQMOqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F&md5=7c080cb982964af88163a9c505d0ee83</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnm.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3009%26sid%3Dliteratum%253Aachs%26aulast%3DFinan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOttaway%26aufirst%3DN.%26aulast%3DStemmer%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DYi%26aufirst%3DC.-X.%26aulast%3DHabegger%26aufirst%3DK.%26aulast%3DSchriever%26aufirst%3DS.%2BC.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1ceres%26aufirst%3DC.%26aulast%3DKabra%26aufirst%3DD.%2BG.%26aulast%3DHembree%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DRaver%26aufirst%3DC.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGelfanov%26aufirst%3DV.%26aulast%3DDiMarchi%26aufirst%3DR.%2BD.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DSupplementary%2520Information%252C%2520Targeted%2520Estrogen%2520Delivery%2520Reverses%2520the%2520Metabolic%2520Syndrome%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26issue%3D12%26spage%3D1847%26epage%3D1856%26doi%3D10.1038%2Fnm.3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sudlow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D. N.</span><span> </span><span class="NLM_article-title">The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">824</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1207674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADyaE28XmvFahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1975&pages=824-832&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=The+Characterization+of+Two+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of two specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">824-32</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The binding of a no. of fluorescent probe mols. to human serum albumin (HSA) has been studied.  Small changes in the amino acid moiety of the dansylamino acids resulted in large changes in the binding of these compds. to HSA.  It is suggested that electrostatic and dipolar forces play a role in the specificity and binding affinity of such compds.  Fluorescent probes which had 1 tight binding site were used for drug displacement studies.  Changes in probe fluorescence were shown, by equil. dialysis and by fluorescence titrations, to be a result of competitive displacement by drugs.  The pattern of displacement of probes by drugs enabled the identification of 2 specific drug binding sites.  The relative affinity of drugs for these binding sites was measured by their ability to displace fluorescent probes specific for the sites.  The method provides a rapid and simple means for detecting potential drug interactions based on competition for protein binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrEH3wzJ0z6LVg90H21EOLACvtfcHk0ljA8CdVIoyfMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFahsQ%253D%253D&md5=a13e1d6d3d0f4dd004d08d62e7b89613</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DThe%2520Characterization%2520of%2520Two%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1975%26volume%3D11%26spage%3D824%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sudlow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D. N.</span><span> </span><span class="NLM_article-title">Further Characterization of Specific Drug Binding Sites on Human Serum Albumin</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1004490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1976&pages=1052-1061&author=G.+Sudlowauthor=D.+J.+Birkettauthor=D.+N.+Wade&title=Further+Characterization+of+Specific+Drug+Binding+Sites+on+Human+Serum+Albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of specific drug binding sites on human serum albumin</span></div><div class="casAuthors">Sudlow, G.; Birkett, D. J.; Wade, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1052-61</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The fluorescent probes, 5-dimethylaminonaphthalene-1-sulfonamide (I) [1431-39-6] and dansylsarcosine [1093-96-5] function as specific markers for 2 distinct binding sites for anionic drugs on human serum albumin (HSA).  The binding of drugs to site I or II was detected by measuring the displacement of these probes.  The results give an indication of some of the structural features required for binding at these sites.  Stearic acid [57-11-4] binding to HSA induced different conformational changes in the albumin at sites I and II, which were detected by changes in the fluorescence and/or strength of binding of probes specific for the 2 sites.  This provides further evidence for qual. differences between the 2 sites.  The specificity of the sites for particular drugs, even at high drug to albumin ratios, was established, and the specificity and characteristics of the 2 sites on human adult and neonatal sera were shown to be similar to those on cryst. HSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZMQN1NBrHM7Vg90H21EOLACvtfcHk0ljA8CdVIoyfMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXjslCqsA%253D%253D&md5=5286ae0da826f2764eb595b22361fe80</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudlow%26aufirst%3DG.%26aulast%3DBirkett%26aufirst%3DD.%2BJ.%26aulast%3DWade%26aufirst%3DD.%2BN.%26atitle%3DFurther%2520Characterization%2520of%2520Specific%2520Drug%2520Binding%2520Sites%2520on%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1976%26volume%3D12%26spage%3D1052%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kragh-Hansen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, V. T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otagiri, M.</span><span> </span><span class="NLM_article-title">Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">June</span><span class="NLM_x">) </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span><span class="refDoi"> DOI: 10.1248/bpb.25.695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1248%2Fbpb.25.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=12081132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=695-704&issue=June&author=U.+Kragh-Hansenauthor=V.+T.+G.+Chuangauthor=M.+Otagiri&title=Practical+Aspects+of+the+Ligand-Binding+and+Enzymatic+Properties+of+Human+Serum+Albumin&doi=10.1248%2Fbpb.25.695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Practical aspects of the ligand-binding and enzymatic properties of human serum albumin</span></div><div class="casAuthors">Kragh-Hansen, Ulrich; Chuang, Victor Tuan Giam; Otagiri, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-704</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Recent work with approaches like recombinant mutants and x-ray crystallog. has given much new information about the ligand-binding properties of human serum albumin (HSA).  The information increases the understanding of this unique transport and depot protein and could give a structural basis for the possible construction of therapeutic agents with altered HSA-binding properties.  A tabulation of high-affinity binding sites for both endogenous and exogenous compds. has been made; it could be useful for the above-mentioned purpose, but it could also be of value when trying to predict potential drug interactions at the protein-binding level.  Drug displacement is not always a complication to therapy; it can be used to increase the biol. effect of a drug.  However, due to rebinding at other sites, the increase in the free concn. of a displaced ligand can be less than expected.  Drugs and drug metabolites can also interact covalently with HSA; thiol-contg. drugs often bind to the single free cysteine residue of HSA, and glucuronidated drugs react irreversibly with other residues of the protein.  Reversible binding of ligands is often stereospecific, and therefore immobilized HSA can be used to sep. drug isomers.  Albumin-contg. dialyzates are useful for extracorporeal removal of endogenous toxins and in the treatment of drug overdoses.  HSA has different types of hydrolytic activities, which also can be stereospecific.  The esterase-like property seems esp. useful in converting prodrugs to active drugs in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrmebO3fPwI7Vg90H21EOLACvtfcHk0ljA8CdVIoyfMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2hu7s%253D&md5=8de11b4e2c17851a6a69485437ab2cb1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1248%2Fbpb.25.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.25.695%26sid%3Dliteratum%253Aachs%26aulast%3DKragh-Hansen%26aufirst%3DU.%26aulast%3DChuang%26aufirst%3DV.%2BT.%2BG.%26aulast%3DOtagiri%26aufirst%3DM.%26atitle%3DPractical%2520Aspects%2520of%2520the%2520Ligand-Binding%2520and%2520Enzymatic%2520Properties%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2002%26volume%3D25%26issue%3DJune%26spage%3D695%26epage%3D704%26doi%3D10.1248%2Fbpb.25.695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, H.</span><span> </span><span class="NLM_article-title">Interactive Associations of Drug-Drug and Drug-Drug-Drug with Iia Subdomain of Human Serum Albumin</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">3259</span><span class="NLM_x">–</span> <span class="NLM_lpage">3265</span><span class="refDoi"> DOI: 10.1021/mp300322y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300322y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2rtrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=3259-3265&issue=11&author=F.+Yangauthor=J.+Yueauthor=L.+Maauthor=Z.+Maauthor=M.+Liauthor=X.+Wuauthor=H.+Liang&title=Interactive+Associations+of+Drug-Drug+and+Drug-Drug-Drug+with+Iia+Subdomain+of+Human+Serum+Albumin&doi=10.1021%2Fmp300322y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Interactive Associations of Drug-Drug and Drug-Drug-Drug with IIA Subdomain of Human Serum Albumin</span></div><div class="casAuthors">Yang, Feng; Yue, Jiping; Ma, Li; Ma, Zhiyuan; Li, Mei; Wu, Xiaoyang; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3259-3265</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Owing to advantageous biochem. and pharmacol. properties of human serum albumin (HSA), HSA-based drug carrier is playing an increasing role in the clin. setting.  Since the IIA subdomain of HSA is a big hydrophobic cavity, we proposed that HSA delivers multiple drugs simultaneously docking on the IIA subdomain and that drugs may influence each other's binding affinity to albumin when cobinding the HSA IIA subdomain.  Therefore, we studied the interactive assocn. of drugs with the IIA subdomain of HSA by fluorescence spectroscopy and X-ray crystallog., in order to elucidate the mol. mechanism and behavior of drugs cobinding the IIA subdomain of HSA, and develop a universal structure-based model for HSA carrier design.  We solved HSA-fatty acid-cinnamic acid, HSA-fatty acid-cinnamic acid-indomethacin and HSA-fatty acid-cinnamic acid-indomethacin-lamivudine complex structures, resp.  HSA complex structures and fluorescence quenching of HSA revealed that different drugs can regulate binding sites, binding mode and binding affinity of each other.  For example, indomethacin renders cinnamic acid to make reposition, and decreases binding affinity of HSA for cinnamic acid, but increases binding affinity of itself to HSA.  Lamivudine makes cinnamic acid and indomethacin to bind new subsites.  Cinnamic acid-indomethacin enhances binding affinity of lamivudine, and cinnamic acid-lamivudine increases binding affinity of indomethacin, but indomethacin-lamivudine decreases binding affinity of cinnamic acid to HSA.  The study provided a biochem. basis for structure-guided development of HSA delivery system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgnqaryPC5-7Vg90H21EOLACvtfcHk0ljfFNEs8EVD-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2rtrnM&md5=a5e8ae79b334ddaec4ce1041ac771cac</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fmp300322y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300322y%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DYue%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DInteractive%2520Associations%2520of%2520Drug-Drug%2520and%2520Drug-Drug-Drug%2520with%2520Iia%2520Subdomain%2520of%2520Human%2520Serum%2520Albumin%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26issue%3D11%26spage%3D3259%26epage%3D3265%26doi%3D10.1021%2Fmp300322y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hüll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebich, B. L.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Drugs: A Hope for Alzheimer’s Disease?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1517/13543784.9.4.671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1517%2F13543784.9.4.671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=671-683&issue=4&author=M.+H%C3%BCllauthor=K.+Liebauthor=B.+L.+Fiebich&title=Anti-Inflammatory+Drugs%3A+A+Hope+for+Alzheimer%E2%80%99s+Disease%3F&doi=10.1517%2F13543784.9.4.671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.4.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.4.671%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCll%26aufirst%3DM.%26aulast%3DLieb%26aufirst%3DK.%26aulast%3DFiebich%26aufirst%3DB.%2BL.%26atitle%3DAnti-Inflammatory%2520Drugs%253A%2520A%2520Hope%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26issue%3D4%26spage%3D671%26epage%3D683%26doi%3D10.1517%2F13543784.9.4.671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Haworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilling, A.</span><span> </span><span class="NLM_article-title">Differential Expression of COX-1 and COX-2 in the Gastrointestinal Tract of the Rat</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1080/01926230590906512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1080%2F01926230590906512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=15902967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1yksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=239-245&author=R.+Haworthauthor=K.+Oakleyauthor=N.+McCormackauthor=A.+Pilling&title=Differential+Expression+of+COX-1+and+COX-2+in+the+Gastrointestinal+Tract+of+the+Rat&doi=10.1080%2F01926230590906512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Expression of COX-1 and COX-2 in the Gastrointestinal Tract of the Rat</span></div><div class="casAuthors">Haworth, Richard; Oakley, Keli; McCormack, Nicola; Pilling, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-245</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The aim of this study was to use immunohistochem. with morphometry to investigate COX-1 and COX-2 expression in the normal rat gastrointestinal (GI) tract and examine if sites of ulceration previously obsd. with long-term COX-2 inhibitor administration in mice correlate with differential COX-1/COX-2 expression.  COX-2 pos. cells were obsd. predominantly in the apical lamina propria of intestinal villi with fewer cells in the mucosal epithelium.  The highest level of COX-2 expression was obsd. at the ileocaecal junction (ICJ).  COX-2 expression was also present in parasympathetic ganglia of the submucosa and muscularis.  In the stomach, the highest grade of COX-2 expression was obsd. in the apical lamina propria of the fundus adjacent to the junctional ridge.  In contrast, COX-1 pos. cells within the lamina propria were evenly distributed along the GI tract but were present in higher nos. than COX-2 pos. cells.  The mean level of COX-1 expression at the ICJ was not significantly different from the ileum and caecum.  Evidence that the highest level of COX-2 expression in normal rats is located on the ileal side of the ICJ provides the first mechanism to explain spontaneous ulceration and perforation of the distal ileum in COX-2-/-animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogBkRkZ9O9krVg90H21EOLACvtfcHk0ljfFNEs8EVD-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1yksg%253D%253D&md5=54a4e4087a7a4a2693fe7176e0dbaaff</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F01926230590906512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230590906512%26sid%3Dliteratum%253Aachs%26aulast%3DHaworth%26aufirst%3DR.%26aulast%3DOakley%26aufirst%3DK.%26aulast%3DMcCormack%26aufirst%3DN.%26aulast%3DPilling%26aufirst%3DA.%26atitle%3DDifferential%2520Expression%2520of%2520COX-1%2520and%2520COX-2%2520in%2520the%2520Gastrointestinal%2520Tract%2520of%2520the%2520Rat%26jtitle%3DToxicol.%2520Pathol.%26date%3D2005%26volume%3D33%26spage%3D239%26epage%3D245%26doi%3D10.1080%2F01926230590906512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Finan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habegger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriever, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Cáceres, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabra, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembree, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irmler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauvais-Jarvis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tilve, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfluger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarchi, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschöp, M. H.</span><span> </span><span class="NLM_article-title">Targeted Estrogen Delivery Reverses the Metabolic Syndrome</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1847</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span><span class="refDoi"> DOI: 10.1038/nm.3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1038%2Fnm.3009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=23142820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1847-1856&issue=12&author=B.+Finanauthor=B.+Yangauthor=N.+Ottawayauthor=K.+Stemmerauthor=T.+D.+M%C3%BCllerauthor=C.-X.+Yiauthor=K.+Habeggerauthor=S.+C.+Schrieverauthor=C.+Garc%C3%ADa-C%C3%A1ceresauthor=D.+G.+Kabraauthor=J.+Hembreeauthor=J.+Hollandauthor=C.+Raverauthor=R.+J.+Seeleyauthor=W.+Hansauthor=M.+Irmlerauthor=J.+Beckersauthor=M.+H.+de+Angelisauthor=J.+P.+Tianoauthor=F.+Mauvais-Jarvisauthor=D.+Perez-Tilveauthor=P.+Pflugerauthor=L.+Zhangauthor=V.+Gelfanovauthor=R.+D.+DiMarchiauthor=M.+H.+Tsch%C3%B6p&title=Targeted+Estrogen+Delivery+Reverses+the+Metabolic+Syndrome&doi=10.1038%2Fnm.3009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted estrogen delivery reverses the metabolic syndrome</span></div><div class="casAuthors">Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; Hrabe de Angelis, Martin; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacol. while eliminating adverse effects in other tissues.  Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice.  The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metab., as shown by loss-of-function models and genetic action profiling.  Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity.  Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism.  This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small mols.  Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small mols. may offer equal promise for other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQGspuH3IemrVg90H21EOLACvtfcHk0lh_Yj3XKdsuVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CktL7F&md5=7c080cb982964af88163a9c505d0ee83</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm.3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3009%26sid%3Dliteratum%253Aachs%26aulast%3DFinan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOttaway%26aufirst%3DN.%26aulast%3DStemmer%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DYi%26aufirst%3DC.-X.%26aulast%3DHabegger%26aufirst%3DK.%26aulast%3DSchriever%26aufirst%3DS.%2BC.%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1ceres%26aufirst%3DC.%26aulast%3DKabra%26aufirst%3DD.%2BG.%26aulast%3DHembree%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DRaver%26aufirst%3DC.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DIrmler%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DTiano%26aufirst%3DJ.%2BP.%26aulast%3DMauvais-Jarvis%26aufirst%3DF.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGelfanov%26aufirst%3DV.%26aulast%3DDiMarchi%26aufirst%3DR.%2BD.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DTargeted%2520Estrogen%2520Delivery%2520Reverses%2520the%2520Metabolic%2520Syndrome%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26issue%3D12%26spage%3D1847%26epage%3D1856%26doi%3D10.1038%2Fnm.3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span>Victoza (Liraglutide) Full Prescription Information; <span class="NLM_publisher-name">Nordisk Novo A/S</span>: <span class="NLM_publisher-loc">Bagsvaerd, Denmark</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span><a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022341lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022341lbl.pdf</a> (accessed Feb 22, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Victoza+%28Liraglutide%29+Full+Prescription+Information%3B+Nordisk+Novo+A%2FS%3A+Bagsvaerd%2C+Denmark%2C+2010%3B+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2010%2F022341lbl.pdf+%28accessed+Feb+22%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DVictoza%2520%2528Liraglutide%2529%2520Full%2520Prescription%2520Information%26pub%3DNordisk%2520Novo%2520A%252FS%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span>Indocin (Indomethacin) Oral Suspension; <span class="NLM_publisher-name">IROKO Pharmaceuticals, LLC</span>: <span class="NLM_publisher-loc">Philadelphia</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018332s032lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018332s032lbl.pdf</a> (accessed Jan 22, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Indocin+%28Indomethacin%29+Oral+Suspension%3B+IROKO+Pharmaceuticals%2C+LLC%3A+Philadelphia%2C+2008%3B+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2009%2F018332s032lbl.pdf+%28accessed+Jan+22%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DIndocin%2520%2528Indomethacin%2529%2520Oral%2520Suspension%26pub%3DIROKO%2520Pharmaceuticals%252C%2520LLC%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span>Dolobid (Diflunisal) Tablets; <span class="NLM_publisher-name">Merck & Co. Inc.</span>: <span class="NLM_publisher-loc">Whitehouse Station, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span><a href="http://www.accessdata.fda.gov/drugsatfda_docs/.../018445s058lbl.pdf" class="extLink">www.accessdata.fda.gov/drugsatfda_docs/2007/018445s058lbl.pdf</a> (accessed Feb 22, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dolobid+%28Diflunisal%29+Tablets%3B+Merck+%26+Co.+Inc.%3A+Whitehouse+Station%2C+NJ%2C+2007%3B+www.accessdata.fda.gov%2Fdrugsatfda_docs%2F2007%2F018445s058lbl.pdf+%28accessed+Feb+22%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDolobid%2520%2528Diflunisal%2529%2520Tablets%26pub%3DMerck%2520%2526%2520Co.%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Laue, T.; Plagens, A.</span><span> </span><span class="NLM_article-title">Williamson Ether Synthesis</span>. In  <span class="citation_source-book">Named Organic Reactions</span>; <span class="NLM_publisher-name">John Wiley and Sons, Ltd</span>: <span class="NLM_publisher-loc">Chichester, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2F0470010428.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=19-49&author=T.+Laue&author=A.+Plagens&title=Named+Organic+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F0470010428.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470010428.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DLaue%26aufirst%3DT.%26atitle%3DWilliamson%2520Ether%2520Synthesis%26btitle%3DNamed%2520Organic%2520Reactions%26pub%3DJohn%2520Wiley%2520and%2520Sons%252C%2520Ltd%26date%3D2005%26spage%3D19%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Steensgaard, D. B.; Thomsen, J. K.; Olsen, H. B.; Knudsen, L. B.</span><span> </span><span class="NLM_article-title">The Molecular Basis for the Delayed Absorption of the Once-Daily Human GLP-1 Analog, Liraglutide</span>.  In Diabetes: American Diabetes Association’s (ADA) 68th Scientific Sessions, San Francisco, 2008,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">57</span>, p  <span class="NLM_fpage">A157</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=A157&author=D.+B.+Steensgaard&author=J.+K.+Thomsen&author=H.+B.+Olsen&author=L.+B.+Knudsen&title=The+Molecular+Basis+for+the+Delayed+Absorption+of+the+Once-Daily+Human+GLP-1+Analog%2C+Liraglutide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26atitle%3DThe%2520Molecular%2520Basis%2520for%2520the%2520Delayed%2520Absorption%2520of%2520the%2520Once-Daily%2520Human%2520GLP-1%2520Analog%252C%2520Liraglutide%26jtitle%3DDiabetes%253A%2520American%2520Diabetes%2520Association%25E2%2580%2599s%2520%2528ADA%2529%252068th%2520Scientific%2520Sessions%252C%2520San%2520Francisco%252C%25202008%26date%3D2008%26volume%3D57%26spage%3DA157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">Grading the Commercial Optical Biosensor Literature-Class of 2008: “The Mighty Binders.</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1002/jmr.1004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1002%2Fjmr.1004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=20017116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2it7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=1-64&issue=1&author=R.+L.+Richauthor=D.+G.+Myszka&title=Grading+the+Commercial+Optical+Biosensor+Literature-Class+of+2008%3A+%E2%80%9CThe+Mighty+Binders.&doi=10.1002%2Fjmr.1004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Grading the commercial optical biosensor literature-Class of 2008: The Mighty Binders'</span></div><div class="casAuthors">Rich, Rebecca L.; Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-64</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Optical biosensor technol. continues to be the method of choice for label-free, real-time interaction anal.  But when it comes to improving the quality of the biosensor literature, education should be fundamental.  Of the 1413 articles published in 2008, less than 30% would pass the requirements for high-school chem.  To teach by example, we spotlight 10 papers that illustrate how to implement the technol. properly.  Then we grade every paper published in 2008 on a scale from A to F and outline what features make a biosensor article fabulous, middling or abysmal.  To help improve the quality of published data, we focus on a few exptl., anal. and presentation mistakes that are alarmingly common.  With the literature as a guide, we want to ensure that no user is left behind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEHOQqiaPHALVg90H21EOLACvtfcHk0liRoEsSLxo38w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2it7nK&md5=e24281c83d0524eeeec82e0f18bf06fc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fjmr.1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.1004%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DGrading%2520the%2520Commercial%2520Optical%2520Biosensor%2520Literature-Class%2520of%25202008%253A%2520%25E2%2580%259CThe%2520Mighty%2520Binders.%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2010%26volume%3D23%26issue%3D1%26spage%3D1%26epage%3D64%26doi%3D10.1002%2Fjmr.1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Jonassen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havelund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeg-Jensen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensgaard, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlund, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribel, U.</span><span> </span><span class="NLM_article-title">Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2104</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span><span class="refDoi"> DOI: 10.1007/s11095-012-0739-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1007%2Fs11095-012-0739-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=22485010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC38XltF2jsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2104-2114&issue=8&author=I.+Jonassenauthor=S.+Havelundauthor=T.+Hoeg-Jensenauthor=D.+B.+Steensgaardauthor=P.+O.+Wahlundauthor=U.+Ribel&title=Design+of+the+Novel+Protraction+Mechanism+of+Insulin+Degludec%2C+an+Ultra-Long-Acting+Basal+Insulin&doi=10.1007%2Fs11095-012-0739-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin</span></div><div class="casAuthors">Jonassen, Ib; Havelund, Svend; Hoeg-Jensen, Thomas; Steensgaard, Dorte Bjerre; Wahlund, Per-Olof; Ribel, Ulla</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2104-2114</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Basal insulins with improved kinetic properties can potentially be produced using acylation by fatty acids that enable sol., high-mol. wt. complexes to form post-injection.  A series of insulins, acylated at B29 with fatty acids via glutamic acid spacers, were examd. to deduce the structural requirements.  Methods: Self-assocn., mol. masses and hexameric conformations of the insulins were studied using size exclusion chromatog. monitored by UV or multi-angle light scattering and dynamic light scattering, and CD spectroscopy (CDS) in environments (changing phenol and zinc concn.) simulating a pharmaceutical formulation and changes following s.c. injection.  Results: With depletion of phenol, insulin degludec and another fatty diacid-insulin analog formed high mol. mass filament-like complexes, which disintegrated with depletion of zinc.  CDS showed these analogs adopting stable T3R3 conformation in presence of phenol and zinc, changing to T6 with depletion of phenol.  These findings suggest insulin degludec is dihexameric in pharmaceutical formulation becoming multihexameric after injection.  The analogs showed weak dimeric assocn., indicating rapid release of monomers following hexamer disassembly.  Conclusions: Insulins can be engineered that remain sol. but become highly self-assocd. after injection, slowly releasing monomers; this is critically dependent on the acylation moiety.  One such analog, insulin degludec, has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7r6MuzFE1K7Vg90H21EOLACvtfcHk0liRoEsSLxo38w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltF2jsrc%253D&md5=32352bc327770e3c54bae7f3277329fe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0739-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0739-z%26sid%3Dliteratum%253Aachs%26aulast%3DJonassen%26aufirst%3DI.%26aulast%3DHavelund%26aufirst%3DS.%26aulast%3DHoeg-Jensen%26aufirst%3DT.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DWahlund%26aufirst%3DP.%2BO.%26aulast%3DRibel%26aufirst%3DU.%26atitle%3DDesign%2520of%2520the%2520Novel%2520Protraction%2520Mechanism%2520of%2520Insulin%2520Degludec%252C%2520an%2520Ultra-Long-Acting%2520Basal%2520Insulin%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26issue%3D8%26spage%3D2104%26epage%3D2114%26doi%3D10.1007%2Fs11095-012-0739-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Younis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen-Jones, D.</span><span> </span><span class="NLM_article-title">Insulin Glargine: A New Basal Insulin Analogue</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span><span class="refDoi"> DOI: 10.1345/aph.1A301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1345%2Faph.1A301" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=1019-1027&author=N.+Younisauthor=H.+Soranauthor=D.+Bowen-Jones&title=Insulin+Glargine%3A+A+New+Basal+Insulin+Analogue&doi=10.1345%2Faph.1A301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1345%2Faph.1A301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1A301%26sid%3Dliteratum%253Aachs%26aulast%3DYounis%26aufirst%3DN.%26aulast%3DSoran%26aufirst%3DH.%26aulast%3DBowen-Jones%26aufirst%3DD.%26atitle%3DInsulin%2520Glargine%253A%2520A%2520New%2520Basal%2520Insulin%2520Analogue%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2002%26volume%3D36%26spage%3D1019%26epage%3D1027%26doi%3D10.1345%2Faph.1A301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agersoe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thøgersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, N. L.</span><span> </span><span class="NLM_article-title">Structure-Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives: Importance of Fatty Acid Length, Polarity, and Bulkiness</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6132</span><span class="refDoi"> DOI: 10.1021/jm070861j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070861j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KisbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6126-6132&issue=24&author=K.+Madsenauthor=L.+B.+Knudsenauthor=H.+Agersoeauthor=P.+F.+Nielsenauthor=H.+Th%C3%B8gersenauthor=M.+Wilkenauthor=N.+L.+Johansen&title=Structure-Activity+and+Protraction+Relationship+of+Long-Acting+Glucagon-like+Peptide-1+Derivatives%3A+Importance+of+Fatty+Acid+Length%2C+Polarity%2C+and+Bulkiness&doi=10.1021%2Fjm070861j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity and Protraction Relationship of Long-Acting Glucagon-like Peptide-1 Derivatives: Importance of Fatty Acid Length, Polarity, and Bulkiness</span></div><div class="casAuthors">Madsen, Kjeld; Knudsen, Lotte Bjerre; Agersoe, Henrik; Nielsen, Per Franklin; Thogersen, Henning; Wilken, Michael; Johansen, Nils Langeland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6126-6132</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We here report a series of derivs. describing the structure-activity relation around liraglutide, a once-daily human glucagon-like peptide-1 fatty acid deriv., with respect to potency as well as protraction in vivo.  The spacer region between the fatty acid and the peptide is mostly important for potency, whereas the fatty acid or fatty acid mimetic is important for both potency and protraction.  The length of the fatty acid is the most important parameter for protraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosAuWJXGV4jrVg90H21EOLACvtfcHk0lhdcNVgv2YH0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KisbnJ&md5=ded10166177422e5e318b767205eb8c9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070861j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070861j%26sid%3Dliteratum%253Aachs%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DAgersoe%26aufirst%3DH.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DN.%2BL.%26atitle%3DStructure-Activity%2520and%2520Protraction%2520Relationship%2520of%2520Long-Acting%2520Glucagon-like%2520Peptide-1%2520Derivatives%253A%2520Importance%2520of%2520Fatty%2520Acid%2520Length%252C%2520Polarity%252C%2520and%2520Bulkiness%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D24%26spage%3D6126%26epage%3D6132%26doi%3D10.1021%2Fjm070861j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäffer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spetzler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofoed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensgaard, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thygesen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reedtz-Runge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, T.</span><span> </span><span class="NLM_article-title">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7370</span><span class="NLM_x">–</span> <span class="NLM_lpage">7380</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00726</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00726" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7370-7380&issue=18&author=J.+Lauauthor=P.+Blochauthor=L.+Sch%C3%A4fferauthor=I.+Petterssonauthor=J.+Spetzlerauthor=J.+Kofoedauthor=K.+Madsenauthor=L.+B.+Knudsenauthor=J.+McGuireauthor=D.+B.+Steensgaardauthor=H.+M.+Straussauthor=D.+X.+Gramauthor=S.+M.+Knudsenauthor=F.+S.+Nielsenauthor=P.+Thygesenauthor=S.+Reedtz-Rungeauthor=T.+Kruse&title=Discovery+of+the+Once-Weekly+Glucagon-Like+Peptide-1+%28GLP-1%29+Analogue+Semaglutide&doi=10.1021%2Facs.jmedchem.5b00726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span></div><div class="casAuthors">Lau, Jesper; Bloch, Paw; Schaffer, Lauge; Pettersson, Ingrid; Spetzler, Jane; Kofoed, Jacob; Madsen, Kjeld; Knudsen, Lotte Bjerre; McGuire, James; Steensgaard, Dorte Bjerre; Strauss, Holger Martin; Gram, Dorte X.; Knudsen, Sanne Moeller; Nielsen, Flemming Seier; Thygesen, Peter; Reedtz-Runge, Steffen; Kruse, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7370-7380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analog that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity.  The aim of the present studies was to design a once weekly GLP-1 analog by increasing albumin affinity and secure full stability against metabolic degrdn.  The fatty acid moiety and the linking chem. to GLP-1 were the key features to secure high albumin affinity and GLP-1 receptor (GLP-1R) potency and in obtaining a prolonged exposure and action of the GLP-1 analog.  Semaglutide was selected as the optimal once weekly candidate.  Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26.  The GLP-1R affinity of semaglutide (0.38 ± 0.06 nM) was three-fold decreased compared to liraglutide, whereas the albumin affinity was increased.  The plasma half-life was 46.1 h in mini-pigs following i.v. administration, and semaglutide has an MRT of 63.6 h after s.c. dosing to mini-pigs.  Semaglutide is currently in phase 3 clin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tFc0FzEro7Vg90H21EOLACvtfcHk0lhdcNVgv2YH0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM&md5=0478fe17f9f4dcc0cb58919b1c55869a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00726%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DBloch%26aufirst%3DP.%26aulast%3DSch%25C3%25A4ffer%26aufirst%3DL.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DSpetzler%26aufirst%3DJ.%26aulast%3DKofoed%26aufirst%3DJ.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DMcGuire%26aufirst%3DJ.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DStrauss%26aufirst%3DH.%2BM.%26aulast%3DGram%26aufirst%3DD.%2BX.%26aulast%3DKnudsen%26aufirst%3DS.%2BM.%26aulast%3DNielsen%26aufirst%3DF.%2BS.%26aulast%3DThygesen%26aufirst%3DP.%26aulast%3DReedtz-Runge%26aufirst%3DS.%26aulast%3DKruse%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520the%2520Once-Weekly%2520Glucagon-Like%2520Peptide-1%2520%2528GLP-1%2529%2520Analogue%2520Semaglutide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7370%26epage%3D7380%26doi%3D10.1021%2Facs.jmedchem.5b00726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Russell-Jones, D.</span><span> </span><span class="NLM_article-title">Molecular, Pharmacological and Clinical Aspects of Liraglutide, a Once-Daily Human GLP-1 Analogue</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.mce.2008.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2Fj.mce.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=19041364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=137-140&author=D.+Russell-Jones&title=Molecular%2C+Pharmacological+and+Clinical+Aspects+of+Liraglutide%2C+a+Once-Daily+Human+GLP-1+Analogue&doi=10.1016%2Fj.mce.2008.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular, pharmacological and clinical aspects of Liraglutide, a once-daily human GLP-1 analogue</span></div><div class="casAuthors">Russell-Jones, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">137-140</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Liraglutide, a human glucagon-like peptide 1 (GLP-1) analog with high homol. to native GLP-1, has structural modifications sufficient to amend pharmacokinetics for once-daily administration without compromising biol. activity.  Data from large, controlled, clin. studies have confirmed the therapeutic profile of Liraglutide, with robust redns. in HbA1c, low risk of hypoglycemia and clin. relevant redns. in body wt. and systolic blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowKOB67do2d7Vg90H21EOLACvtfcHk0lgYOlsYmn7vsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73I&md5=f69909ac99dde6cfcd765e0c046b9e13</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DRussell-Jones%26aufirst%3DD.%26atitle%3DMolecular%252C%2520Pharmacological%2520and%2520Clinical%2520Aspects%2520of%2520Liraglutide%252C%2520a%2520Once-Daily%2520Human%2520GLP-1%2520Analogue%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D297%26spage%3D137%26epage%3D140%26doi%3D10.1016%2Fj.mce.2008.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Deryabina, M. A.; Daugaard, J. R.; Knudsen, C. B.; Shelton, P. T.; Fog, J. U.; Jessen, L.; Noerregaard, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and Pharmacodynamics of GLP-1-GIP Receptor Dual Agonist Peptides: From Once-Daily to Once-Weekly</span>. In Integrated Physiology - Other Hormones: The American Diabetes Association’s (ADA) 75th Scientific Sessions, Boston, 2015,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">2086-P</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=2086-P&author=M.+A.+Deryabina&author=J.+R.+Daugaard&author=C.+B.+Knudsen&author=P.+T.+Shelton&author=J.+U.+Fog&author=L.+Jessen&author=P.+Noerregaard&title=Pharmacokinetics+and+Pharmacodynamics+of+GLP-1-GIP+Receptor+Dual+Agonist+Peptides%3A+From+Once-Daily+to+Once-Weekly"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDeryabina%26aufirst%3DM.%2BA.%26atitle%3DPharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520GLP-1-GIP%2520Receptor%2520Dual%2520Agonist%2520Peptides%253A%2520From%2520Once-Daily%2520to%2520Once-Weekly%26jtitle%3DIntegrated%2520Physiology%2520-%2520Other%2520Hormones%253A%2520The%2520American%2520Diabetes%2520Association%25E2%2580%2599s%2520%2528ADA%2529%252075th%2520Scientific%2520Sessions%252C%2520Boston%252C%25202015%26date%3D2015%26spage%3D2086-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Tofteng Shelton, P.; J. Jensen, K.</span><span> </span><span class="NLM_article-title">Linkers, Resins, and General Procedures for Solid-Phase Peptide Synthesis</span>. In  <span class="citation_source-book">Peptide Synthesis and Applications</span>; <span class="NLM_contrib-group">J. Jensen, K.; Tofteng Shelton, P.; L. Pedersen, S.</span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1007%2F978-1-62703-544-6_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=23-43&author=P.+Tofteng+Shelton&author=K.+J.+Jensenauthor=K.+J.+Jensen&author=P.+Tofteng+Shelton&author=S.+L.+Pedersen&title=Peptide+Synthesis+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-544-6_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-62703-544-6_2%26sid%3Dliteratum%253Aachs%26aulast%3DTofteng%2BShelton%26aufirst%3DP.%26atitle%3DLinkers%252C%2520Resins%252C%2520and%2520General%2520Procedures%2520for%2520Solid-Phase%2520Peptide%2520Synthesis%26btitle%3DPeptide%2520Synthesis%2520and%2520Applications%26aulast%3DJ.%2BJensen%26aufirst%3DK.%26pub%3DHumana%2520Press%26date%3D2013%26spage%3D23%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Mathiesen, J. M.; Vedel, L.; Bräuner-Osborne, H.</span><span> </span><span class="NLM_article-title">cAMP Biosensors Applied in Molecular Pharmacological Studies of G Protein-Coupled Receptors</span>. In  <span class="citation_source-book">Methods Enzymol.</span>. <span class="NLM_contrib-group">Pyle, A. M.; Christianson, D. W.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">522</span>, pp  <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1016%2FB978-0-12-407865-9.00011-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=191-207&author=J.+M.+Mathiesen&author=L.+Vedel&author=H.+Br%C3%A4uner-Osborneauthor=A.+M.+Pyle&author=D.+W.+Christianson&title=Methods+Enzymol."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-407865-9.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-407865-9.00011-X%26sid%3Dliteratum%253Aachs%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26atitle%3DcAMP%2520Biosensors%2520Applied%2520in%2520Molecular%2520Pharmacological%2520Studies%2520of%2520G%2520Protein-Coupled%2520Receptors%26btitle%3DMethods%2520Enzymol.%26aulast%3DPyle%26aufirst%3DA.%2BM.%26pub%3DElsevier%26date%3D2013%26volume%3D522%26spage%3D191%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">High-Resolution and High-Throughput Protocols for Measuring Drug/human Serum Albumin Interactions Using BIACORE</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1006/abio.2001.5314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=10.1006%2Fabio.2001.5314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=11554715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms12rsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2001&pages=197-207&author=R.+L.+Richauthor=Y.+S.+Dayauthor=T.+A.+Mortonauthor=D.+G.+Myszka&title=High-Resolution+and+High-Throughput+Protocols+for+Measuring+Drug%2Fhuman+Serum+Albumin+Interactions+Using+BIACORE&doi=10.1006%2Fabio.2001.5314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution and High-Throughput Protocols for Measuring Drug/Human Serum Albumin Interactions Using BIACORE</span></div><div class="casAuthors">Rich, Rebecca L.; Day, Yasmina S. N.; Morton, Thomas A.; Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Characterizing how chem. compds. bind to human serum albumin (HSA) is essential in evaluating drug candidates.  Using warfarin as a test system, we validate the application of BIACORE SPR biosensors to reliably det. binding consts. for drug/HSA interactions.  The binding responses for warfarin over HSA surfaces were extremely reproducible even though warfarin is small compared to the size of the immobilized protein.  At high concns., warfarin bound at more than one site on HSA, which is consistent with its known binding properties.  The affinity we detd. for the high-affinity site (K25°Cd = 3.7±1.2 μM), as well as the dissocn. rate const. (k25°Cd = 1.2 s-1), are also consistent with binding consts. detd. previously.  These results validate the biosensor technol. and illustrate how BIACORE can be used to study drug/HSA interactions in a high-resoln. mode.  Using a set of 10 test compds., we present a protocol for detg. equil. dissocn. consts. for HSA in a high-throughput mode.  Our method involves working at low compd. concns. and fitting the equil. data for all compds. simultaneously.  We show that the % bound values detd. by SPR correlate with the values detd. by soln.-based methods.  The ability to examine directly the binding of small mols. (130-800 Da), coupled with minimal sample requirements and automated instrumentation, makes BIACORE technol. applicable for evaluating drug/HSA interactions.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol1RkwlH6QBbVg90H21EOLACvtfcHk0lhDTtiOITr4EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms12rsLg%253D&md5=2a6ec9d23dd6a2c54db703b546cdf2b9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5314%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DDay%26aufirst%3DY.%2BS.%26aulast%3DMorton%26aufirst%3DT.%2BA.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DHigh-Resolution%2520and%2520High-Throughput%2520Protocols%2520for%2520Measuring%2520Drug%252Fhuman%2520Serum%2520Albumin%2520Interactions%2520Using%2520BIACORE%26jtitle%3DAnal.%2520Biochem.%26date%3D2001%26volume%3D296%26spage%3D197%26epage%3D207%26doi%3D10.1006%2Fabio.2001.5314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00787">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82231"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00787">10.1021/acs.jmedchem.7b00787</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">LCMS chromatograms and HRMS of peptides, structure of compound <b>8</b>, SEC calibration data, in vivo activity curves from the functional screening experiments, and information regarding the synthesis of <b>15</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00787/suppl_file/jm7b00787_si_001.pdf">jm7b00787_si_001.pdf (903.14 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00787&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00787%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00787" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a1d4e9945d1a3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
